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This thesis attempts to investigate the effect of an urban walking environment 
on postural control, using tri-axial accelerometers, while walking in healthy 
individuals and individuals with vestibular disorders or stroke. This thesis also 
investigates illness behaviour, using illness behaviour questionnaire (IBQ) in 
individuals with vestibular disorder or vestibular migraine.  
The first two studies (Chapter 2 and Chapter 3) of the current thesis explored 
the effectiveness of use of accelerometers in measuring upper body stability 
control when walking in real urban environment for healthy individuals and 
individuals with a vestibular disorder or stroke. The findings of the current study 
showed that accelerometers can be used to measure gait and balance 
impairment particularly in outdoor settings i.e. urban walking environment. The 
findings demonstrated that accelerometers were able to differentiate the 
postural strategies utilised by people with a vestibular disorder or stroke 
compared to healthy controls. More specifically, both patient groups employed 
compensatory mechanisms including reduced walking speed and reduced trunk 
accelerations in order to maintain postural stability during gait in urban 
environments. However, greater AP head accelerations were noted in patients 
with stroke, indicating that stroke patients have difficulties stabilizing their head 
in space during walk in urban environment. In addition, mobilising on uneven 
surfaces had greatest effect and induced head instability particularly in ML 
direction in patients with vestibular disorders and in the AP direction (the 
direction of progression) in patients with stroke. These results indicate that 
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walking in an urban environment provides challenges to postural stability control 
in people with vestibular disorders or stroke. 
The final study (Chapter 4) of the thesis investigated the pattern of illness 
behaviour by using illness behaviour questionnaire (IBQ) in patients with 
vestibular impairment including vestibular migraine. Findings of this study 
showed that the IBQ can be used to differentiate illness behaviour patterns 
between patients with vestibular disorders including vestibular migraine and 
healthy controls. Patients with vestibular migraine show a significantly greater 
fear concern about their health status, disease conviction, dysphoria and 
irritability which suggested the global aspects of abnormal illness behaviour. In 
addition greater anxiety and depression level were also noted in people with 
migraine.   
Overall, the three studies in the current thesis present novel findings and open 
up to further exciting areas of research aiming at intervention options for 
patients with vestibular disorders, vestibular migraine or stroke. Investigation of 
patient's functional mobility in real environment and the examination of patient's 
illness behaviour associated with their vestibular impairment may provide a 
critical way to identify and  better understand factors that could hinder some 
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CHAPTER 1  GENERAL INTRODUCTION 
 
1.1 Overview of adult human locomotion 
Human locomotion has been described as an ability of a person to move from 
one place to another and manifests in many ways including walking, running or 
jumping. Walking provides the basic foundation of independent mobility in most 
activities of daily living (ADL) in humans and 'gait' is the term used to describe a 
particular manner or style of walking. Understanding of the basic mechanism 
and requirement for successful gait are essential to identify any potential threat 
such as fall during gait.  
The human gait cycle, defined as a single sequence function of one limb, 
consists of the stance and swing phases. Stance phase is the time during which 
the limb is in contact with the ground, while  the swing phase denotes the time 
when the same limb lifts off the ground and swing forward towards the 
anticipated landing position. This cyclic movement pattern is repeated over and 
over with an assumption that successive cycles are all about the same. During 
the stance phase, the supporting limb is in a state of receiving body weight 
(weight acceptance) as the person‘s body weight immediately transfers onto the 
limb as soon as the opposite limb moves forward in the direction of progression 
(Kirtley, 2006). During the swing phase, the same supporting limb is lifted off the 
ground and swing forward to the anticipated landing surface. It begins 
immediately after toe-off and ends once the foot touch the ground again (heel 
contact). At the end of the swing phase, the foot is positioned for weight bearing 
and muscles stabilize the body to absorb shock of heel contact (Kirtley, 2006).  
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At heel contact the swing phase ends and a new gait cycle begins.  An adult's 
typical gait cycle consists of 60% stance and 40 % swing phase (Perry, 1992) 
however the phase proportions change as walking speed increases or decrease 
(Andriacchi et al., 1977).   
Approximately two-third of a person‘s total body mass is located in the head-
arms-trunk (HAT) segment. During gait HAT mass progresses in a hypothetical 
line of progression and is balanced over the moving lower limbs. This causes 
the body‘s centre of gravity to frequently be located outside the base of support 
(feet) thus introducing a continuous state of imbalance during gait (Jian et al., 
1993, Lugade et al., 2011). The ability of one's body to effectively balance the 
HAT mass over the lower extremities through coordination of joints and body 
segments motion specifically within pelvic, knee and ankle, provides smooth 
forward progression of the CoM and postural control during gait (Kepple et al., 
1997).  
A systematic and synchronised interaction between various systems and 
subsystems is crucial for successful gait where goal-directed continuous 
movement and maintenance of balance (postural control) needs to be executed 
simultaneously. This could be achieved through a contribution from both 
neurological and non-neurological aspects. Neurological aspects include the 
central pattern generator (CPG), descending motor pathway, sensory feedback 
and cognitive system (MacKay-Lyons, 2002, Takakusaki et al., 2008, Jahn and 
Zwergal, 2010, Woollacott and Shumway-Cook, 2002, Yang and Gorassini, 
2006, Nielsen, 2003), whereas non-neural aspects are musculoskeletal and 
environmental contributions (Shumway-Cook et al., 2002, Fraix, 2012, Sadeghi 
et al., 2000). Interruption to these systems due to pathology or aging could 
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affect the dynamic stability and functional gait (Dietz, 2002, Jonkers et al., 2009, 
Schrager et al., 2008, Lamontagne et al., 2007b, Shkuratova et al., 2004) 
1.2 Requirements for successful gait 
1.2.1 Rhythmic patterns of gait 
The existence of neural networks in the spinal cord producing rhythmic 
movements such as walking, hopping and swimming, even when isolated from 
brain and sensory inputs, have been widely observed in animals (Rossignol, 
1996, MacKay-Lyons, 2002). These specialised neural circuits known as central 
pattern generators (CPG) and the existence of CPG in human spinal cord was 
also noted (MacKay-Lyons, 2002). A study using electrical stimulation of the 
posterior structures of the second lumbar segment in complete paraplegics 
elicited locomotor-like EMG and flexor movement in the lower limbs, this finding 
suggests that human spinal circuitry is capable to generate locomotor-like 
activity even in the absence of input from brain (Dimitrijevic et al., 1998).  
 
Although CPG is capable of generating a rhythmic gait pattern, input from 
supraspinal levels and sensory systems are important for effective locomotor 
behaviour. Sensory afferents involved in muscle and cutaneous reflexes have 
important regulatory functions in preserving balance and ensuring stable phase 
transitions in the locomotor cycle (Rossignol et al., 2006). Supraspinal inputs 
are important in initiating locomotion and in adapting gait patterns in response 
to environmental perturbations (Yang and Gorassini, 2006, Nielsen, 2003).  
 
1.2.2 Postural control 
Postural control refers to the ability to maintain body stability and orientation in 
space (Horak, 2006). Postural orientation is an ability to maintain appropriate 
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alignment between body segments and appropriate relationship between the 
body and the environment. While postural stability is an ability to control the 
body‘s centre of gravity in relation to the base of support (Horak, 2006). 
Postural control is a complex motor skill derived from multiple sensorimotor 
integration (Peterka, 2002). 
Gait would introduce greater challenges to the postural control system 
compared to quiet stance because postural stability needs to be continuously 
and  accurately adjusted according to environmental changes and task 
demands (Winter, 1995, Pozzo et al., 1995).  
Sensory information from vestibular, somatosensory and visual system must be 
integrated to interpret complex sensory environments and to provide information 
about head and body orientation in relation to gravity or space. Musculoskeletal 
component provides appropriate posture alignment, adequate joint range of 
movement and muscle tone. Ideal alignment during stance alignment allow 
minimal muscular effort to  maintain the upright position. Adequate muscle 
strength is important to generate sufficient muscle force to counteract the force 
of gravity while loss of joint range movement can limit the ways in which a 
person can move for postural control (Shumway-Cook and Woollacott, 2007).  
Healthy person should be able to use three different movement strategies to 
recover from postural instability due to perturbations (Horak et al., 1997).  When 
a person is exposed to a slow and small amount of sway, an ankle strategy is 
used in which the body moves primarily at the ankle as a flexible inverted 
pendulum. A hip strategy is used when a person is exposed to a larger and 
faster perturbations in which ankle rotational  forces are insufficient to maintain 
postural stability (Buchanan and Horak, 1999). When both ankle and hip 
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strategies not sufficiently recover stability, step is taken to prevent body from 
falling. Taking a step to recover imbalance is common during gait in which the 
centre of gravity commonly moved forward beyond the body limit of stability. 
1.2.3 Adaptation according to task and environment 
One of requirement of successful locomotion is the ability to adapt gait to a 
wide-range of environmental conditions. The central nervous system (CNS) 
must continuously anticipate and counteract any destabilising forces result from 
the locomotion activity. For example, when a person walk from a level onto 
inclined walking surface (such as a ramp), limb trajectory and body posture 
need to be modified to ensure safe toe clearance and foot placement as the 
elevation and orientation of the support surface changes. Inappropriate body 
segments movement can adversely affect dynamic stability (Prentice et al., 
2004).  
Central nervous system uses information from sensory systems to detect any 
destabilising forces such as a slip or a trip, and trigger stabilizing reactions 
(reactive strategies) and also proactively modify gait patterns in advance to 
avoid obstacles that threaten balance (Marigold and Patla, 2005). Prior 
experience with a perturbation helps subsequent modification of postural 
responses and allow safe locomotion in complex environmental condition 
(Marigold and Patla, 2002). 
Shumway-Cook and colleagues (2003, 2002) highlighted the effect of 
environment on functional limitation. In these studies, the authors suggest that 
physical environment dimensions such as terrain, ambient conditions (light and 
weather conditions), distance etc.  play a significant role in mediating the 
relationship between functional limitations related to walking and the 
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development of mobility disability. An ability to dynamically re-weigh sensory 
inputs relative to environmental changes, is important for postural stability 
control (Horak and Macpherson, 2010), for example when a person moves from 
a well-lit to a dimly lit sidewalk. Previous studies have demonstrated relative 
contributions of sensory systems under altered sensory environment on 
postural control in healthy individuals (Peterka and Loughlin, 2004, Oie et al., 
2002, Kuo et al., 1998). Sensory reweighting has been shown reduced due to 
ageing, sensory system and CNS impairment (i.e. stroke, Parkinson's Disease) 
(Peterka and Black, 1990, Woollacott et al., 1986). 
Although studies have demonstrated the importance of gait adaptability to task 
and environmental demands, most of the studies have focused on gait analysis 
in a well-controlled indoor setting (Pozzo et al., 1995; Horak and Macpherson, 
2010, Marigold and Patla, 2002). The indoor setting may not reflect to the true 
picture of difficulty faced by patients when they are navigating in real 
environment where constant adjustment to postural stability control is required 
when walking in a crowd, crossing obstacles and road, avoid bumping into 
people and scanning environment for navigational and safety purpose.  
Standard clinical outcome measures for example functional walk tests, are 
commonly  conducted  in a well-controlled indoor setting and the outcomes 
mainly focus on walking speed and distance covered during gait in which 
commonly short distance walked in indoor setting (Iosa et al., 2012c, Eng et al., 
2002). However this is different from being able to navigate complex 
environments which usually involves longer walking distance and requires gait 
adaptation according to environmental (walking on cobbled pathway vs. level 
ground) and task demands (carrying a shopping bag). This requirement is 
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crucial for community ambulation particularly in patients with sensory or CNS 
impairment (Lord et al., 2006).  
 
1.2.4 Cognitive factors 
There is considerable evidence of cognitive function contribution to the 
regulation of gait and postural stability particularly in older adults (Alexander 
and Hausdorff, 2008, Woollacott and Shumway-Cook, 2002, Yogev-Seligmann 
et al., 2008). Safe ambulation may require a specific cognitive contribution e.g. 
executive function (EF) and reduced cognitive function has been shown to be 
associated with increased gait instability and risk of falls (Montero-Odasso et 
al., 2012, Yogev-Seligmann et al., 2008, Mirelman et al., 2012). Executive 
function consists of a set of high-level cognitive domains (e.g. cognitive 
ﬂexibility, inhibition control, problem solving, planning) that are necessary to 
plan, initiate, execute, and monitor goal-directed behaviour through regulation of 
basic cognitive abilities and attentional resources (Yogev-Seligman et al., 
2008).   
Walking in an everyday environment (i.e. local high street) which is often 
complex requires a person to pay attention to various environmental features 
and potential threats to postural perturbation. A person may continually needs 
to adapt his/her gait patterns in negotiating obstacles, change progression 
direction or  re-plan a navigation path (Frank and Patla, 2003). Moreover, a 
person may require to execute additional task concurrently e.g. walk and talk, 
walk and reading a sign board.  Ability to divide attention between tasks and 
give prioritisation to the more important task (commonly referred as the posture 
first strategy) is important, particularly in public where the ability to negotiate 
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competing/interfering demands from environment are dominant. Appropriate 
prioritization helps to prevent loss of balance (Shumway-Cook et al., 1997). 
Reduced gait speed is commonly observed in healthy adults when they are 
required to perform a secondary task (Yogev-Seligmann et al., 2008, Woollacott 
and Shumway-Cook, 2002). The effects of divided attention are more evident in 
condition where a locomotor task is challenged (i.e. obstacle course) 
(Weerdesteyn et al., 2003) and/or in other population e.g. patients population 
(Bessot et al., 2012, Yogev-Seligmann et al., 2008) or older adults (Harley et 
al., 2009, Dubost et al., 2006). Study has also shown that higher cognitive 
function i.e. cognitive shifting and flexibility contribute significantly in curve path 
navigation which further support increased cognitive demands during complex 
gait (Lowry et al., 2012). 
 
1.3 Gait impairments 
Gait is a critical component of many activities of daily living that are necessary 
for independent life. Some studies have identified functional status including 
self-care, mobility, and the capacity to perform various family and work roles as 
predictor of decrement in health related quality of life (HRQOL) in patients with 
gait impairment e.g. stroke, Parkinson Disease (Ellis et al., 2011, Marras et al., 
2008, Carod-Artal et al., 2000). Particularly, functional assessment items related 
to postural instability and gait limitation appears to have a strong relationship 
with HRQOL (Ellis et al., 2011, Marras et al., 2008). 
Impairments of the spatio-temporal, kinetic and/or kinematic aspects of gait 
commonly occur as a result of damage to the sensory, nervous, and/or 
musculoskeletal systems. The following sections will discuss the effect of these 
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factors on gait. Understanding the contribution of these elements to gait 
abnormality may lead to a better treatment and management of patients with 
gait impairment.  
1.3.1 Effect of motor impairment on gait 
1.3.1.1 Musculoskeletal factor 
Lower extremity muscle weakness, reduce range of joint motion or change in 
skeletal alignment could affect gait and postural stability. Lower limb muscles 
including ankle plantar flexors (gastrocnemius, and soleus), hip and knee 
extensors, rectus femoris as well as hamstrings  provide vertical support and 
forward propulsion of trunk, contribute to leg swing initiation and power 
generation during unimpaired gait cycle (Liu et al., 2008, McGowan et al., 2008, 
Hall et al., 2011, Neptune et al., 2001). The muscles contribution generally 
increase with increasing gait speed (Liu et al., 2008). Deficit in lower limb 
muscles that contribute in forward propulsion, leg swing initiation and power 
generation due to pathology (e.g. stroke) is directly associated with reduced 
functional walking status (Hall et al., 2011). Musculoskeletal limitations found in 
person with neurologic dysfunction (e.g. stroke) most often develop secondary 
to a central nervous system lesion and restricted movement. 
Muscles generate forces that are transmitted by bones and connective tissue to 
other body segments, causing the foot to apply a force to the ground (Zajac et 
al., 2002). The ground applies a reaction force that is equal in magnitude and 
opposite in direction to each foot, which accelerates the centre of gravity 
forward (i.e. propulsion), backward (i.e. braking) and  vertical (i.e. support) 
(Winter, 1995). This external force known as ground reaction force (GRF) 
passes upward from the foot and produces movement at each lower extremity 
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joint (Winter, 1995). To maintain postural stability, the GRF must be exactly 
balanced by the internal force produced by lower limb muscles particularly at 
the ankle (Kirtley, 2006). Asymmetrical generation of propulsion GRF between 
two feet can therefore lead to asymmetrical gait in  patients with stroke 
(Balasubramanian et al., 2007). 
Body alignment refers to the relationship of individual body segments to each 
other and also the position of the body in relation to gravity and base of support 
(Shumway-Cook and Woollacott, 2007). Correct body alignment allows 
execution of movement strategies that will be effective for posture control.   
Changes in body alignment could be due to musculoskeletal impairment or as a 
postural compensation secondary to other impairment e.g. patients with stroke 
(Shumway-Cook and Woollacott, 2007). For the later reason, asymmetry 
postural alignment during upright stance could be observed in a person with 
stroke due body weight shifted to non-paretic side (weight bearing asymmetry 
(WBA) (Genthon et al., 2008). The WBA could be attributable from motor 
weakness on the paretic side,  asymmetry muscle tone, somatosensory deficit  
and alteration in spatial cognition with reference to the postural body scheme  
following stroke (Genthon et al., 2008, Barra et al., 2009, Pérennou, 2005, 
Roerdink et al., 2009). A study has shown significant association between WBA 
and functional ambulation in chronic stroke whereby reduced WBA associated 
with a better functional ambulation (Adegoke et al., 2012).  
Musculoskeletal problems can reduce range of joint motion and flexibility thus 
will limit the ways a person can move to maintain dynamic stability. For 
example, loss of an ankle range of movement will limit a person to use ankle 
strategy for postural control (Horak and Nashner, 1986). Reduced range of joint 
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motion of lower limbs has been shown associated with altered spatio-temporal 
gait parameters i.e. reduced gait speed, stride length and also decrease foot 
elevation angle during gait particularly at toe-off (Laroche et al., 2006, Laroche 
et al., 2007). Failure to properly clear foot from ground or obstacle during gait 
could possible lead to a tip and subsequently fall (Said et al., 1999). 
 
1.3.1.2 Neuromuscular factor 
In human gait, the neuromuscular system contributes in re-directing the centre 
of gravity forward and over the support limb during step-to-step transition of the 
gait cycle. Neuromuscular control is required to reduce the metabolic cost of 
walking and is important for modulating walking speed, particularly in older 
adults (Kuo et al., 2005, Clark et al., 2013). A study by Clark et al. (2013) 
showed that maximum walking speed in healthy, well functioning older adults is 
limited by impaired neuromuscular activation and force production of triceps 
surae muscle group. Previously, walking speed has been shown highly 
dependent on neuromuscular function of the triceps surae muscles (Liu et al., 
2008).  
Precise control of dynamic stability of the ankle joint particularly at the terminal 
swing phase is essential during normal gait (Tropp, 2002). During the swing 
phase, a process of neuromuscular preparation for the subsequent weight-
bearing stage of the gait cycle is important to ankle stability and  inappropriate 
positioning of the lower limb before heel strike would appear to increase the 
potential for hyperinversion injury (Troop, 2002). A study has shown increased 
activation of peroneal muscles, which  plays an integral role in controlling the 
amount of inversion occurring at the ankle joint, during the terminal swing phase 
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in subjects with functional instability of the ankle joint (Delahunt et al., 2006). 
The authors suggest increased the muscle activation may serve as a protective 
mechanism to prevent ankle sprain. 
Walking on unstable terrain (i.e. changes in surface compliance) can disturb 
normal movement dynamics and strategies to accommodate such disturbances 
must be readily available. Neuromuscular systems is important in producing 
recovery response of limbs to a compliant-surface perturbation e.g. stepping on 
a compliant surface  (Marigold and Patla, 2005) to ensure dynamic stability is 
still preserved. The central nervous system actively modulated muscles activity 
throughout the recovery response particularly during stepping off the compliant 
surface (Marigold and Patla, 2005).  
Mobility tasks often require rapid alterations of muscle activation, and a slower 
neuromuscular activation rate may pose a particular challenge when task 
demands are high such as fast walking, stair negotiation, and balance recovery 
after tripping (Schmitz et al., 2009, Larsen et al., 2008, Madigan, 2006). It is 
suggested that impaired neuromuscular activation rate may limit mobility 
function by compromising the ability to produce acceleration and power at joints 
of the lower extremities particularly during tasks that require rapid movement or 
high levels of effort (Clark et al., 2011). 
 
1.3.2 Effect of sensory impairment on gait 
1.3.2.1 Somatosensory 
Somatosensory receptors including muscles spindle, Golgi tendon organs, joint 
receptors and cutaneous mechanoreceptors provide information about joint 
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position in space and the position and movement of body in relation to the 
support surface. Loss of somatosensory information from the lower limbs 
resulting from experimental manipulation is known to result in increased 
postural sway and altered postural control (Diener et al., 1984, Horak et al., 
1990). 
Role of somatosensory input during gait, can be investigated by using 
mechanical vibration. Mechanical vibration to muscle or  tendon can selectively 
activate the Ia  afferent, which is a primary proprioceptive receptor (Inglis et al., 
1991). When mechanical vibration was applied to the lower limb muscles of 
healthy adults during walking, it elicited changes in walking velocity, muscle 
activation patterns, or joint kinematics (Ivanenko et al., 2000, Verschueren et 
al., 2002, Verschueren et al., 2003). Findings of these  studies suggest that  the 
proprioceptive input from muscle spindles important  for maintaining the steady 
state of human gait, contribute to the regulation of gait phase and the Ia input is 
used in the online control of local joint displacement during gait. It is also 
suggested that  proprioceptive information from lower limb muscles may convey 




Vision improves upright stability during standing and gait by providing 
information about self-motion and posture and movement of body segments 
relative to surrounding environments and can also influence the postural 
alignment with reference to gravity and the environment during gait. Vision also 
provides support in gait cycle modulation, provides environmental information at 
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a distance thus support navigation and obstacle avoidance during gait 
(McFadyen et al., 2007, Schubert et al., 2003, Rossignol, 1996). Obstacle 
information provided by vision can control mode of gait regulation through a 
feed-forward mechanism. Specifically, visual information  is used to alter gait 
patterns in anticipation of upcoming obstacles (Patla and Vickers, 1997). During 
navigation, for example around obstacle in a cluttered terrain, visual information 
provides information about the obstacle and identification of safe corridors. This 
information thus help a person in path planning (Patla et al., 2004).The role of 
vision to modify gait patterns in response to environmental constraint has been 
reviewed extensively and it has been suggested that integration of visually 
perceive the environmental properties at a distance and modify the movement 
patterns in an anticipatory manner is crucial  to ensure dynamic stability during 
adaptive locomotion (Higuchi, 2013). 
Studies have shown that optic flow has a modulating effect on gait patterns i.e. 
speed and stride length (Konczak, 1994, Prokop et al., 1997). These findings 
suggest that imposed optic flow has a modulating effect on gait patterns 
wherein global backward and forward optic flow tended to decreased and 
increased gait speed respectively (Konzack, 1994, Prokop et. al., 1997), 
changes observed in the gait speed was closely related to a modulation of step 
length (Prokop et al., 1997).  
Aforementioned studies have shown the importance of visual input to feed-
forward control of equilibrium during gait, gait regulation, navigation and 
obstacles avoidance. Therefore loss of vision may affect the stability and 




1.3.2.3 Vestibular  
The role of the vestibular system is to contribute to gaze and posture 
stabilization as well as sensation of orientation and movement. Human 
vestibular system is made up of three components: a peripheral sensory 
apparatus, a central processor, and a mechanism for motor output (Hain and 
Helminski, 2000). The peripheral apparatus includes the three semicircular 
canals (horizontal, anterior, posterior SCC) and the otoliths (utricle and saccule) 
and they are responsible for detecting and providing information about angular 
head velocity, linear acceleration and static head tilt with respect to the vertical 
axis (gravity). The CNS processes these signals and integrates them with other 
sensory information to estimate head and body orientation in space.  
The reflexes involving the vestibular system include the vestibule-ocular (VOR), 
the vestibulo-cervical (VCR), and vestibule-spinal reflexes (VSR). The VOR 
produces and maintains conjugate eye movement that is synchronised with the 
velocity of head motion to generate stable fixation of the eyes on an object 
during head movement (Hain and Helminski, 2000). The VSR and VCR allow 
input from the vestibular organs to be used for the body postural orientation in 
gravity environment and help stabilize head and body in space (Hain and 
Helminski, 2000, Buchanan and Horak, 2001).  Vestibular input is essential for 
postural orientation when both visual and somatosensory are inadequate to 
control centre of gravity over the base of support such as standing in the dark 
on an uneven surface (Horak, 2010).  
It is well documented that vestibular disorders result in postural instability 
(Pozzo et al., 1991, Allum et al., 2001), impaired gaze stability (Whitney et al, 
2009, Hillman et al., 1999), change in gait patterns (Cohen, 2000, Borel et al., 
 29 
 
2004, Marchetti et al., 2008) and an increased falls risks (Whitney et al., 2004a). 
Patients with a peripheral vestibular disorder show significant changes in their 
walking pattern compared to healthy individuals including a wide base of 
support, reduced walking speed and step length, and deviations from the 
walking path (Cohen, 2000, Borel et al., 2004, Marchetti et al., 2008). These 
changes are particularly evident when patients are walking with head 
movements, at a fast speed, or when visual input is unavailable (Borel et al., 
2004, Cohen, 2000, Nascimbeni et al., 2010).  
The head is relatively stable during many walking tasks (Pozzo et al., 1990). 
However voluntary head movements are common during activities of daily living 
involving both walking and standing. Examples include looking side to side to 
cross the street, turning the head in response to an auditory signal, and 
navigating through a visually challenging and busy environment  e.g. a 
supermarket, shopping centre or train station. These movements are necessary 
in order to scan the environment and obtain information regarding surrounding 
objects and our proximity to them. These typical everyday dynamic movements 
exacerbate symptoms of dizziness and unsteadiness as well as blurry vision in 
patients with a vestibular disorder and it is understandable that these difficulties 
can lead to activity limitations and contribute to a decreased quality of life. It has 
been suggested that a phenomenon referred to as visual vertigo (Bronstein, 
2004) or space and motion discomfort (Jacob et al., 1993), may be a 
contributing factor to the difficulties experienced by patients particularly during 
gait in challenging environments.  
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1.4 Current approaches to balance and gait assessments 
1.4.1 Functional assessments 
Functional balance assessment tools rate performance of various tasks 
challenging balance control  in order to identify functional limitations to do a task 
or an activity and it also provide information about balance status and its 
changes with time (Horak, 1997).  
The Time Up and Go test (TUG) is widely used as clinical balance test because 
it is quick, easy and convenient to be performed in the clinic (Yelnik and Bonan, 
2008). It provides information about the time required for a person to rise from a 
chair, walk 3 meters, turning and returning to the start point. It has been used to 
assess mobility performance in older adults and to assess risk of falls 
(Shumway-Cook et al., 2000, Podsiadlo and Richardson, 1991). Its scores 
relate to risk of falls in older adults and in patients with a peripheral vestibular 
disorder (Shumway-Cook et al., 2000, Whitney et al., 2004a). Although TUG 
involves several important mobility skills that challenged postural control such 
as sit-to-stand and turning, it is not able to separate which balance and gait 
components are affected.  
The Functional Gait Assessment (FGA) is an ambulation-based balance test 
specially developed for patients with vestibular disorders (Wrisley et al., 2004). 
It was derived from Dynamic Gait Index (DGI), which was validated in various 
populations yet had a potential ceiling effect (Jonsdottir and Cattaneo, 2007, 
Wrisley et al., 2004). The FGA eliminated the ceiling effect noted in DGI when 
the test was used in patients with a vestibular disorder (Wrisley et al., 2004). It 
consists of 10 tasks and includes tasks such as walking with head movements, 
tandem, or backwards. It has been shown easy to administer in most clinical 
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setting (Wrisley et al., 2004).  The FGA has shown to be a reliable tool with 
intra-rater and inter-rater reliability reported as r=0.86 and r= 0.75 respectively 
(Wrisley et al., 2004). For adults up to the age of 60 years, the normal score on 
the FGA would be considered >27/30 (Walker et al., 2007). The cut off of 22 
points predictive of falls in older adults (Wrisley and Kumar, 2010).  
 
1.4.2 Objective assessments 
1.4.2.1 Computerised dynamic posturography 
The Sensory Organization Test (SOT) allows systematic evaluation of sensory  
contribution to balance control via manipulation of either visual or support 
surface or both. The testing is performed under six different sensory conditions 
to assess the influence of visual, vestibular and somatosensory inputs on 
balance. In conditions 1 to 3 subjects stand on a stationary support surface with 
eyes open, eyes closed, and with sway-referenced vision, respectively. In 
conditions 4 to 6 a similar procedure is followed except the support surface is 
also sway referenced. The program yields an average composite equilibrium 
score, ranging from 0 % (no balance) to 100% (maximum stability). Scores 
below 70% are considered abnormal (Neurocom, 1999). Although the system 
could provide accurate information about dynamic postural control during 
standing, it does not provide information about dynamic postural control during 
gait. It also requires time for both training and testing, space for the storage and 
high cost (Visser et al., 2008). 
1.4.2.2 Gait analysis systems (non-wearable sensors)  
Standard gait analysis systems can be classified into image processing based 
system, floor sensors (force platforms or instrumented walkway) or dynamic 
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electromyography (EMG). The image processing system (camera or optic 
sensors camera) provides information about  the magnitude, timing and phasic 
relationships of a person's gait. The floor sensors system allows measurement 
of force exerted by a person's feet on the floor during walking thus provides 
information about the kinetics aspect influencing gait. Overall, these systems 
provide biomechanical measures of kinematic, kinetics, muscular activity that 
are essential for a complete picture of specific gait characteristics (Coutts, 
1994).   
Study has demonstrated the validity of these systems to quantify and analyse 
different aspects of human gait (Muro-de-la-Herran et al., 2014). These systems 
would provide comprehensive outcomes due to its high accuracy of analysis in 
detecting more specific gait parameters. Other advantages of these gait 
analysis system are that they could isolate external factors from influencing the 
measurements and allow more controlled analysis on data being studied. Thus 
resulting in high repeatability and reproducibility levels.  
Typically standard gait analysis session in patients with disability e.g. stroke 
involves a few short successive recording gait trials for a person (Kim and Eng, 
2004). However previous evidence demonstrated that gait performance during 
community ambulation among stroke survivors were influenced by several 
factors including fatigue (poor endurance) (Eng et al., 2002), reduce ability to 
adapt to environmental task demands (Said et al., 1999, Lord et al., 2006). 
These factors are not taken into account in the system data interpretation. Other 
disadvantages includes high cost (expensive) due to the needs for the setting 
up in a specialised gait laboratory, took longer for set up and it requires post-
processing times. For the floor sensors set up, the instrumented walkway size 
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(the length of a mat sensor) would limit the data collection from a person. In 
addition, these systems do not allow evaluation and monitoring of patient's gait 
while conducting activity of daily living outside the laboratory setting. Thus 
extrapolating the study findings outside a well-controlled laboratory studies may 
not reflect the patient's actual performance.  
To alleviate the limitation of the standard gait analysis based on the non 
wearable system, an alternative method based on wearable sensors was 
studied. This alternative system allow gait analysis in outdoor setting and can 
provide information about gait characteristics while a person is conducting 
activity of daily living in real environment (Muro-de-la-Herran et al., 2014) 
 
1.4.2.3 Accelerometers  
Accelerometers are wearable motion sensors that can be used to examine 
human body segmental accelerations in up to  three planes (anterior–posterior, 
mediolateral and vertical). Accelerometers have been shown to be a valid and 
reliable tool to measure dynamic movements and are able to provide an 
objective measurement of postural stability control during walking (Mayagoitia et 
al., 2002, Kavanagh et al., 2006). It has been tested for accuracy (Moe-Nilssen, 
1998) and for test-retest reliability during standing and walking. By using single 
triaxial accelerometer at L3 spinous region, the intraclass correlation coefficient 
(ICC) ranged from 0.79 to 0.94 when considering the vertical (V), anterior-
posterior (AP) and medio-lateral (ML) acceleration axes as well as walking on 
even and uneven surface. Reliability was on the similar level for even and 
uneven walking surface. Good reliability evidenced from multiple 
accelerometers attached to different segments of the upper body (head, C7 and 
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L3 of spinous region and shank) (Menz et al., 2003b, Kavanagh et al., 2006) 
prove that the accelerometers are valid tools for measuring dynamic movement.  
Accelerometers can accurately measure simple parameters of gait e.g. stride 
time, stride symmetry and speed (Kavanagh and Menz, 2008b, Kavanagh et al., 
2004, Menz et al., 2003c, Moe-Nilssen and Helbostad, 2004). Repeated 
patterns obtained with measures of acceleration contain information on the 
smoothness or variability of the walking pattern particularly trunk accelerations 
(Kavanagh and Menz, 2008b, Kavanagh et al., 2004, Menz et al., 2003c). It can 
also quantify gait pattern in healthy and person with balance or gait problems 
e.g. elderly, stroke, Parkinson disease, multiple sclerosis (Menz et al., 2003c, 
Menz et al., 2003a, Huisinga et al., 2012, Latt et al., 2009, Iosa et al., 2012b). In 
previous studies, head and/or pelvic accelerations were observed to be 
signiﬁcantly less stable in healthy older adult compared to young adults (Menz 
et al., 2003c ), in older people with a high risk of falls compared to those at a 
low risk (Menz et al.,2003a), and in people with stroke (Iosa et al., 2012b, 
Mizuike et al., 2009). Moreover, accelerometers have also been used to 
examine the effects of ageing on head and trunk movements while walking on 
level or irregular surfaces (Menz et al., 2003b). Aforementioned studies suggest 
that accelerometry data could provide useful indicators of gait stability.  
 
1.4.3 Potential use of accelerometers to measure complex task in real 
walking environments. 
Causes of falling are multifactorial, however, impairment in gait and balance are 
often fundamental (Tinetti et al., 1988). Ambulation in real environment which 
require a person walk at faster speed and a longer distance was noted to further 
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increase the risk of fall among high risk faller population (Shumway-Cook et al., 
2002, Lord et al., 2004). Identification of these gait abnormalities is essential to 
early initiation of appropriate therapeutic intervention as part of a falls 
prevention strategy. Accelerometers can be used to measure these gait 
changes. 
Accelerometers have advantages over the standard gait analysis system (non 
wearable system) primarily due to its small size, light weight, limited restrictions 
to regarding anatomical placement, and it also provides minimal obstruction to 
body movement. It can be used to measure movement including gait, in 
laboratory and real world environments without the limitations inherent to more 
immobile laboratory approaches such as force plate/camera systems. It also 
allow continuous measurement of a person's daily activities in his/her own 
environment (Haeuber et al., 2004). Many accelerometers are wireless and 
either send signals to a base station or collect data onboard for subsequent 
download, further promoting the usefulness of accelerometers especially in an 
environment with exposure to various conditions such as when ambulating 
within the community. 
A limited number of studies have incorporated the use of accelerometers to 
assess free-living physical activities and mobility in the community (Hendelman 
et al., 2000, Haeuber et al., 2004). Haebuer and colleugues (2004) compared 
the accuracy and reliability of conventional accelerometers and Step Watch 
Activity Monitor (SAM) to quantify stride counts during two 48 hour monitoring 
periods in subjects with a chronic stroke. The SAM was an ankle-mounted 
microprocessor-linked accelerometer and allow recording of gait cycle, or stride 
human. However the conventional accelerometer was a hip-mounted 
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mechanical accelerometer. Findings revealed that both types of accelerometers 
were able to quantify the stride counts however SAM showed higher accuracy 
and reliability for quantifying ambulatory activity in stroke population (Haueber 
et al., 2004).  
Prolonged walking in living environment is more challenging compared to short 
distances walked in clinic setting. Prolonged walking has been shown to affect 
gait dynamic stability in patients with stroke (Iosa et al., 2012c) which may 
potentially increase risk of fall. In the study, accelerometery data was able to 
distinguish gait stability patterns between patients with stroke and healthy 
during prolonged walked (6 minutes walking task-6 MWT) (Iosa et al., 2012c). 
Patients with stroke showed progressive reduction of dynamic gait stability 
during prolonged walk.  Furthermore the accelerometer could pick up 
differences of gait strategies used by the patients wherein patients either 
maintain gait speed but showed progressive reduction of gait stability or 
reduced both gait speed and gait stability.  Reduced both speed and stability 
was noted in patients with less ability to walk prolonged (Iosa et al., 2012c). 
Accelerometer has been shown reliable to measure dynamic movement. It has 
been proposed as being suitable for fall detection in person who are at high risk 
of fall. It can be used continuously and provide objective assessment of mobility 




1.5 Effects of psychological state on subjective symptoms and functional 
capacity 
1.5.1 The relationship between psychological state, dizziness and 
functional ability in patients with peripheral vestibular dysfunction 
 
Significant comorbidity between vestibular dysfunction, migraine and anxiety 
has been reported. Patients with a vestibular disorder, including migraine 
associated dizziness often have a comorbid psychiatric disorders (e.g. anxiety 
or depression) (Staab and Ruckenstein, 2005, Staab and Ruckenstein, 2003, 
Furman et al., 2005). Patients with psychiatric disorders also often experience 
subjective unsteadiness, dizziness or vertigo as a concomitant phenomenon of 
their illness (Yardley et al., 2001). The relationship between vestibular disorders 
and psychiatric disorders has been thought as bidirectional: a vestibular 
disorder may trigger a psychiatric disorder (Jacob and Furman 2001) while a 
psychiatric disorder may trigger symptoms of vertigo and dizziness (Yardley et 
al., 2001; Staab and Ruckenstein, 2003). However, some studies report no 
relationship between the presence of a vestibular deficit and the development of 
a secondary psychiatric disorder (Best et al., 2006; 2009).  
A complex interaction between vestibular disorders and psychiatric disorders 
has been described previously (Balaban and Thayer, 2001, Yardley et al., 2001, 
Staab and Ruckenstein, 2003, Eckhardt-Henn et al., 2008). Based upon 
neuroscience evidences, the link between balance control and anxiety is 
suggested to be associated with neural circuits that are shared by pathways 
related to autonomic control, vestibular-autonomic interactions and anxiety 
(Balaban and Thayer, 2001). This may explain the high rates of co-existence 
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and co-morbidity observed clinically in patients with organic and psychiatric 
dizziness (Furman et al., 2005). 
  
1.5.2 Illness behaviour and its potential influence on functional capacity 
The concept of illness behaviour relates to the ways in which people attend to 
somatic information, interpret and respond to symptoms and seek medical care 
(Mechanic, 1986). Although symptoms may share similar clinical characteristics, 
different forms of illness behaviour may be elicited suggesting substantial inter-
individual variability in a way a person responses to their symptoms (Mechanic, 
1986). A term of abnormal illness behaviour (AIB) can be described as a 
persistent inappropriate or maladaptive mode of experiencing, perceiving, 
evaluating and responding to one‘s own health status, despite the fact that 
appropriate medical assessments and management have been provided 
(Mechanic, 1986, Pilowsky and Spence, 1994). It can also be used to describe 
either somatic or psychological focus and either illness is affirmed or denied 
(Pilowsky, 1993a). 
Abnormal illness behaviour has been examined predominantly in patients with 
chronic pain (Pilowsky and Katsikitis, 1994, Waddell et al., 1989, Keefe et al., 
1986, Prior and Bond, 2008) and psychiatric problems (Pilowsky, 1993b, Boyle 
and Le Déan, 2000, Guo et al., 2001, Duddu et al., 2006, Lykouras et al., 2006). 
Abnormal illness behaviour can be found in somatoform disorders (Chaturvedi 
et al., 2006), chronic pain disorders (Pilowsky and Katsikitis, 1994), 
psychological problems (Fava et al., 1982) and in people with diagnosed 
medical conditions e.g. stroke (Clark and Smith, 1997), Meniere's Disease 
(Savastano et al., 1996), cancer (Grassi et al., 1989). There is evidence of 
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increased level of illness-affirming AIB among patients with somatic symptoms 
or with psychological distress compared to those who were not. 
Previous longitudinal studies showed that AIB could emerge during stroke 
rehabilitation (Clark and Smith, 1997, Clark and Smith, 1998). Proportion of 
patients who developed AIB during rehabilitation were doubled by the time of 
discharge and this remained stable at 12 months (Clark and Smith, 1997). 
Patients with stroke who developed AIB upon discharge also demonstrated 
poorer ADL ability and worse social and psychological outcomes compared to 
those who did not develop AIB and these discrepancies were not significant 
upon patient‘s admission to the rehabilitation (Clark and Smith, 1997). 
Furthermore these patients (with AIB) were consistently poorer at both 6 and 12 
months post rehabilitation. It was noted that no change in illness behaviour 
pattern observed between patients with and without AIB at 12 months. Both 
depression and AIB emerged as important predictors of long-term functional 
disability and poorer social outcome following rehabilitation from stroke, the 
authors suggest that AIB may compromise the long-term functional recovery of 
stroke patients (Clark and Smith, 1998, Clark and Smith, 1999). 
Evidence on the existence of abnormal illness behaviour in some patient 
populations as well as significant association between psychological state and 
illness behaviour on patients' ADL ability and social outcomes, may help health 
professionals to recognize possible underlying reasons for a patient‘s poor 
response to treatment. Abnormal illness behaviour has been shown to influence 
patient's manner towards seeking treatment (i.e. delay treatment) (Rizzardo et 
al., 1991). Improved understanding of illness pattern and AIB as well as its 
association with psychological disturbance could offer important insight into 
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early indicators of potentially maladaptive illness response. This may lead to a 
better planning of management strategies for patients. 
 
1.6 Aims of the thesis 
The following will provide a brief description of the purpose of each study 
included in this thesis. The first two studies in the current thesis (Chapter 2 & 3) 
were conducted to investigate postural control by using accelerometers, during 
walking in different urban environments in healthy participants and patient 
groups. Based on laboratory studies, head stability is obtained via modulation of 
lower trunk movement during gait cycles in healthy individual. However little is 
known about the head-trunk coordination while a person is walking in a real, 
uncontrolled environment and the effect of impaired sensory (i.e. vestibular 
system) or central nervous system (i.e. stroke) function on dynamic postural 
control in challenging walking environments. It was hypothesised that walking in 
real environment may reduce postural stability control among patients with 
sensory or CNS impairment due to reduce gait adaptability. It was expected that 
when patients walk through challenging environment i.e. busy or uneven 
surfaces, these patients would experience greater difficulty. It was also 
expected that healthy individuals able to maintain head stability  during walking 
in urban environment indicating good postural stability control. 
The main purpose of the first study of the current thesis (Chapter 2) was to 
examine the effect of a vestibular impairment on the head and trunk postural 
control during walking in real urban environments. The secondary aim was to 
correlate subjective and objective clinical outcome measures with overall 
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postural control strategies utilised in real environments. Outcome measures 
used were specific to the patients population. 
Chapter 3 repeated the first study (Chapter 2) in patients with stroke. The 
second study focussed on the effect of CNS (i.e. stroke) damage on postural 
stability control. The main aim was to determine upper body stability control, by 
using accelerometers, when walking in urban environment for independently 
community-dwelling stroke survivors. The secondary aim was to determine 
association between acceleromtery data and functional abilities, visual 
dependency and subjective outcome measures in people with stroke.  
The final study of the current thesis (Chapter 4) aimed to describe illness 
behaviour profile (the way a person responds to a perceived health threat or 
illness), using illness behaviour questionnaire (IBQ), in patients with chronic 
vestibular disorders or vestibular migraine. Secondary aim was to assess the 
relationship between illness behaviour, functional gait, postural control and 
subjective symptoms.  
Overall this thesis aims to assess dynamic postural stability control in urban 
environments in healthy individuals and in patients with sensory or central 
nervous systems impairment and also the effect of illness behaviour state on 




CHAPTER 2  EFFECT OF URBAN WALKING ENVIRONMENTS ON 
POSTURAL CONTROL IN PATIENTS WITH A VESTIBULAR DISORDER 
 
2.1 INTRODUCTION  
Sensory input from the visual, somatosensory, and vestibular (i.e. inner ear 
balance system) systems play an important role in the control of walking. In 
urban environments the integration of sensory input from all three systems 
plays a significant role in a person‘s ability to maintain balance when walking 
where the movements performed must be modified in response to changes in 
environmental and task demands (Lord et al., 2006). 
The vestibular system plays an important role in head and trunk stabilisation 
with respect to gravity during walking. This facilitates gaze stabilisation and 
provides a stable reference frame from which to generate postural responses 
and maintain balance (Pozzo et al., 1995, Beidel and Horak, 2001). It also 
contributes to navigation tasks such as walking to a previously seen target in 
the absence of vision (Guidetti et al., 2008). 
Previous studies in patients with peripheral vestibular disorders have shown 
impairment in gaze stability (Hillman et al., 1999, Whitney et al., 2009), 
disrupted head- trunk coordination and head movement (Pozzo et al., 1991, 
Allum et al., 2001, Mamoto et al., 2002, Borel et al., 2002), change in spatio-
temporal gait patterns (Cohen, 2000, Borel et al., 2004, Marchetti et al., 2008) 
and an increased fall risks (Whitney et al., 2000).  
These changes are particularly evident when patients are walking with head 
movements, at a fast speed, when visual input is unavailable or while 
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completing a dual-task (cognitive) (Borel et al., 2004, Cohen, 2000, Nascimbeni 
et al., 2010, Glasauer et al., 1994). In addition, patients experience difficulty 
controlling head accelerations, and suffer from the unpleasant illusion of 
movement or blurring of images when walking due to impairment of the 
vestibular ocular reflex (VOR) (Takahashi et al., 1988, Hillman et al., 1999, 
Hirasaki et al., 1993, Schubert et al., 2002). The VOR produces and maintains 
conjugate eye movement that is synchronised with the velocity of head motion 
and as a result VOR generates stable gaze fixation on an object during head 
movement. It has been suggested that the reduced walking speed noted in this 
patient group helps to maintain gaze stability (Mamoto et al., 2002) and to 
reduce unsteadiness and falls risk (Borel et al., 2004) during walking.  
The head is relatively stable during many walking tasks. However voluntary 
head movements are common during activities of daily living involving both 
walking and standing. Examples include looking side to side to cross the street, 
turning the head in response to an auditory signal, and navigating through a 
visually challenging and busy environment e.g. a supermarket, shopping centre 
or train station. These movements are necessary in order to scan the 
environment and obtain information regarding surrounding objects and our 
proximity to them. These typical everyday dynamic movements exacerbate 
symptoms of dizziness and unsteadiness as well as blurry vision in patients with 
a vestibular disorder and it is understandable that these difficulties can lead to 
activity limitations and contribute to a decreased quality of life. 
It has been suggested that a phenomenon referred to as visual vertigo 
(Bronstein, 1995) or space and motion discomfort (Jacob et al., 1989), whereby 
patients become significantly more susceptible to visual motion and complain of 
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discomfort, symptom exacerbation and a feeling of imbalance in challenging 
visual environments (e.g. walking down a busy street, crossing the road and 
performing simple tasks such as shopping) (Kerbs et al., 1993, Tee and Chee, 
2005) may be a contributing factor to the difficulties experienced by patients 
when walking in urban environments. 
It is well documented that peripheral vestibular disorders may result in 
unsteadiness, particularly when walking in busy environments (i.e. crowds and 
supermarkets) or on uneven surfaces, and these patients have an increased 
falls risk (Herdman et al., 2000). Patients also show changes in walking 
parameters compared to healthy adults. However these studies have been 
conducted in highly controlled, predictable laboratory settings which are very 
different to walking during daily activities in an urban environment. Therefore 
results may not provide a true indication of the balance strategies adopted by 
patients with peripheral vestibular disorders in everyday life. Previous research 
has discussed the merits of evaluating walking and adaptations over uneven 
surfaces, when negotiating obstacles, and in busy places covering a variety of 
distances (Patla, 2001) however, it was not possible to assess these factors 
outside a laboratory setting because adequate techniques for use in real 
environments had not been established until recently.  
Accelerometers, which are a wearable motion sensors, have been shown to be 
a valid and reliable tool to measure dynamic movements and are able to 
provide an objective measurement of postural stability during walking 
(Mayagoitia et al., 2002, Kavanagh et al., 2006). Accelerometers are able to 
demonstrate changes in postural stability due to different factors e.g. age, 
pathology etc. in various indoor walking conditions e.g. walking on ground or 
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uneven surfaces (Kavanagh et al., 2004, Kavanagh and Menz, 2008a, Menz et 
al., 2003b). It has been found to be able to distinguish between fallers and non-
fallers (Menz et al., 2003a). It can be used continuously and has been proposed 
as a quantitative measure of balance in both clinical and in free-living 
environments.  
No studies to date have assessed and compared postural stability control, using 
data from accelerometers, during walking in different urban environments. Also 
no studies have investigated the association between subjective reports of 
symptom severity, symptom triggers, balance confidence and emotional state 
with objective walking performance in real everyday environments. The purpose 
of this study was to 1) use accelerometers to assess postural control during 
walking in common urban environments including a colonnade with 
checkerboard floor pattern, a darker area, a busy section, a quiet section, and 
on an uneven surface (cobbled pathway) in patients with a vestibular disorder 
and healthy individuals and 2) investigate for associations between data 
obtained from the accelerometers and subjective reports of symptom severity, 
triggers, balance confidence and emotional state. It was hypothesised that 
accelerometers data can be used to differentiate gait patterns between healthy 
and patients and walking in challenging urban environments i.e. busy or 
cobbled increase postural instability, particularly in the latter. The information 
obtained may provide insight of the postural stability control strategies 






2.2 MATERIAL AND METHODS 
2.2.1 Subjects 
All participants were aged between 18 and 65 years old and independently 
mobile community dwelling individuals. Two participant groups were recruited: 
- Patients with a diagnosed peripheral vestibular disorder (Group PV) who had 
never received or completed a vestibular rehabilitation programme were 
recruited from the Department of Neuro−otology at the National Hospital for 
Neurology and Neurosurgery (NHNN), Queen Square, London. All patients had 
completed routine audio-vestibular investigations performed by a senior 
audiologist prior to the recruitment. The routine audio-vestibular investigations 
include otoscopic examination, tympnanometry test, pure tone audiometry, 
bithermal caloric test (either video nystagmography (VNG) or Fitzgerald-
Hallpike with optic fixation technique) and electronystagmography. 
Departmental norms were used for significant canal paresis and directional 
preponderance. A significant unilateral canal paresis was either based on 
Fitzgerald-Hallpike caloric testing as measured by the duration parameter using 
the Jongkee’s formula of more than 8% in the absence of the optic fixation or 
≥20% on VNG bithermal caloric. For directional preponderance, 12% for 
Fitzgerald-Hallpike or 20% for VNG (Jacobson et al., 1993) are the normal 
values. Diagnosis (or exclusion) of peripheral and/or central vestibular disorder 
was based upon review of the history, clinical assessment, caloric and ENG 
data by the attendant consultant neuro-otologist. Exclusion criteria were 1) 
fluctuating symptoms e.g. acute Meniere‘s Disease 2) Benign Paroxysmal 
Positional Vertigo (BPPV); 3) central vestibular disorder other than controlled 
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vestibular migraine and 4) a medical problems condition in the acute phase 
which may affect postural stability and gait e.g. orthopaedic injury. 
- Healthy adults (Group C) were recruited via circular email to students and 
member of staff at King's College London, London, UK. The inclusion criteria 
were no self-reported history of vestibular or neurological disease, dizziness or 
any medical problems condition in the acute phase which may affect postural 
stability and gait e.g. orthopaedic injury. 
All participants were asked to avoid consuming alcohol for 24 hours prior to 
testing. No participant with a vestibular disorder had taken vestibular 
suppressants or sedatives at least 24 hours prior the testing. Local ethics 
committee approval was obtained.  
 
2.2.2 Self-report assessments 
All participants completed a set of validated questionnaires prior to completing 
the urban walking task. For copies of all questionnaires please refer to 
appendixes. 
a. The Situational Vertigo Questionnaire (SVQ) (Jacob et al., 1989, Guerraz et 
al., 2001) yields a normalized score between 0 (never) to 4 (always) measuring 
how frequently symptoms are provoked or exacerbated in environments with 
visual-vestibular conflict or intense visual motion (e.g. walking down a 
supermarket aisle, watching moving television scenes). Normalised scores >0.7 
indicate the presence of visual vertigo symptoms (Pavlou et al., 2006; Pavlou et 




b. The Vertigo Symptom Scale (VSS)(Yardley et al., 1992) measures the 
frequency of vestibular (VSS-V; e.g. vertigo, giddiness, unsteadiness) and 
autonomic/somatic anxiety symptoms (VSS-A; i.e. heart pounding or fluttering, 
excessive sweating, tingling/numbness in body part). Scores range from 0 (no 
symptom) to 4 (daily symptoms); Normalised scores ≥ 0.3 on the VSS-V 
subscale indicate a significant level of vestibular symptoms (Pavlou et al., 
2006).  
 
c. The Activities Specific Balance Confidence Scale (ABC) assesses patients‘ 
confidence in conducting activities of daily living (ADLs) such bending over, 
reaching for items, indoor and outdoor mobility (i.e. walking around the house, 
outdoors in busy places such as a mall or on uneven surface such as a ramp) 
without losing balance or becoming unsteady (Powell and Myers, 1995). It has 
been validated for use in individuals with peripheral vestibular dysfunction and 
demonstrates acceptable validity in this population (Whitney et al., 1999, 
Wrisley et al., 2004, Legters et al., 2005, Karapolat et al., 2010). Scores range 
from 0% (no confident) to 100% (complete confidence). Responses to individual 
questions are then averaged to get a percentage score, with lower scores 
indicating less confidence in ADL performance and scores of ≤67% indicate 
increased falls risk (Lajoie and Gallagher, 2004). 
 
d. The Vestibular Activities of Daily Living Scale (VADL) (Cohen and Kimball, 
2000) evaluates the impact of vertigo or balance disorders on a person‘s ability 
to carry out ADLs. The scale is separated into three domains: a) functional 
which relates to items associated with self-care (VADL-F; i.e. sitting or standing 
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up, bathing, meal preparation); b) ambulation which includes items addressing a 
person‘s ability to walk in various environments (VADL-A; i.e. narrow  or 
crowded spaces, stair climbing) and instrumental which includes items relating  
to leisure activities, productivity and home management (VADL-I; i.e. carrying 
out light or heavy household chores, travelling on public transport). Score 
ranges between 0 (independent) to 10 (too difficult, no longer able to perform). 
The VADL demonstrated good test-retest reliability and validity (Cohen and 
Kimball, 2000).  
 
e. The Hospital Anxiety and Depression Scale (HAD) (Zigmond and Snaith, 
1983) independently measures anxiety (HAD-A) and depression (HAD-D) 
symptoms. Score range from 0 to 21 for each subscale. Score between 8-10 
indicate borderline symptoms; scores ≥ 11 indicate a significant level of 
depression or anxiety symptoms. 
 
2.2.3 Functional measures 
2.2.3.1 Timed Up and Go (TUG) 
The TUG is a simple and quick clinical test that can be used to assess 
functional mobility in older adultsand patients with a vestibular disorder 
(Whitney et al., 2004a, Gill-Body et al., 2000). The TUG is the time (seconds) 
required for a person to stand up from a chair, walk, at their normal speed for 
three meters, turn, around and walk back to the chair and sit down. In patients 
with a vestibular disorder, the TUG appears to be helpful in identifying fall risk 
(Whitney et al., 2004a). Higher (i.e. worse) TUG scores (>11.1 seconds) have 
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been shown to correlate with self-reported falls in this patient population 
(Whitney et al., 2004a). In addition TUG scores significantly correlate with self-
reported disability in persons with vestibular dysfunction (Gill-Body et al., 2000).  
 
2.2.3.2 Functional Gait Assessment (FGA) 
A ten-item test, specially developed for patients with vestibular disorders, based 
on the Dynamic Gait Index (DGI). It includes tasks such as walking with head 
movements, tandem, or backwards. Each item is rated between 0 (severe 
impairment) and 3 (normal) with a maximum score of 30; higher scores indicate 
better performance.  The FGA eliminated the ceiling effect noted in DGI when 
the test was used in patients with a vestibular disorder (Wrisley et al., 2004). 
The FGA has shown to be a reliable tool with intra-rater and inter-rater reliability 
reported as r=0.86 and r= 0.75 respectively (Wrisley et al., 2004). It also 
demonstrates acceptable concurrent validity with other balance outcome 
measures (i.e. DHI, ABC, DGI) for patients with a vestibular disorder (Marchetti 
et al., 2014).  
 
2.2.4. Urban walking procedures 
2.2.4.1 Instruments and preparation stage 
Three triaxial accelerometers (MTx, Xsens Technologies BV; 38x53x21mm, 
30g) were used to measure the acceleration and movement in pitch, roll and 
yaw. The accelerometers were placed at 1) the occcipital protuberance using an 
elastic head band;  2) over C7 and 3) over L3 respectively. Each accelerometer 
was affixed to the participant‘s skin using a hypoallergenic adhesive tape. The 
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accelerometers were connected to a light-weight laptop, onto which the MT 
Manager recording software had been installed via a data logger box. Later, 
both the data logger and laptop were placed in a backpack (Dimension: 34 (H) 
X 24 (L) X 12 (W) cm) worn by the subjects (Fig. 1A-C). The researcher 
ensured that normal arm movement was not affected by backpack placement 
before the start of the urban walking task. All participants were instructed to a) 
wear comfortable clothing and flat shoes, b) walk at their preferable walking 
speed and c) perform as they normally would in the specific environments. Two 








Figure 1 Recording device. 
Fig. 1A The recording device used for the urban walking task which consists of 
3 accelerometers, data logger XBus Master, elastic head band and a notebook. 
Fig. 1B shows the position of the accelerometers on a participant. Fig. 1C Final 







Data logger  
B 
Backpack contains the notebook 





2.2.4.2 Orientation of accelerometer on subject 
All the accelerometers were similarly oriented with the box placed with the Y 
axis pointing upwards, the X axis towards the right hand side of the participant 
and finally the Z axis pointing anterior to posterior. The cable from each 
accelerometer extended towards the left hand side of the participant.  
 
2.2.4.3 Recording stage 
Once the set-up was completed, the participant was instructed to stand still with 
their head facing straight ahead. The alignment reset method was used to reset 
the local coordinate system (LCS) of each sensor corresponding to the global 
coordinate system (GCS) simultaneously. This type of reset method changes 
the Z axis of the LCS to coincide with the gravity vector (i.e. vertical). The new X 
axis is the projection of the old X axis onto the plane perpendicular to the new Z 
axis. The new Y axis is the vector mutually perpendicular to the new Z and new 
X axes. This new Y axis is approximately in the posterior to anterior orientation 
and will lie close to the line of advance during walking. The reset method was 
carried out only once for each participant prior to starting the walking task. In 
case of interruption to data recording during the walking route, the alignment 
reset method was carried out again before beginning to record again. The 
recording ended when the participant completed the walking route and return to 
the starting point.   
2.2.5 Walking route 
The walking route distance was 1 kilometre and was separated into 54 
checkpoints.  Chalk crosses drawn on the road were used to identify 
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checkpoints where participants stopped and stood still for five seconds to allow 
for recognition of interest points during the analysis and to ensure for 
repeatability between subjects. Along the route, five 30 metre long sections of 
interest (quiet, dark, busy, cobbled street and a colonnade with a checkered 


















2.2.6 Data acquisition and processing 
2.2.6.1 Extraction of raw data from MT software. 
Recorded data for each subject was exported from the MT software and saved 
as a .txt file format. Each output file was renamed corresponding to the position 
of each sensor on the participant‘s body (e.g. output from sensor 153 was 
renamed to ‗participant‘s ID‘-‗position‘).  In total, three .txt output files were 
obtained from each participant.  Each output file contains the following 
information:  
a. Acceleration information in X ( medio-lateral), Y (walking direction)  and Z 
(vertical). 
b. Angular velocity information from the gyroscopes in pitch, roll and yaw 
directions.  
c. Magnetometers information in X,Y and Z directions. This provides information 
regarding earth‘s gravity field.  
d. Orientation information calculated by the on-board processor in the 
accelerometer using information from all the accelerometers, gyroscopes and 
magnetometers.  The algorithm is proprietary.   This information is output either 
as a quaternion or as an embedded vector base (EVB).  When quaternion 
information has been output it is converted to EVB information in the MatLab 
program reading the text file.An EVB is a description of an orthogonal 3D axes 
system. It describes a relation of the Local Coordinate System (LCS) to the 
Global Coordinate System (GCS). At initial quiet stance position, the initial 




2.2.6.2 Data processing 
All raw data were processed using Matlab 7.12.0 (R2011a) Student Version. 
This involved three stages before the final output with regards to accelerations 
and movements were obtained.  
 
Stage 1: Identification of five environmental conditions (Colonnade, Dark, 
Busy, Cobbled and Quiet) from the raw acceleration data. 
Raw data from lower trunk (L3) accelerometer output in the vertical direction 
was used to identify the five walking conditions. Previous work has shown that 
the vertical direction of trunk acceleration provides consistent acceleration 
patterns with peaks corresponding to heel strike in walking (Menz et al., 2003b, 
Kavanagh and Menz, 2008b).  The five environmental conditions were identified 
manually. The initial peaks after a stop (I), and last peak before a stop (S), were 
used to define sections with the selection criteria that the peak had to be half 
the average amplitude of the majority of peaks. This time information was 
recorded as a point number with a point occurring at 100 recording per second. 
The time coordinates were then used as reference points for data selection in 
Stage 2. Figure 3 showed a graphical representation of raw accelerations data 






Figure 3 Graphical representation of raw accelerations data and the point selection to determine the 
environment section of interest.  
The raw accelerations data was obtained at the trunk level of a healthy control participant while the person 
walked for a distance of 30 metres in a quiet section. Both ‘I’ and ‘S’ represent the first and the last point of 
selections respectively.  
 
Stage 2: Extraction of gravity effects from raw accelerations using EVB 
information. 
During the walking task, gravity (g) contributes to accelerations measured along 
all three axes of the local coordinate system.  In order to subtract the gravity 
effect, first acceleration in the global coordinate system (AG) needs to be 
calculated. This can be achieved by rotating (transforming) the LCS so it is in 
agreement with the GCS. This is achieved by pre-multiplying the accelerations 
in the LCS (AL) by the transpose of the EVB (embedded vector base) of the 
LCS. 
AG=  EVB‘  x   AL 
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Gravity‘s effect can now be subtracted from AG (Z axis) by subtracting - 9.81 
m/s/s and this provides information about non-gravitational acceleration in GCS  
(IAG) 
IAG= AG-g 
Once the value of IAG has been established, the initial walking acceleration 
(IAW) can be obtained.   Vertical acceleration is then correctly aligned.  Aligning 
the ‗Y‘ axis with the walking direction during each walking condition is achieved 
by averaging the direction of the Y axis for all time during the walking condition. 
The X axis is calculated as mutually perpendicular between Y and Z. The Z axis 
remains vertical as before.  
 
Stage 3: Root mean square (RMS) for accelerations and orientation data in 
each environmental condition. 
The RMS is a measure of dispersion of the data relative to zero and this value 
provides information on the average magnitude of accelerations or angular data 
(pitch, roll and yaw) in each direction during a walking trial. The RMS of 
accelerations and orientation data were displayed in all three directions (ML, AP 
and V). Figure 4 showed graphical representation of raw accelerations and 






Figure 4 Example of raw accelerations and orientation data obtained from a person with a 
vestibular disorder during walking in a quiet section. 
 
Stage 4: Normalization of the acceleration RMS data 
There are clear evidences of a high correlation between upper body 
accelerations RMS and walking speed (Moe-Nilssen and Helbostad, 2004, 
Menz et al., 2003b). Higher acceleration RMS was noted when a person walked 
faster (Menz et al., 2003b). In the present study, normalised accelerations RMS 
(nRMS) was calculated by taking into account walking speed. In order to 
normalise accelerations RMS, correlation between this factor and walking 
speed for individual environmental segments was first determined and 
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regression coefficients values were obtained. Subsequently, raw acceleration 
RMS was speed normalised using the following equation: 
Normalised acceleration RMS (nRMS) = b0 + [b1 x walking velocity] 
Both b0 and bi were regression coefficients wherein b0 was the y-intercept value 
and b1 represented the gradient of the regression line. Normalisation was only 
performed for accelerations data.  
 
2.2.7 Analysis 
Statistical analyses were performed using SPSS version 17 (SPSS Inc., 
Chicago, Ill). Normal distribution of the gait and accelerometers outcome 
measures was assessed by Kolmogorov-Smirnov test. When data was normally 
distributed, an independent sample t-test was used to compare between-group 
differences. For non-normally distributed and ordinal data, a Mann-Whitney U 
test was performed. One-Way ANOVA was conducted to examine effect of 
environmental conditions on the postural strategies used by each group. 
Spearman‘s correlation was performed to investigate the relationship between 
total acceleration data and self-reported outcome measures (SVQ, ABC, VADL, 
VSS and HAD), objective outcome measures (TUG and FGA) and spatio-
temporal variables (gait speed, walking duration and steps) within-groups. Only 
significant findings were reported in the result section (2.3). Significant results 





Age significantly differ between-groups with Group PV participants significantly 
older than Group C [z=-2.34; p<0.05]. Four participants from Group PV showed 
normal findings on vestibular assessments and these participants were 
recruited based on medical examination and/or clinical history that was 
compatible with uncompensated vestibular disorder as a consequence of 
vestibular neuritis. Demographic and clinical characteristics of participants upon 
















Table 1 Demographic and clinical characteristics of participants upon 
recruitment 
Variable Group PV Group C 
Age (year) (mean, range) 47 (20-64) 37 (21-62) 
Gender,n 
       Male, n (%) 









43 (5-204) NA 
Diagnosis, n  





      Meniere‘s Disease 1 
      Migraine vertigo 2 
      Idiopathic 3 
Vestibular findings, n  NA 
      CP (+DP) 13 (3) 
      DP 1 
      Normal caloric  4 
 
Abbreviations: Group C=healthy control group; Group PV= patients with a 
unilateral peripheral vestibular disorder; CP=canal paresis either based on 
Fitzgerald - Hallpike caloric testing as measured by the duration parameter 
using the Jongkees formula of more than 8% in the absence of optic fixation or 
≥20 % asymmetry for video-nystagmography; DP = directional preponderance 
either ≥ 12% based on Fitzgerald - Hallpike caloric testing or ≥ 20 % asymmetry 





2.3.2 Self-reported measures 
Significant differences were noted between-groups for all self-report measures. 
Compare to Group C, Group PV reported significantly lower (i.e. worse) on the 
ABC scale [z=-5.42; p<0.01] and showed a higher (i.e. worse) mean score for 
each VADL subscale [Functional: z=-6.13; p<0.01; Ambulation: z=-6.24; p<0.01; 
Instrumental: z=-6.14; p<0.01], and for global vestibular (VSS-V) [z=-6.00; 
p<0.01], somatic anxiety (VSS-A) [z=-5.07; p<0.01], non-somatic anxiety (HAD-
A) [z=-4.54; p<0.01], depression (HAD-D) [z=-4.73; p<0.01] and visual vertigo 
(SVQ) scores  [z=-5.04; p<0.01].  
Significant correlations were noted between age and HAD-A [r=-0.51,p<0.05] as 
well as VSS-V scores [r=-0.48; p<0.05] in Group PV, whereby lower anxiety and 
global vestibular symptoms were associated with increase age. Descriptive data 
for all questionnaire scores is displayed in Table 2.  
Seventy-one percent of Group PV (n=15) and 3% of Group C (n=1) scores were 
abnormal with scores outside the normative range for the SVQ. Hospital Anxiety 
and Depression subscales, HAD-A and HAD-D scores indicated borderline or 
higher scoresfor 57% (n=12) and 71% (n=15) of Group PV participants 
respectively. An increased falls risk was indicated for 38% of Group PV 
participants (n=8) based on ABC scores.  For the VSS-V, 90.5% (n=19) of 
Group PV had scores outside the normative range. All Group C participants 






Table 2 Mean (SD) score for questionnaires data 
 




VADL-F 2.59 (0.28) * 1.01 (0.01)  
VADL-A 3.20 (0.33) * 1.01 (0.01)  
VADL-I 3.39 (0.38) * 1.01 (0.01)  
VSS-V 1.07 (0.15) * 0.05 (0.01)  
VSS-A 1.24 (0.17) * 0.25 (0.05)  
HAD-A 9.43 (0.94)* 3.73 (0.42)  
HAD-D 7.19 (0.90) * 1.43 (0.36)  
SVQ 1.54 (0.21) * 0.24 (0.10)  
ABC 65.70 (4.40) * 96.00 (0.85) 
Abbreviations: Group PV= patients with a unilateral peripheral disorder; Group 
C= control healthy; SVQ=Situational Vertigo Questionnaire;HAD-A=Hospital 
Anxiety and Depression (Anxiety scale);HAD-D=Hospital Anxiety and 
Depression (Depression scale); VSS-V=Vertigo Symptom Scale (common 
vestibular symptoms); VSS-A=Vertigo Symptom Scale (autonomic and somatic 
anxiety symptoms);ABC=The Activities Specific Balance Confidence Scale; 
VADL-F= Vestibular Activities of Daily Living Scale (functional subscale); VADL-
A= Vestibular Activities of Daily Living Scale (ambulation subscale); VADL-I= 
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Vestibular Activities of Daily Living Scale (Instrument subscale). The asterisk (*) 
indicates a significant between-group difference (p<0.01). 
 
2.3.3 Functional measures 
A significant between-group difference was noted for FGA scores with Group 
PV significantly lower (i.e. worse) scores than Group C [z=-6.1; p<0.01]. Group 
PV took significantly longer time to complete TUG [t(22)=2.26; p<0.05]. Age 
significantly correlated with TUG [r=0.47; p<0.05] and FGA [r= -0.47; p<0.01] for 
Group PV whereby increasing age was associated with higher (i.e. worse) TUG 
and lower (i.e. worse) FGA scores. It was noted that mean age of Group PV 
was significantly higher than Group C thus age could be one of contributing 
factor to FGA and TUG scores in Group PV. Descriptive data for functional and 
gait outcome measure is shown in Table 3. 
 
2.3.4 Urban walking analysis 
2.3.4.1 Gait speed and duration 
Significant between-group differences were noted for walking velocity across all 
environmental conditions except for the ―busy‖ section [Colonade: t(49)=-3.94; 
p<0.01; Dark: t(49)=-2.50; p<0.05; Busy: t(29)=-1.82; p>0.05; Cobbled: t(49)=-
2.90; p<0.05; Quiet: t(49)=-2.57; p<0.05]. The time required to complete the 
urban walking task also significantly longer for Group PV [z=-3.28, p=0.01]. 
Descriptive data for walking speed, duration and number of steps taken for each 










FGA 23.62 (4.65) ** 29.63 (0.56)  
TUG 9.01 sec (3.05) * 7.46 sec (0.88) 
Urban gait  
Number of steps taken 
to complete route 
1155.53 (168.19) 1121.13 (133.3) 
Walk duration, minutes 17.53 (2.86) ** 15.28  (1.24)  
Urban walking velocity (ms-1) 
Colonade 1.28 (0.21) ** 1.47 (0.14)  
Dark 1.33 (0.25) * 1.48 (0.15)  
Busy 1.23 (0.26) 1.35 (0.15) 
Cobbled 1.33 (0.27) * 1.52 (0.18)  
Quiet 1.35 (0.25) * 1.50 (0.17)  
 
Abbreviations: Group PV= patients with a unilateral peripheral disorder; Group 
C= control healthy; FGA=functional gait assessment; TUG=Time up and go. 





2.3.4.2 Acceleration patterns 
2.3.4.2.1 Overall normalised accelerations patterns 
Significant between-group differences were noted for total normalised 
accelerations RMS in both the AP [z= -2.05; p=0.04] and V [z=-2.91; p=0.00] 
directions with Group PV demonstrating significantly reduced accelerations 
compared to Group C.  Mean total nRMS (SD) for Group PV and Group C in the 
AP direction were 1.15ms-2 (0.17) and 1.26ms-2 (0.15) respectively as well as 
2.5ms-2   (0.54) and 2.96ms-2  (0.46) in V directions respectively. 
Normalised acceleration RMS (nRMS) patterns for the head, neck and trunk 
across the five environmental conditions for both groups are illustrated in Fig. 5. 
Group PV had significantly smaller mean nRMS accelerations at the head and 
neck compared to Group C for each individual environmental condition in the 
vertical direction only [VHead: Col z= - 4.33 p=0.00; Dark t(49)= - 2.97 p=0.01; 
Busy t(49)= - 2.76 p=0.01; Cobbled t(49)= - 3.7 p=0.00; Quiet t(49)= -2.9 p=0.01 
and VNeck: Col z=-4.01 p=0.00; Dark t(49)= - 2.41 p=0.02; Busy t(49)= -2.5 
p=0.02; Cobbled t(49)= - 3.28 p=0.00; Quiet t(49)= - 2.42 p=0.02].  
Mean trunk nRMS accelerations in the ML direction were significantly smaller in 
Group PV except for quiet condition [Colonade  z=-3.42 p=0.00; Dark t(49)= - 
2.48 p=0.02; Busy t(49)= - 3.03 p=0.00; Cobbled t(49)= -2.7 p=0.01; Quiet z= - 
1.89 p=0.06 (n.s)]. A significant reduction of trunk accelerations were also noted 
in both the  AP and V directions across the environmental conditions in Group 
PV [AP:Colonade z= - 3.92 p=0.00; Dark t(49)= -3.39 p=0.00; Busy t(49)= - 3.58 
p=0.00; Cobbled t(49)= - 3.67 p=0.00; Quiet z= - 2.81 p=0.00 and V: Colonade 
z= - 3.69 p=0.00; Dark t(49)= -2.32 p=0.02; Busy t(49)= - 2.41 p=0.02; Cobbled 
t(49)= - 3.12 p=0.00; Quiet t(49)= -2.42 p=0.02]. Between-group mean 
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differences of RMS accelerations at the head, neck and trunk levels are 
displayed in Table 4.   
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Figure 5 Acceleration patterns at the head, neck and trunk levels across the five 




























































































































Table 4  Mean difference between groups,    (SD) of head, neck and trunk normalised 
RMS accelerations, nRMS (ms-2).  
 
  nRMS accelerations 
 
Level Environmental condition 









































































































The negative values indicate the nRMS was smaller in patients group as 
compared to healthy control group. Abbreviations:     nRMS= the difference of 
mean normalised RMS accelerations between groups; ML = medio-lateral; AP = 
antero-posterior; V=vertical. The asterisk (*) denotes significant between-group 
difference (* p < 0.05; ** p < 0.01). 
 
2.3.4.2 Effect of environmental conditions on within-group RMS 
accelerations. 
A significant effect of environment conditions on mean head nRMS 
accelerations was noted for Group PV in both ML [F(4,100)=4.09; p=0.00] and 
AP directions [F(4,100)=2.59; p=0.04]. For the ML direction, head nRMS 
acceleration was significantly lesser in both colonnade and busy condition 
compared to the cobbled environment.  In the AP direction, however, the 
significant effect observed earlier was no longer evident after post-hoc analysis. 
For Group C, a significant effect of environmental conditions on head nRMS 
acceleration was noted in the vertical direction only [F(4,145)=5.66; p=0.00 ] 
with post-hoc Bonferroni test revealed significant lesser accelerations in the 
busy compared to the cobbled and quiet environments.  
A significant effect of walking condition on mean neck nRMS acceleration was 
noted for all directions [ML:  F(4,100)=6.26 p=0.00; AP:F(4,100)=2.80; p=0.03; 
V: F(4,100)=2.76; p=0.03] for Group PV and in the AP and V directions for 
Group C [AP: F(4,145)=4.71; p=0.00; V:F(4,145)=7.4; p=0.00]. On post-hoc 
Bonferroni analysis, the significant effect observed in the vertical direction for 
Group PV was no longer evident. 
In both groups, the environmental condition significantly affected nRMStrunk 
accelerations in all directions [Group PV: ML: F(4,100)=6.13; p=0.00; 
AP:F(4,100)=5.73; p=0.00; V: F(4,100)=2.66; p=0.04 and Group C: ML: 
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F(4,145)=11.4; p=0.00;  AP: F(4,145)=11.35; p=0.00; V:F(4,145)=6.42; p=0.00]. 
However, the significant effect observed in vertical direction for Group PV was 
no longer evident following post-hoc Bonferroni analysis. Figure 6,7 and 8 
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Figure 7 Effect of environmental conditions on AP nRMS acceleration at head, neck 

















































































Figure 8 Effect of environmental conditions on V nRMS acceleration at head, neck and 
trunk.  
Abbreviation: nRMS=normalised accelerations RMS. The asterisk (*) indicates 
significant between- environmental condition difference. 
 
 
2.3.5 Angular movement patterns 
2.3.5.1 Overall angular movement patterns 
A significant between-group difference was noted only at the neck level for 
mean pitch RMS in the busy condition [z=-1.93; p=0.05]. Between-group mean 




















































Table 5 Mean difference (SED) of angular movement RMS at the head, neck and trunk 





Level Environmental condition 
Colonade Dark Busy Cobbled Quiet 





























































































The negative values indicate smaller values in patients compared to healthy 





2.3.5.2 Effect of environmental conditions on within-group mean angular 
movements 
A significant correlation was noted only between age and mean yaw RMS in the 
busy condition for Group PV [r=-0.52; p<0.05]. For Group PV, one-way ANOVA 
showed a significant effect of environmental conditions on mean yaw RMS at 
both the neck [F(4,100)=3.24; p=0.02] and trunk [ F(4,100)=2.79; p=0.03] levels. 
Post-hoc analysis revealed mean yaw RMS at the neck level was significantly 
higher for the ―busy‖ compared to both the colonnade [mean difference 
(MD)=2.21;  SED= 0.74; p<0.05] and quiet [MD=2.20; SED=0.74; p<0.05] 
environments. Yaw RMS at the level of the trunk was significantly greater for 
the ―busy‖ compared to the colonnade [MD=2.35; SED= 0.79; P<0.05] 
environment.  
For Group C, significant effect of environmental conditions at the head level was 
noted only in yaw RMS [f(4,145)=2.74; p=0.03]. However after the post-hoc 
analysis, the significant effect observed earlier in yaw RMS was no longer 
evident. At neck level, significant differences were noted for mean pitch RMS 
[f(4,145)=18.89; p=0.00] and yaw RMS [f(4,145)=2.7; p=0.03]. In pitch, 
significant differences occurring between the busy and colonnade environments 
as indicated by the post-hoc [MD= 0.44; SE=0.15; p<0.05]. While in yaw, 
significant differences were noted between the dark and colonnade [MD= 2.11; 
SE=0.15; p<0.01] as well as between the busy environment compared to the 
other four environmental conditions [Colonade: MD= 4.53; SE=0.55; p<0.01; 
Dark: MD= 2.42; SE=0.55; p<0.01; Cobbled: MD= 2.99; SE=0.55; p<0.01; 
Quiet: MD=3.56; SE=0.55; p<0.01] by which the former in each comparison was 
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always greater.  One way ANOVA showed significant environmental conditions 
effect on the mean trunk yaw RMS [f(4,145)= 12.16; p=0.00] whereby  higher 
trunk yaw movement noted in the busy environment compared to the colonnade 
[MD=3.60; SE=0.54; p<0.01], dark [MD=2.25; SE=0.54; p<0.01] and quiet 
[MD=2.49; SE=0.54; p<0.01] environments as indicated by the post-hoc. Similar 
pattern was also observed between the cobbled and the colonnade 
environments with the former showed greater yaw angular movement 
[MD=2.08; SE=0.54; p<0.01].  
For both groups, different environmental conditions were not significantly 
change head angular movements in pitch, roll and yaw. Figs. 9, 10 and11 
















Group PV Group C 
  
Figure 9 Effect of environmental conditions on mean pitch RMS angular at head, neck 













































































Figure 10 effect of environmental conditions on mean roll RMS at head, neck and trunk 
for each group.  
Yaw 
Group PV Group C 
  
Figure 11 Effect of environmental conditions on mean yaw RMS at head, neck and 
trunk level for each group. 
The asterisk (*) indicates significant differences between specified conditions.  
 
2.3.6 Relationship between mean total nRMS accelerationsand gait spatio-
temporal parameters.  
Figure 12 shows the relationship between preferred walking speed and the 
mean total raw accelerations and nRMS accelerations in both groups. In Group 
C, weak to strong positive correlations were noted between the mean total raw 
acceleration RMS for all directions and mean walking speed (ML: r=0.39; 
p=0.31; AP: r=0.54; p=0.02 and V: r= 0.72; p=0.00). Although normalised 


































































nRMS in the ML direction was weakly influenced by walking speed (ML: r=0.57; 
p=0.02). On the other hand, for Group PV, normalised accelerations RMS 
(nRMS) was strongly associated with walking speed [ML: r=0.99; p=0.00; AP: 
r=0.99; p=0.00 and V : r=1].  
Age did not significantly correlate either with mean raw total accelerations RMS 












Figure 12 Scatterplot showing the relationship between gait speed and RMS 
accelerations. 
The effect of gait speed on the mean total raw accelerations RMSin ML (a), AP (b) and 
V (c) directions and the mean total normalised accelerations (nRMS)  in ML (d), AP (e)  
and V (f) directions. 
 
For both groups, walking duration was inversely correlated with nRMS 
acceleration in all directions whereby shorter walking duration correlated with 
higher accelerations [For Group PV ML: r=-0.84; p=0.00; AP: r= -0.81; p=0.00; 
V: r=-0.84; p=0.00 and Group C ML: r=-0.37; p=0.04; AP: r= -0.69; p=0.00; V: 
r=-0.76; p=0.00]. A significant negative correlation was noted between walking 
steps and vertical nRMSacceleration in Group C [V: r= -0.41; 0.03]. 
 
2.3.7 Relationship between mean total nRMS accelerations and objective 
and subjective outcome measures in patients group.  
For subjective outcome measures, a significant positive correlation was noted 




r=0.5; p=0.02; AP: r= 0.53; p=0.01; V: r=0.51; p=0.02) whereby higher nRMS 
accelerations were noted with increased balance confidence levels.  
For objective outcome measures, both FGA and TUG were significantly 
correlated with the mean total nRMS accelerations. Increased total nRMS 
accelerations in each direction significantly correlated with increased (i.e. better) 
FGA scores [ML: r=0.69; p=0.00; AP: r= 0.70; p=0.00; V: r=0.69; p=0.00]. While 
lower (i.e. better) TUG scores associated with increased total nRMS 
accelerations [ML: r=-0.67; p=0.00; AP: r= -0.66; p=0.00; V: r=-0.67; p=0.00].  
 
2.4 DISCUSSION 
This study investigated postural stability, using data from accelerometers, 
during walking in urban environments between healthy-control adults and 
patients with a vestibular disorder. Association between the accelerometry data 
during urban walking and subjective clinical scales, functional capacity and 
spatio-temporal gait parameters were also investigated.  
The following discussion is separated into the following sections: (a) Gait 
patterns b) Postural stability during walking in different urban environments(c) 
Relationship between urban walking and standard clinical scales and 
assessments (d) Clinical implications. 
 
A) Gait pattern changes 
Our results showed that Group PV walked significantly slower and took longer 
duration of walking compared to healthy-control group (Group C) in almost all 
walking sections. No significant between-group difference was noted for walking 
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speed in a ―busy‖ environment and this could possibly due to the fact that 
participants need to adjust their walking speed to accommodate walking 
through a ‗crowd‘ such as to avoid bumping into people or vice versa. Reduced 
walking speed was previously reported in individuals with vestibular disorders 
compared to control group (Borel et al., 2004, Mamoto et al., 2002). It is 
suggested that adjustment to spatio-temporal gait parameters in individuals with 
a peripheral vestibular disorder is to compensate for dynamic instability during 
walking (Borel et al., 2004; Mamoto et al. 2002, Marchetti et al., 2008). Previous 
study have shown steps taken over a specific walking distance was not 
significantly different between healthy and patients with a unilateral vestibular 
disorder (Cohen and Sangi-Haghpeykar, 2011). This finding was in line with the 
current study.   
 
B) Postural stability during walking in different urban environments  
Relative to Group C, reduced trunk accelerations in the ML, AP and V directions 
were noted in almost all environmental conditions for Group PV. Reduced head 
and neck vertical accelerations were also noted for Group PV.  Comparisons of 
the head, the neck and the trunk accelerations data during walking in real urban 
environments between healthy controls and individuals with a confirmed 
peripheral vestibular disorder have not been reported previously. 
Patients with vestibular dysfunction, for which the central nervous system has 
not compensated, commonly report unstable gaze during active head 
movements. This is associated with impaired VOR which is a primary 
mechanism for gaze stability during head movement, especially at high velocity. 
Degradation of visual acuity is noticeable objectively in patients with unilateral 
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vestibular disorder although many patients may not complaint (Roberts and 
Gans, 2007, Dannenbaum et al., 2009, Badaracco et al., 2010). To enable 
optimum function of the impaired VOR in this patient, head movement need to 
be controlled. Head-trunk coordination helps organize inputs from the visual, 
somatosensory and vestibular systems to optimize dynamic postural control and 
gaze stabilization functions while walking. Therefore, it is hypothesized that 
reduced trunk acceleration during walking was implemented as a strategy to 
control head stability in Group PV. 
Reduced vertical head velocities during a walking task on a motorized treadmill 
at a controlled walk speed in patients with unilateral vestibular dysfunction 
(uVD) compared to healthy has previously been reported (Crane and Demer, 
2000). The authors suggested that limiting the head movement probably 
enabled compensation for impaired VOR gain in uVD patients. Current study 
finding was in line with previous work that found individuals with a peripheral 
vestibular disorder have reduced head accelerations in vertical direction. It is 
hypothesised that reduce head accelerations lessens vestibular stimulation 
thereby avoiding exacerbation of dizziness symptoms and unsteadiness due to 
an uncompensated vestibular disorder. 
Acceleration patterns during walking have been investigated in different groups 
including healthy young (Menz et al., 2003b) and older adults (Menz et al., 
2003c), frail community-dwelling older adults (Menz et al., 2003a), older adults 
in pathologic group (Parkinson Disease) and fallers (Latt et al., 2009). Older 
adults and patients with Parkinson Disease (PD) who experience falls 
demonstrate reduced head and trunk RMS accelerations compared to healthy 
younger adults and patients with PD respectively (Menz et al., 2003c, Latt et al., 
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2009). Community-dwelling older adults who were at higher risks for falls 
showed smaller amplitude and less rhythmic patterns of head and pelvis 
accelerations as compared to low-risk fallers older adults (Menz et al., 2003a). 
In addition, changes in gait characteristics (i.e. walking speed) were also noted 
in these groups as in our patients with unilateral peripheral vestibular 
dysfunction. 
Taken together the similar changes in acceleration patterns and gait 
characteristics found in previous and current studies, suggest that adjustment in 
gait patterns are necessary for a greater control over trunk motion, which helps 
head stabilization.  
No study to date has investigated the effect of different urban walking 
environments on acceleration patterns of the head, neck and trunk during 
walking. Effects of different walking surfaces i.e. level ground or uneven surface 
on acceleration patterns in young adults has previously been reported (Menz et 
al., 2003b). A study reported that, in young healthy adults, walking on an 
unpredictable uneven walkway (i.e. layers of artificial grass, foam and wooden 
blocks walkway) compared with a flat walkway resulted in higher acceleration at 
the pelvis, however the head accelerations remained relatively stable (Menz et 
al., 2003b). Although the aforementioned study was conducted in a controlled 
laboratory setting, similar findings were noted for Group C individuals in the 
current study, particularly for head and trunk nRMS accelerations in the ML and 
AP directions. Unlike the healthy control group, Group PV showed higher head 
and neck nRMS in the ML direction, in addition to increased trunk accelerations. 
This suggests that head stability in the ML direction has been compromised in 
Group PV while they walk on a cobbled street. Overall, Group PV had reduced 
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trunk movements compared to the healthy control group. It is known that the 
trunk plays an important role in attenuating gate-related oscillations from 
impacting head motion during walking (Cappozzo, 1984). Efficient coordination 
of trunk and lower limbs movements provides stability for upright posture during 
walking. Our findings showed that patients with a vestibular disorder have 
difficulty controlling trunk movement and maintaining head stability particularly 
when walking on irregular terrain. It has been reported previously that 
modulation of ML accelerations is not only linked to shock absorption but also to 
walking balance.  Greatest attenuation of upper body accelerations in upward 
direction (i.e. from  lower trunk to head) noted in the ML direction has been 
suggested to provide stability to head-on-trunk as a platform for optimal 
vestibular and visual information processing (Wilhelmsen et al., 2010). It is likely 
that this function is impaired in patients with vestibular disorder. Therefore 
normalised RMS accelerations in the ML direction may potentially be useful as 
a measurement for gait abnormality (Wilhelmsen et al., 2010, Sekine et al., 
2013). 
It was noted that, in Group C, walking on a cobbled street compared to the 
other walking environments led to higher head and neck accelerations in the 
vertical direction, in addition to increased trunk acceleration. This could possibly 
relate to the vertical ground reaction force (GRF). Association of GRF, vertical 
impact and walking speed has been studied extensively whereby GRF 
increased linearly with gait speed within a specified speed during walking 
(Keller et al., 1996). As this force transmitted through the body, neuromuscular 
systems and joints contribute to attenuating the force impact from reaching the 
head. The trunk acts as the attenuator, filtering excessive vibrations from 
reaching more superior levels thus reducing the impact and helping to maintain 
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a stable trajectory at head level (Prince et al., 1994).  However the filtering 
effect has been shown to be minimal in the vertical plane (Prince et al., 1994). 
Although the GRF was not measured in the current study, walking velocity was 
significantly higher in Group C compared to Group PV in almost all 
environmental conditions.  A higher walking speed produces a greater force 
upon foot contact with the ground during the gait cycle. Therefore the remaining 
vibrations passed to the head from the trunk are possibly enough to threaten 
upper body stability in vertical direction during walking which agrees with our 
findings showing increased vertical head accelerations. 
In the current study, the head, the neck and the trunk rotations in pitch, roll and 
yaw directions were also investigated. Overall, mean RMS rotation of the head, 
neck and trunk in all three directions was not significantly different between 
Group PV and Group C for all walking environments. Previous studies have 
already demonstrated that during gait, head motion is minimised through the 
coordination of trunk and lower limbs movements (Pozzo et al., 1990). The 
lower limbs i.e. legs moved in a wider range relative to head and acts like 
actuators of head-trunk unit (Pozzo et al., 1990). This is believed to serve as a 
stable platform for visual and vestibular processing which is important which is 
important for maintaining postural stability control during walking (Pozzo et al., 
1990, Lang et al., 2013). Our finding support previous reports regarding the 
importance of head movement control within the body postural control system 
during walking. Furthermore, the current study found that walking through a 
‗busy‘ section compared to other walking sections, produced higher mean 
rotation in the yaw direction at both the trunk and neck level, both groups. It was 
hypothesised that walking in a busy environment induce greater yaw rotation of 
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the trunk and neck as a way to accommodate walking through a 'crowded' to 
avoid bumping into people as well as a mechanism to keep the head stable. 
These results indicate that walking in an urban environment provides 
challenges to postural stability control in patients with a unilateral vestibular 
disorder. Walking at a slower speed and reduced trunk accelerations could be 
compensatory mechanisms to provide stability in an upright position during 
walking in the patient group.  
 
Association of urban walking postural control strategies with standard 
functional assessment and ABC scale. 
Increased total nRMS acceleration, was significantly associated with an 
increased balance confidence level (ABC), higher (i.e. better performance) 
functional gait assessment (FGA) and reduced (i.e. better performance) time up 
and go (TUG) scores in Group PV. The ABC finding was in line with previous 
studies which showed significant association between the balance confidence, 
gait performance  (Marchetti et al., 2011) and self-perceived handicap (Whitney 
et al. 1999, Whitney et al., 2004b). Although the ABC scale has been shown to 
discriminate recent fallers from non-fallers in an older adults population, but the 
scale has not been shown to correlate with falls in patients with unilateral 
vestibular disorders (Marchetti et al., 2011). An ABC score of less than 80% has 
been considered abnormal (Herdman et al., 2012, Myers et al., 1998). However 
further research is warranted to identify to what extend of abnormal balance 




A significant association was also noted between nRMS acceleration and both 
FGA and TUG in Group PV only whereby higher total normalised RMS 
acceleration was associated with higher FGA score (i.e. better performance) 
and shorter time for TUG. Both FGA and TUG have been used to assess 
functional mobility in different patient populations including those with vestibular 
disorders (Wrisley et al., 2004, Whitney et al., 2004a, Gil-Body et al., 2000). The 
TUG includes timed walking at speeds required to safely cross a street 
(Robinett and Vondran, 1988) and the FGA includes complex tasks necessary 
for functional mobility. Reduced gait speed is associated with reduced functional 
activity capacity and increased falls risks (Whitney et al., 2004a). The TUG has 
been shown to be associated with change in physical performance following 
vestibular rehabilitation in adults with balance and vestibular disorders (Meretta 
et al., 2006) and difficulty of performing ADLs in older adults (Podsiadlo and 
Richardson, 1991).  Although the TUG assesses gait speed, which is 
functionally important, it does not assess the quality of performance such as 
ability to modify gait to task demands or ability to perform other functional 
activities. Both FGA and TUG are useful as a screening tool to identify potential 
balance problems and predict falls risk. However they are unable to provide 
information regarding the underlying balance impairments that limit functional 
independence.  
Given all findings from the current study, a higher level of balance confidence 
and better functional performance is associated with higher nRMS accelerations 
which suggesting better postural stability control in patients with a vestibular 
disorder (uVL). There is no study to date assesses relationship between upper 
body accelerations during walking with standard clinical scales as well as 
functional assessments in patients with a peripheral vestibular disorder. These 
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preliminary findings, findings of the current study suggested that data from 
accelerometry can be used to assess dynamic functional performance which 
may be helpful in identifying the underlying balance impairment in patients with 
a vestibular disorder. 
 
Clinical implication 
It has been shown that the majority of patients with peripheral vestibular 
disorders respond well to rehabilitation but some remain affected by dizziness 
and imbalance symptoms (Whitney and Sparto, 2011, Herdman et al., 2012). 
Previous studies have highlighted the impact of vestibular disorders on dynamic 
locomotion including changes in postural stability and orientation as well as 
spatio-temporal gait parameters. Unfortunately, most of the assessments were 
conducted in controlled environment settings and this may not reflect to the 
actual conditions that patient‘s balance control usually challenged. Therefore 
the use of accelerometers as part of clinical tool may provide additional 
information related to balance control that could not be identified by standard 
clinical tools. Accelerometers have also been shown to be capable of 
monitoring changes in trunk acceleration patterns following vestibular 
rehabilitation in patients with a unilateral vestibular disorder (Wilhelmsen et al., 
2010). A study showed that ML RMS acceleration at the upper trunk was 
reduced while accelerations at the lower trunk increased following vestibular 
rehabilitation (Wilhelmsen et al., 2010). The authors suggested that the change 
in the upper trunk attenuation particularly in the ML direction and associated 
with improved mobility of the lower trunk, indicated better head control as well 
as increased adaptability of the lower trunk to external demands. These 
 91 
 
changes are compatible with improved balance control during walking in 
patients with unilateral vestibular disorder. This previous finding further supports 
the potential usage of the accelerometers in assessing balance control during 
walking and also to measure the effectiveness of treatment in patients with 
unilateral vestibular disorder. In addition accelerometers are small in size and 
relatively low cost make it potentially useful to be used to assess a patient's 
outdoor mobility.  
It is noted in this study that ABC scale score is significantly associated with 
normalised RMS acceleration in patients. Although it is not clear whether 
reduced acceleration as a result of low balance confidence or impaired postural 
control directs to poor balance confidence, it is important to acknowledge this 
relationship. If the former is true, identifying patients with low balance 
confidence level follows by a proper intervention in treating the confidence level 
may facilitate to a better postural control.  
It is hoped these findings may provide better understanding of dynamic postural 
stability control in patients with a vestibular disorder and helps to further 
develop advances in vestibular rehabilitation where optimal treatment strategies 
remain to be determined. 
 
Conclusion  
Current study findings indicate that people with a vestibular disorder employ 
compensatory mechanisms including reduced walking speed and reduced trunk 
acceleration to maintain postural stability while mobilising in urban environment. 
Walk on uneven surfaces further challenged upper body stability particularly in 
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ML direction in patients. This supports previous reports on the importance of 
trunk movement to facilitate head stability during walking. Significant correlation 
has been noted between normalised RMS accelerations and balance 
confidence, walking duration and some standard clinical assessment tools (i.e. 
TUG and FGA). Accelerometer could be a useful tool to measure gait and 
balance impairment particularly in outdoor setting, monitor changes in postural 
stability while performing dual-tasking, and monitor the effectiveness of 














CHAPTER 3 :EFFECT OF URBAN WALKING ENVIRONMENTS ON 
POSTURAL CONTROL IN PATIENTS WITH STROKE 
 
3.1 INTRODUCTION 
Stroke is a leading cause of disability in the United Kingdom and a primary goal 
in stroke rehabilitation is to improve walking ability. Post-stroke, sixty to eighty 
percent of people can walk independently (Kelly-Hayes et al., 2003), but only 
50% regain community ambulation (Perry et al., 1995). The majority of people 
with stroke rate community ambulation as ―essential‖ (Lord et al., 2004) and 
when limited it has been shown to affect quality of life, level of satisfaction, and 
mood disorders (Pound et al., 1998). In recent years, studies have begun to 
identify the factors which are associated with participation in community 
ambulation after stroke.  
Community ambulation requires a person's ability to integrate walking with other 
tasks such as walk while carrying a shopping bag, in a complex environment. 
People with chronic stroke report community ambulation as difficult; with factors 
such as reduced gait speed (Olney and Richards, 1996, Lamontagne et al., 
2007b), poor endurance (Eng et al., 2002, Iosa et al., 2012c) and reduced 
ability to adapt to environmental tasks demands (Said et al., 1999, Lamontagne 
et al., 2003, Lamontagne et al., 2005b, Lord et al., 2006, Hollands et al., 2010) 
suggested as contributing factors to this. A recommended gait velocity for safe 
community ambulation has been suggested depending upon the task performed 
e.g. walking indoors vs crossing a road and the environment e.g. rural vs. urban 
where faster gait speeds are crucial for the latter tasks and environments 
(Shumway-Cook et al., 2002, Robinett and Vondran, 1988).  Reduced gait 
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speed in chronic stroke patients may increase gait instability (Iosa et al., 2012c) 
and as a consequence increase a person‘s risk for falls. Fall during walking are 
commonly reported for this population (Harris et al., 2005). 
Walking in urban environment constantly required changes in postural control 
strategies in order to adapt to the environmental demands such as walking in a 
crowd, crossing obstacles and roads, avoiding bumping into people and 
scanning the environment for navigational and safety purposes. Altered 
orientation and coordination of gaze and body movements during walking and 
turning post stroke, results in difficulty to execute head motion, turning and 
steering while walking (Lamontagne et al., 2007a, Lamontagne and Fung, 
2009). Reduced ability to step over obstacles successfully; particularly high 
obstacles has also been noted (Said et al., 1999). Failure to clear obstacles 
which may, or may not be clearly visible e.g. uneven terrain, holes, bumps 
during ambulation could provide more challenges to dynamic balance control in 
people with stroke.  
Functional walk tests such as the 6 and 12-Minutes Walk Test (6MWT and 12 
MWT respectively) are commonly used in clinical settings to assess walking 
endurance in patients with stroke (Iosa et al., 2012c, Eng et al., 2002).  
Outcomes from these functional walk tests mainly focus on walking speed and 
the distance covered during ambulation which is commonly a short distance 
indoors setting. Furthermore, these tests do not  take into consideration change 
in gait patterns resulting from environmental (walking on cobbled pathway vs. 
level ground) and task demands (carrying a shopping bag)  which is known 
crucial for community ambulation following stroke (Lord et al., 2006). Therefore 
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outcomes of these tests may not reflect a person's actual gait performance in 
real world situations. 
As previously stated accelerometers allow for the measurement of postural 
stability control during walking in healthy people and in patients with sensory 
impairment (i.e. vestibular system). In a stroke population, accelerometers have 
been widely used for assessing physical activities involving the upper and lower 
extremities. Systematic reviews demonstrate that accelerometry based system 
is a valid and reliable tool to measure physical activity in stroke survivors 
(Green, 2007, Gebruers et al., 2010). The system has been used in different 
settings (indoor and outdoor) and to monitor different stages of stroke 
rehabilitation (acute or chronic), however limited studies have used 
accelerometers to evaluate gait stability during walking. A study by Iosa and 
colleagues (2012c) focused on the effect of prolonged walking on gait stability in 
stroke. The findings showed a significant reduction in walking speed, walking 
distance and raw trunk accelerations in people with stroke compared to the 
healthy group. In addition, stroke patients with different level of walking 
capability (i.e. walk shorter vs longer distance) demonstrated different walking 
strategies in which longer- distance walkers maintained their walking speed with 
their trunk acceleration progressively increasing overtime. This suggests an 
increase in gait instability over the duration of the walk in patients who walked 
longer distance. In contrast, those walked at a shorter distance progressively 
reduced their walking speed without any significant change in trunk acceleration 
(Iosa et al., 2012c).  
Therefore the aim of this study remains to determine upper body stability 
control, by using accelerometers when walking in real urban environments in 
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independent, community-dwelling stroke survivors. Furthermore, patients with 
stroke have been shown to be over-reliant on visual cues for balance (Slaboda 
et al., 2009). Therefore it was hypothesised that in busy visual environments i.e. 
walking through a crowded train station where visual cues are inaccurate this 
patient cohort would experience greater difficulty with regards to healthy control 
individuals. A secondary aim was to determine the association between 
accelerometry data and functional abilities, visual dependence and subjective 
outcome measures in patients with stroke.   
 
3.2 MATERIAL AND METHODS 
3.2.1 Subjects 
All participants were aged between 18 and 65 years old and independently 
mobile community dwelling individuals. Participants with history of stroke 
(Group S) were recruited from members of the Different Strokes charity set up 
for younger stroke survivors and from other local community support group for 
patients with stroke in central and southeast London. The inclusion criteria were 
1) history of a single stroke; 2) able to independently walk in the community with 
or without the use of a single-pointed stick. Exclusion criteria were 1) presence 
of additional neurological condition other than stroke; 2) Other medical problem 
in acute phase e.g. orthopaedic injury; 3) severe visual impairment (i.e. visual 
field deficits); 4) Abbreviated Mental test score ≤7 (Hodkinson, 1972). 
Healthy individuals (Group C) were recruited via circular email to students and 
staff members attending King's College London, London, UK. The inclusion 
criteria were no self-reported history of 1) a balance problem or dizziness; 2) an 
acute orthopaedic injury; or 3) neurological condition including stroke.  
 97 
 
All participants were requested to avoid from taking alcohol 24 hours prior 
testing. Local ethic committee approval was obtained and informed consent 
from all participants was obtained after study procedures were fully explained.  
 
3.2.2 Self-report assessments 
All participants completed a set of validated questionnaires relating to 
confidence level, current emotional state and vertigo-related provoking 
situations prior to completing the urban walking task.  
a. The Situational Vertigo Questionnaire (SVQ) (Guerraz et al. 2001) yields a 
normalized score between 0 (never) to 4 (always) measuring how frequently 
symptoms are provoked or exacerbated in environments with visual-vestibular 
conflict or intense visual motion (e.g. walking down a supermarket aisle, 
watching moving television scenes). Normalised scores >0.7 indicate the 
presence of visual vertigo symptoms (Pavlou et al. 2006).  
 
b. The Activities Specific Balance Confidence Scale (ABC) assesses confidence 
level (percentage) a person has in conducting activities of daily living such as 
bending over, reaching things, indoor and outdoor mobility (i.e. walk around the 
house, walk outdoor in busy places such as mall and walk on uneven surface 
such as a ramp, icy sidewalks) without losing balance or becoming unsteady 
(Powell and Myers, 1995).  ABC has been used widely in stroke population 
(Botner et al., 2005, Salbach et al., 2006, Ng, 2011, Schmid et al., 2012) and 
has been shown to be a valid and reliable tool for assessing confidence level in 
performing ADLs for individual with stroke (Botner et al., 2005). Scores range 
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between 0% (no confident) to 100% (complete confidence). Responses to 
individual questions are then averaged to get a percentage score, with lower 
scores indicating less confidence in ADL performance.  
 
c.  The Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 
1983) independently measures anxiety (HAD-A) and depression (HAD-D) 
symptoms. Score range between 0 and 21 for each subscale. The scale has 
been validated for stroke group and score of 8 and more indicating a significant 
level of depression or anxiety symptoms (Aben et al., 2002). 
 
3.2.3 Fugl-Meyer Motor function assessment of post-stroke hemiplegic 
The Fugl-Meyer Motor Assessment scale (Fugl-Meyer et al.,1975) was used to 
assess motor function ability. Only Group S participants completed this test. 
The scale has been validated and shown good reliability for use in a stroke 
population (Gladstone et al., 2002, Salter et al., 2005). The assessment items 
include measurement of movement ability (i.e. shoulder, elbow, forearm, wrist, 
hand, hip, knee, ankle flexion and etc), reflexes and movement speed. Score 
ranges between 0 (cannot perform) and 2 (perform fully). Total score ranges 
between 0 (hemiplegic) and 100 points (normal motor performance) and divided 
into two parts: 1) upper extremity which consists of maximum 66 points and 2) 
lower extremity maximum points of 34.  Each movement was performed on the 




3.2.4 Objective measures 
3.2.4.1 Rod and Disc test 
The Rod and Disc test measures perceptual responses for visual dependence. 
Each participant was instructed to sit upright 80cm, eye levelled, from a disc 
covered with white dots projected from a screen. A chin rest secured the 
participant‘s head position and feet were positioned on a footstool throughout 
the experiment. Four trials were completed for each disc condition (static disc, 
clockwise (CW), or counter clockwise (CCW) rotation). Before each trial, 
participant was asked to close his/her eyes, the disc either static or begins to 
rotate approximately 30°/s and the rod was tilted approximately 40º, clockwise 
or counter clockwise, in counterbalanced order and this was randomized 
between participants for each test condition. Each participant was instructed to 
adjust the tilted rod to his/her perceived gravitational vertical using a wireless 
mouse without time constraint. The experiment was conducted in darkness with 
the only visible object being the rod and dots.  All participants completed the 
static disc condition as a baseline prior to rotational disc conditions.  The Rod 
and Disc software is a customised programmed by Mr. David Buckwell at 
Imperial College London, U.K. Subjective visual vertical (SVV) was calculated 
as angular deviations (degrees) of the top of the rod from the true gravitational 
position (00) for each trial. The positive and negative values indicated the 
direction of disc rotation CW and CCW respectively. The SVV values were 




3.2.4.2 Timed Up and Go (TUG) 
The TUG is a simple and quick clinical test that can be used to assess 
functional mobility in frail elderly including stroke patients (Faria et al., 2012, Ng, 
2011, Salbach et al., 2006, Ng and Hui-Chan, 2005, Podsiadlo and Richardson, 
1991). TUG has shown excellent interrater (0.91 ≤ICC ≤ 0.95) (Faria et al., 
2012, Ng et al., 2005) and intrarater reliability (ICC = 0.75) (Faria et al., 2012) in 
patients with stroke and TUG also able to discriminate functional mobility 
between healthy and chronic stroke (Ng et al., 2005). The TUG score was 
recorded in a unit of ‗seconds‘. 
 
3.2.4.3 Functional Gait Assessment (FGA) 
A ten-item test based on the Dynamic Gait Index (DGI) includes tasks such as 
walking with head movements, tandem, or backwards. Each item is rated 
between 0 (severe impairment) and 3 (normal) with a maximum score of 30; 
higher scores indicate better performance.  The FGA has shown to be a valid 
and reliable tool for patients with stroke with high intrarater (0.95 ≤ICC ≤ 0.97) 
(Lin et al., 2010, Thieme et al., 2009) and inter-rater reliability (ICC=0.94) 
(Thieme et al., 2009).  The FGA has also shown a moderate responsiveness in 
detecting changes following rehabilitation in patient with stroke (Lin et al., 2010). 
A minimal ceiling effect has been noted in FGA as compared to the DGI 
indicating FGA has the best discriminative ability for stroke patients who are 




3.2.5 Urban walking procedures 
All participants were instructed to walk at their own comfortable walking speed 
throughout the urban walking task. The use of a walking aid (i.e. single-pointed 
walking stick) for Group S participants, as normally applied for the person‘s 
mobility routine, was allowed. The procedure for the experimental set-up, urban 
walking route, data acquisition and processing are followed as under the 
heading "Urban walking procedures" in Chapter 2 (Sections 2.2.4 to 2.2.6). 
 
3.2.6 Analysis 
Statistical analyses were performed using SPSS version 17. For normally 
distributed data, an independent sample t-test was used to compare between-
group differences. For non-normally distributed and ordinal data, a Mann-
Whitney U test was performed. One-Way ANOVA was conducted to examine 
the within-group effect of urban environments on the postural strategies used. 
Spearman‘s correlation was performed to investigate the relationship between 
total acceleration data and self-reported outcome measures (SVQ, ABC, and 
HAD), Fugl-Meyer scores, objective outcome measures (TUG and FGA) and 
spatio-temporal variables (gait speed, walking duration and steps) within-
groups. Only significant findings were reported in the result section.Significant 





3.3.1 Subject information 
Thirty-three subjects participated in this study (Group S=17 and Group C=16). 
Mean age was 52 years (range: 36-65 years) for Group S and 46 years (range: 
26-62 years) for Group C. There was no significant between-groups difference 
for age (t(31)=1.67; p=0.11). Full demographic and clinical characteristics of 
Group S upon recruitment are displayed in Table 6.  
Table 6 Table 6 Demographic and clinical characteristics of Group S upon recruitment 
Variable Group S 
Age (y) (mean, range) 52 (range: 36-65 years) 
Gender,n 
       Male, n (%) 
















3.3.2 Self-reported outcome measures 
Significant differences were noted between-groups for all self-report measures. 
Group S scored significantly lower (i.e worse) on the ABC scale [z=-4.79; 
p<0.01] and showed a higher (i.e worse) mean score for non-somatic anxiety 
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(HAD-A) [z=-2.50; p=0.01], depression (HAD-D) [z=-4.59; p<0.01] and SVQ [z=-
1.95; p=0.05] as compared to Group C. Descriptive data for all questionnaire 
scores are displayed in Table 7. Within-group descriptive data, significant HAD 
scores were noted in seven and eight of Group S participants for anxiety and 
depression symptoms respectively. More than half (n=10) of Group S scored 
ABC less than 67% which indicating of risks for falls. Abnormal SVQ score was 
noted in five of Group S participants which suggesting of visually vertigo. All 
Group C participants HAD and ABC score were within normal range and almost 
all (n=15) had SVQ within normal range.   
 
Table 7 Mean (SD) for self-reported outcome measures 




HAD-A 7.59 (4.84)  3.44 (2.42)* 
HAD-D 7.71 (3.93) 1.00 (1.00)** 
ABC 57.77 (25.75) 97.19 (2.53) ** 
SVQ 0.72 (0.86) 0.28 (0.73) * 
Abbreviations: Group S= patients with stroke; Group C= control healthy; 
SVQ=Situational Vertigo Questionnaire;HAD-A=Hospital Anxiety and 
Depression (Anxiety scale);HAD-D=Hospital Anxiety and Depression 
(Depression scale);ABC=The Activities Specific Balance Confidence Scale. The 




3.3.3 Objective outcome measures 
Significant between-group differences were noted for all objective measures 
outcomes except RDT static scores. Group S mean scores were significantly 
lower (i.e. worse) for the FGA [z=-4.88; p<0.01], required a longer time to 
complete the TUG [t(18)=6.24; p<0.01] and showed greater SVV tilt [z=-1.98; 
p=0.05] compared to Group C. Mean scores (SD) for FGA, TUG and RDT are 
shown in Table 8. 
 
3.3.4 Urban gait outcomes 
3.3.4.1 Steps, walking duration and gait speed 
Significant between-group differences were noted for all gait variables. The time 
required to complete the urban walking task was significantly longer for Group S 
[t(18)=5.47; p=0.00] who also took more steps [t(15)=2.18; p=0.05] and had a 
reduced gait speed in each environmental condition [Colonade: t(26)=-6.13; 
p<0.01; Dark: t(28)=-6.17; p<0.01; Busy: t(25)=-6.42; p<0.01; Cobbled: t(29)= -
5.96; p<0.01; Quiet: t(30)=-5.67; p<0.01]. Descriptive data for walking speed, 
duration and number of steps taken for each group can be found in Table 8. 
 
Table 8  Mean (SD) values for objective outcome measures and urban gait data 




FGA 19.7 (5.85) 29.6 (0.62)** 
TUG 13.8 s (3.96) 7.6 s(1.02)** 
Static SVV (degrees) 0.15 (1.92) 0.49 (0.59) 
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Dynamic SVV ( degrees) 4.99 (2.82) 3.36 (3.58)* 
Urban gait  
Number of steps taken to 
complete route 
1350 (435) 1089 (118.6)* 
Walk duration (min.) 21.63 (4.50) 15.2 (1.32)** 
Urban walking velocity, ms-1 
Colonade 0.99 (0.28) 1.47  (0.16)** 
Dark 1.00 (0.27) 1.50 (0.18)** 
Busy 0.95 (0.24) 1.36 (0.12)** 
Cobbled 0.97 (0.33) 1.55 (0.22)** 
Quiet 1.03 (0.27) 1.50 (0.20)** 
 
Abbreviations: Group C= patients with stroke; Group C= control healthy; 
FGA=functional gait assessment; TUG=Time up and go; SVV=Subjective visual 
vertical. The asterisk (*) denotes a significant between-group  difference 
(*p<0.05; **p<0.01) 
3.3.5 Acceleration patterns 
3.3.5.1 Overall acceleration patterns 
Normalised RMS acceleration (nRMS) patterns for the head, neck and trunk 
across the five environmental conditions for both groups are illustrated in Figure 
13. Greater AP head nRMS was noted in Group S compared to Group C 
[APHead: Colonade: t(31)= 2.25 p=0.03; Dark t(31)= 2.24 p=0.03; Busy t(31)= 
2.14 p=0.04; Cobbled t(31)= 3.51 p=0.00; Quiet t(31)= 3.10 p=0.00]. Reduced 
head nRMS was noted in the V direction for Group S compared to Group C 
 106 
 
[VHead: Colonade t(31)= -5.78 p=0.00; Dark t(31)= -5.84 p=0.00; Busy t(31)=-
6.75 p=0.00; Cobbled t(31)= -6.36 p=0.00; Quiet t(31)= -5.46 p=0.00].  
At neck level, mean  nRMS in V directions were significantly smaller for Group 
S compared to Group C in all environmental conditions [ Colonade t(31)= -5.72 
p=0.00; Dark t(31)= -5.61 p=0.00; Busy t(31)=-6.31 p=0.00; Cobbled t(31)= -
5.76 p=0.00; Quiet t(31)= -5.27 p=0.00]. Smaller AP neck nRMS was noted in 
‗busy‘ [t(31)=-2.29 p=0.03] and ‗cobbled‘ [t(31)=-2.63 p=0.01] conditions.  
Group S demonstrated smaller trunk V and AP nRMS compared to healthy 
controls (Group C) for all environment conditions [APTrunk: Colonade t(31)= -
6.08 p=0.00; Dark t(31)= -6.28 p=0.00; Busy t(31)=-6.98 p=0.00; cobbled AP 
t(31)=-6.17 p=0.00; Quiet t(31)= -6.00 p=0.00 and VTrunk: Colonade t(31)= -
5.37 p=0.00; Dark t(31)= -5.32 p=0.00; Busy t(31)=-5.97 p=0.00; Cobbled 
t(31)=-5.68 p=0.00; Quiet t(31)= -4.99 p=0.00]. Reduced trunk nRMS was also 
noted in the ML direction for Group S, particularly in the cobbled environmental 
condition [Trunk Cobbled: ML t(31)=-2.67 p=0.01]. Between-group mean 
differences of RMS accelerations at the head, neck and trunk levels are 
displayed in Table 9 with a negative value indicating a reduction of acceleration 















Figure 13 Accelerations patterns at the head, neck and trunk levels across the five 
environmental conditions.  
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Table 9 Mean difference between groups (    )  for  nRMS accelerations at the head, 
neck and trunk. 
 
  nRMS accelerations 
 
Level Environmental condition 
Colonade 
Dark Busy Cobbled Quiet 


























































































The negative values indicate the nRMS was smaller in patients group as compared to 
healthy control group. Abbreviations:     nRMS= the difference of mean normalised 
RMS accelerations between groups; ML = medio-lateral; AP = antero-posterior; 





3.3.5.2 Effect of environmental conditions on within-group RMS 
accelerations. 
A significant effect of environmental condition on nRMS head acceleration was 
only noted for Group S  with post-hoc tests revealing a significantly greater AP 
acceleration in the ‗cobbled‘ compared to ‗busy‘ environmental condition 
(F(4,80)=2.43 p=0.05).  
A significant effect of environmental conditions on neck acceleration was noted 
only for Group C with post-hoc test revealed a significantly increment in vertical 
acceleration in the ‗cobbled‘ compared to the ‗busy‘ environmental condition 
(F(4,80)=0.88 p=0.48).  
For both groups, RMS trunk acceleration in both ML and AP directions 
significantly varied with environmental conditions [Group S: ML:F(4,80)=3.30 
p=0.02; AP:F(4,80)=2.62 p=0.04; Group C: ML: F(4,75)=4.96 p=0.00;    AP: 
F(4,75)=4.22 p=0.00]. For Group C, trunk acceleration in both ML and AP 
directions was significantly greater in ‗cobbled‘ compared to ‗colonade‘ and 
‗busy‘ environmental conditions. For Group S, post-hoc analysis revealed 
significant different between environments in the ML direction only. Figure 14, 






Group S Group C 
  
Figure 14 Effect of environmental conditions on ML nRMS acceleration at head, neck 
and trunk.  
Antero-Posterior 
Group S Group C 
  

























































































Figure 16 Effect of environmental conditions on within-group V nRMS acceleration at 
head, neck and trunk.  
Abbreviation:nRMS=normalised accelerations RMS. The asterisk (*) indicates 























































3.3.7Association between mean total accelerations and gait spatio-
temporal parameters. 
Figure 17 shows the relationship between the mean total preferred walking 
speed and the mean total raw accelerations and nRMS accelerations in both 
groups. For Group C, significant positive correlations were noted between the 
mean total raw accelerations RMS in AP and V direction and the mean walking 
speed (AP: r=0.85; p=0.00 and V: r= 0.89; p=0.00). A significant correlation was 
also noted between the normalised accelerations (nRMS) in all directions and 
the walking speed (ML: r=0.57; p=0.21; AP: r=0.94; p=0.00 and V: r= 1; p=0.00) 
for Group C. For Group S, the mean walking speed was significantly correlated 
with mean total raw accelerations (AP:r=0.62; p=0.01 and V : r=0.87;p=0.00) 
and nRMS (AP: r=0.70; p=0.00 and V : r=1;p=0.00) both in AP and V directions. 
Age was not significantly correlated either with mean total raw accelerations 














The effect of walking speed on the mean total raw accelerations RMS in ML (a), AP (b) 
and V (c) directions and the mean total normalised accelerations (nRMS) in ML (d), AP 
(e)  and V (f) directions. 
 
 
In both groups, a shorter total walk duration and smaller number of steps taken 
to complete the walking task significantly correlated with a greater nRMS 
acceleration in V direction [Group S: Steps r=-0.72; Duration=-0.88 p=0.00; 
Group C: Steps r=-0.60 p=0.01; Duration r=-0.74 p=0.00].  
 
3.3.8 Correlation between mean total nRMS accelerations and objective 
and subjective outcome measures in patients group.  
A significant positive correlation was noted between Fugl-Meyer scores and 
total nRMS accelerations particularly in the AP and V directions. Higher Fugl-
Meyer scores (i.e. better performance) were associated with greater total RMS 
accelerations [Fugl-Meyer upper limb: AP r=0.61 p=0.01; V r=0.69 p=0.00 and 
Fugl-Meyer lower limb: AP r=0.55 p=0.03; V r=0.72 p=0.00]. Lower TUG (i.e. 
better) scores significantly correlated with higher vertical nRMS accelerations 
(r= -0.79; p=0.00). No subjective outcome measures significantly correlated with 








Vertical head, neck and trunk nRMS was significantly smaller in Group S 
compared to the age-matched healthy control group. Greater head and smaller 
AP trunk nRMS were also noted in Group S. Overall, the healthy group 
maintained head stability by modulating trunk coordination while navigating in 
an urban environment. Mobilising on an uneven surface had the greatest effect 
and induced head instability particularly in the AP direction (the direction of 
progression) in patients with stroke (Group S). 
The following discussion is separated into the following sections: (a) Gait 
pattern changes; b) Postural stability during walking in an urban environment; 
(c) the relationship between urban walking and standard clinical scales and 
assessments (d) Clinical implications. 
A) Gait pattern changes 
Findings of the current study showed that patients with stroke walked at a 
slower speed, took more time and more steps to complete the urban walking 
task than the age-matched control individuals. Although no statistical 
comparison was made between two pathological groups (stroke vs vestibular 
impairment (finding from Chapter 2)), it was noted that patients with stroke 
walked at a slower rate compared to the latter group.  Our results agree with 
previous findings showing impaired gait parameters (i.e. gait speed, ambulation 
duration) following stroke (Sibley et al., 2009, Mizuike et al., 2009, Iosa et al., 
2012b, Iosa et al., 2012c).  
Some researchers (Perry et al., 1995, Hill et al., 1997) have found a correlation 
between gait velocity and community ambulation in patients with stroke while 
others do not (Lord et al., 2004). A recent study found that gait velocity, 
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balance, and physical factors of the hemiparetic limb, including lower limb 
strength, explained only a small amount of the variance for community 
ambulation (Robinson et al., 2011). There was also no association noted 
between participation and ability on complex walking tasks performed in a 
laboratory setting (Robinson et al., 2011). However this is different to being able 
to navigate complex environments and adapt gait according to environmental 
(walking on cobbled pathway vs. level ground) and task demands (carrying a 
shopping bag) which is crucial for community ambulation following stroke (Lord 
et al., 2006, Patla, 2001, Perry et al., 1995). 
Robinett and Vondran data (1988) showed that walking in urban environments 
(i.e. cities with a population size > 95 000) requires faster gait speed and ability 
to walk longer distances compared to rural or small towns. One of the 
requirements for safe community ambulation is gait velocity of at least 0.8m/s. A 
person with chronic stroke who walks less than 0.80m/s in a clinical setting has 
been shown to have difficulties in navigating slopes and busy environments 
(supermarket) during community ambulation (Taylor et al., 2006). In the present 
study gait velocity for people with stroke ranged from 0.95 to 1.03 m/s and this 
is slower than gait speed (i.e. ranged between 1.23 and 1.35 m/s) recorded 
from people with vestibular disorder (Chapter 2).  This range in gait speed may 
not be sufficient for person with stroke to safely negotiate an intersection 
crossing before the signal change, as crossing times are based on  a minimum 
gait speed of 1.2 m/s (Bohannon et al., 2011). Following stroke, gait speed is 
dependent upon several underlying factors, of which diminished aerobic 
endurance and lower limb muscle strength have been shown to be major 
contributors to reduced gait speed in chronic stroke (Taylor-Piliae et al., 2012).   
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All people with stroke in the current study were able to complete the determined 
walking routes, however duration to complete the walking rout and number of 
steps taken were significantly longer time and greater, respectively compared to 
the healthy controls.  
 
B)  Postural control strategies in urban walking 
Vertical head, neck and trunk nRMS accelerations, were significantly smaller in 
Group S (stroke) compared to the age-matched healthy group. Greater head 
and smaller AP trunk accelerations were also noted in stroke patients. Walking 
on uneven surfaces had the greatest effect, and induced head instability 
particularly in the AP direction in patients. Overall, the healthy group maintained 
head stability by modulating trunk coordination while navigating in urban 
environments.  
Studies incorporating accelerometers to assess  upper body stability during 
level walking in patients with stroke revealed various outcomes (Iosa et al., 
2012a, Iosa et al., 2012b; Mizuike et al., 2009) depending on post-stroke stage 
(sub-acute or chronic). A significant reduction of normalized trunk accelerations 
and harmonic ratios (implies stable, regular and rhythmic acceleration patterns) 
in AP and V directions has been noted in patients with sub-acute stroke in 
comparison to age-matched healthy individuals (Iosa et al., 2012a). Another 
study showed that normalised RMS trunk acceleration was significantly greater 
in all three directions in patients with chronic stroke compared to age-matched 
healthy individuals (Mizuike et al., 2009). An increase in trunk acceleration is 
associated with smoother or better dynamic gait stability (Iosa et al., 2012b), 
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reflecting motor system recovery and gait capability in stroke (Mizuike et al., 
2009).  
It is known that trunk control plays an important role in attenuating gait-related 
accelerations, as evidenced by low amplitude accelerations at the head 
compared to lower trunk during gait, to facilitate head and upright stability 
during walking (Kavanagh et al., 2006). During walking, heel-strike and push-off 
cause the upper body to oscillate backward and forward (unstable) due to 
changes in hip acceleration. Backward hip acceleration (at heel-strike) due to 
ground reaction force causes the upper body to lean forward and forward hip 
acceleration (at push-off) causes the upper body to lean backwards (Winter 
1995). Therefore to overcome upper body instability, counterbalancing torque 
around the hip and trunk has to be generated to prevent the upper body from 
falling forward or backward (Woollacott and Tang, 1997). It is known that lower 
extremity joints produce systematic kinematic changes during the swing and 
stance phases of the gait cycle that help stabilise the upper extremity (Ratcliffe 
and Holt, 1997). However changes in kinematic and kinetic parameters 
including muscle weakness, abnormal timing and amplitude of muscle 
activation, altered joint movement and coordination, impaired anticipatory 
postural control have been shown  following stroke which may impact on gait 
parameters and stability (Lamontagne et al., 2003, Lamontagne et al., 2005a, 
Lamontagne et al., 2007a). Fore-aft stability is achieved through somatosensory 
feedback from the limbs to the spinal cord which is important for body weight 
support, energy supply and stability control in the plane of progression during 
walking (Bauby and Kuo, 2000). These impairments may suggest possible 
reasons why patients with stroke have difficulty maintaining head stability in the 
AP direction while navigating in an urban environment.  
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The effect of different urban walking environment on accelerations pattern of the 
head, neck and trunk during walking was also investigated in each experimental 
group. It was predicted in the current study that people with stroke may 
experience greater difficulty when walking in a busy environment compared to 
other walking environments i.e. dark, colonade, quiet and cobbled street. This 
was based on evidence that showed people with stroke are over-reliant on 
visual cues for balance (Slaboda et al., 2009). Therefore in busy visual 
environments, such as walking through a crowded train station where visual 
cues are inaccurate, it was expected that person with stroke would experience 
greater difficulty. However no significant effect of busy environment was noted 
in the current study. Few possibilities that could explain our findings. First, time 
of day testing was conducted which avoided peak times. This precaution was 
taken to avoid unnecessary disruption to a traffic flow of commuters within the 
busy area  i.e. train station at peak times. Second, patient cohort in the current 
study may not be  visually dependent as shown on their low visual dependency 
scores. Previous study reported on a significant dynamic subjective visual 
vertical (SVV) deviation (>10o)  in respect to rod and frame test (RFT) in people 
with stroke (Slaboda et al., 2009). Lack of clinical normative value and 
homogeneity in experimental settings such as different characteristics of stroke 
or assessment tools (i.e. RDT, RFT) will make comparison between studies less 
reliable. Further work is required to investigate the effect of visual dependency 
on postural stability control during community ambulation in a larger study of 
people with stroke.  
Similar to findings in Chapter 2 investigating urban walking in people with a 
vestibular disorder, walking on a cobbled street provided greater challenges to 
postural stability in people with stroke. People with stroke experienced greater 
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AP head acceleration. A possible cause of the head instability could be 
attributed to reduced flexibility of the lower limbs due to muscle weakness 
muscle weakness observed during gait (Jonkers et al., 2009). This limitation 
may lead to limb clearance difficulties(Jonkers et al., 2009), and potentially 
threat postural stability, particularly when dealing with unpredictable 
perturbations resulting from uneven terrain. Higher accelerations at the head 
may increased optic flow which reduces the effectiveness of vestibular system 
(Bethoz and Pozzo, 1994) and therefore may lead to an increased instability 
and likelihood for falls.  
  
C) Relationship between urban walking and standard clinical scales and 
assessments 
The current study found that higher normalised acceleration in V direction was 
associated with faster gait speed (i.e. reduced TUG scores and walking 
duration), less number of steps and better motor performance of  both the lower 
and upper limbs as measured by Fugl-Meyer test (FM). No significant 
correlations were noted between the FGA, RDT, and subjective outcome 
measures with total acceleration in any direction. These findings suggest that 
standard clinical test i.e. TUG and FM  affects directly RMS accelerations in 
people with stroke.  
The TUG is a commonly used clinical tool to assess functional ability and falls 
risk, respectively,, in older adults including those with stroke. A significant 
associations between lower limb muscles weakness, gait speed, some gait 
parameters (i.e. step length), distance walked and TUG scores have been 
observed in patients with stroke (Ng and Hui-Chan, 2005, Faria et al., 2009). It 
 121 
 
has been suggested that factors including cardiovascular performance, muscle 
strength, balance impairment and spasticity influence the gait speed and walked 
distance as indirectly measured in TUG. Contribution of lower limb motor 
function to gait pattern parameters such as gait speed and trunk acceleration  
has also been explored in people with stroke (Lin, 2005, Mizuike et al., 2009). A 
greater motor function recovery of the lower extremities was associated with 
better gait performance and greater trunk acceleration, thus providing postural 
stability during walking in people with stroke. Current findings are in agreement 
with previous work showing a significant relationship between increased gait 
speed (i.e. TUG) or lower limb range of motion and strength (i.e. FMA) with 
greater total acceleration in the direction of progression and vertically.  
A significant correlation was noted between functional gait assessment (FGA) 
and accelerometry data in people with a vestibular impairment (Chapter 2) 
however a significant finding was not noted in people with stroke. The FGA was 
mainly designed to assess balance and gait problem associated with vestibular 
disorders, although the use of the test has been extended to other patient 
population (Lin et al., 2010, Thieme et al., 2009). There is a possibility that tasks 
assessed in the FGA could not detect subtle change in balance control 
mechanism during walking in people with chronic stroke, in specific those with a 
higher functioning level. Therefore future  work on this should include people 
with stroke at various functioning levels such as a non-community dwelling 
individual (low functioning level).    
There is no study to date that assesses the relationship between upper body 
accelerations during walking in real-life environments with standard clinical 
scales, as well as functional assessments in patients with chronic stroke. These 
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preliminary findings, could suggest the usefulness of TUG and Fugl-Meyer tests 
in predicting dynamic postural control in chronic stroke patients in real, 
uncontrolled environments where most  patient‘s mobilise and where their 
capability is challenged.  
D) Clinical implication 
Impairments in balance and gait coordination have been well documented 
following stroke, with higher severity usually observed during the acute stage. 
However, some impairments in balance and gait coordination persist within the 
chronic stage. Deficits in gait coordination; such as altered temporal and spatial 
coordination between the head, trunk and pelvis, impaired pelvic, knee and 
ankle control during the gait cycle, and poor interlimb coordination such as 
asymmetries in propulsive forces between paretic and non-paretic limbs, step 
length and width have been documented in chronic stroke survivors despite 
receiving rehabilitation. As a consequence, these deficits may lead to overall 
reduction in gait performance e.g. walking speed and endurance among 
community ambulatory stroke survivors.  
The selection of an appropriate outcome measure is crucial to precisely assess 
walking ability for adults with stroke to help determine the rehabilitation provided 
to patients. A wide range of walking tests are available to assess 1) walking 
distance such as Two minute walk test (2minWT), 2) functional ambulation for 
example Functional Gait Assessment (FGA); and (iv) Walking on different 
surfaces such as the Six metre Walk Test on parquet and carpe (6mWTPC) 
(Mudge and Stott, 2007, van Bloemendaal et al., 2012). However the most 
frequently used clinical walking tests are limited to a short distance walk (<1km 
as described  in The international Classification of Functioning, Disability and 
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Health (ICF) framework) and are conducted in a well controlled environment 
e.g. laboratory (Mudge and Stott, 2007). These may not reflect the actual 
performance of stroke survivors during community ambulation which commonly 
requires patients to walk longer distances, around obstacles and over uneven 
ground and navigate around outside or inside buildings (e.g. shopping mall, 
shops).  
The current findings showed that accelerometers can be used to determine 
postural stability control in a real-world environments and are able to distinguish 
walking patterns between healthy adults and patients with chronic stroke in 
addition to patients with unilateral vestibular impairment (Chapter 2).  It is 
suggested that the differences in upper body stability control observed in 
patients with chronic stroke compared to healthy may possibly be due to 
impairment in the neuro-muscular-skeletal systems. While in patients with 
vestibular disorders, gait pattern differences noted may possibly occur as a 
strategy used to reduce the impact of gait related oscillation on the head, which 
could further impair gaze stability during walking. This information may be 
missed if using standard clinical outcome measures and therefore lead to 
different management strategies that may not tackle the important elements 
required to improve independent community ambulation among patients.   
There is evidence on the influence of gait analysis data on clinical decision-
making in the management of post-stroke patients (Ferrarin et al., 2015). In the 
study (Ferrarin et.  al., 2015) gait analysis data (including non-wearable 3D gait 
analysis system, force plate and EMG) in addition to standard clinical evaluation 
tools, were used as part of intervention planning. The study found that clinical 
recommendations made by clinicians who incorporated gait analysis data were 
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significantly different from those who used only clinical examination and visual 
observation gait analysis during the ongoing treatment care for stroke. Change 
in treatment planning i.e. surgical vs non-surgical was also noted in 71% of the 
studied population i.e. chronic stroke patients when gait analysis data is used 
by clinicians to facilitate therapeutic planning (Ferrarin et. al., 2015). Thus the 
authors suggested that the analysis of gait data provides additional information 
that improved decision-making with regards to chronic stroke care among 
clinicians.  This finding might support the potential use of accelerometry data 
which is more convenient to be used i.e. less complicated instruments 
compared to a standard non-wearable 3D gait analysis system, in clinical 
settings.  
E) Conclusion 
Current study findings indicate that people with a stroke employ compensatory 
mechanisms including a reduced walking speed and reduced trunk 
accelerations to maintain postural stability during gait in an urban environment. 
However greater AP head accelerations were noted in patients, indicating 
patients may have difficulty stabilising their head in space compared to a 
healthy control group. Mobilising on an uneven surfac had greatest effect on 
postural stability and induced head instability particularly in the AP direction (the 
direction of progression) in patients with stroke.  A significant correlation was 
noted between accelerometry data and the TUG and FMA indicating 
accelerometers could be a useful tool to measure gait parameters especially in 
outdoor settings, monitor changes in postural stability control following stroke 








An average of 38% of patients with a vestibular disorder carry a risk of 
psychiatric or psychological disorders (Eckhardt-Henn et al., 2003). Psychiatric 
co-morbidity such as anxiety, phobic disorders and depression have been found 
to be greater in patients with vestibular migraine or Meniere‘s Disease 
compared to other groups (i.e. vestibular neuritis or BPPV) (Eckhardt-Henn et 
al., 2008, Tschan et al., 2011). Possible explanation was due to the 
unpredictable, more severe and uncontrollable nature of attacks in vestibular 
migraine and Meniere‘s Disease compared to the other vestibular disorder 
subgroups (Tschan et al., 2011).  
Godemann et al. (2005) found a strong correlation between dizzy symptoms 
and anxiety in 1/3 of patients who continue to experience symptoms one year 
post onset.A one year follow-up study on patients with peripheral vestibular 
impairment showed that patients with high levels of subjective well-being were 
less likely to develop secondary somatoform vertigo and dizziness (SSVD), 
whereas SSVD was commonly correlated with individuals with depressive and 
anxiety disorders (Tschan et al., 2011). The study also demonstrated that SSVD 
was more prevalent in patients with vestibular migraine compared to other 
vestibular impairment subgroup (i.e. vestibular neuritis) and those with  
vestibular migraine experience greater level of disability (Tschan et al., 2011). 
This has led to a suggestion that psychiatric disturbance may be more 
associated with certain subgroups of vestibular disorders.   
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The relationship between vestibular disorders and psychiatric disorders has 
been thought as bidirectional: a vestibular disorder may trigger a psychiatric 
disorder (Jacob and Furman, 2001) while a psychiatric disorder may trigger 
symptoms of vertigo and dizziness (Yardley et al., 2001b, Staab and 
Ruckenstein, 2003). However, some studies report no relationship between the 
presence of a  vestibular deficit and the development of a secondary psychiatric 
disorder (Best et al., 2006; 2009). 
Since not all patients with vestibular dysfunction develop a psychiatric disorder, 
this suggests that the underlying causes of illness behaviour is multi-factorial 
and that some individuals may have traits that make them more vulnerable. An 
examination of patients‘ illness behaviour and its association with vestibular 
dysfunction may provide a critical way in better understanding and identifying 
the factors that may predispose certain individuals to anxiety disorders and 
chronic dizziness. Screening for co morbidities such as anxiety and depression 
offers psychological interventions that are important  for patients treatment plan 
(i.e. patients education). 
Illness behaviour has been described as the way an individual responds to a 
perceived health threat or illness (Mechanic, 1986). It embraces the ways in 
which people attend to somatic information, interpret and responds to 
symptoms, and seek medical care. There is substantial interindividual variability 
of illness behaviour although the symptoms may objectively share comparable 
characteristics (Mechanic, 1986). Many factors attribute to the illness behaviour 
including past illness behaviour, coping competency, psychological states, 
beliefs and personality traits/attitudes. 
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The term abnormal illness behaviour is used to describe a persistent 
inappropriate  or maladaptive response to an underlying organic pathology. This 
maladaptive behaviour can manifest in a form of illness denial or somatisation 
of psychogenic disorders (Pilowsky and Spence, 1994). When abnormal illness 
behaviour comorbid with psychological distress such as anxiety or depression, 
exacerbation in physical symptoms, functional impairment and impede recovery 
in patients has been observed in clinical setting (De Waal et al., 2004; Clark and 
Smith 1997). Abnormal illness behaviour is suspected when individuals show 
excessive concern about their illness with somatic symptoms and when 
inappropriate treatment is sought. It is usually associated with absence of 
organic pathology that would account for the person‘s physical complaint (Guo 
et al., 2001). Furthermore abnormal illness behaviour could increase 
socioeconomic burdens such as increased dependence on others (i.e. doctors, 
family members), sick role, relief from social responsibilities and avoidance of 
physical demands (Prior and Bond 2008).  
The high prevalence of the comorbidity of psychiatric disorders and the 
symptoms of vestibular dysfunction (even in the absence of physical deficits) 
has been well documented. This combination is highly likely to aggravate the 
illness impact and levels of handicap (EckhardtHennet al. 2003). In addition, 
abnormal illness behaviour has been reported in patients with Menier's 
diesease (Savastano et al., 1996). Abnormal illness behaviour may be a 
contributing factor to the unexplained physical/subjective symptoms and long 
term handicap observed in some patients with  vestibular impairment. Despite 
these clear links there is a lack of research focussing on the issue of illness 
behaviour in patients with vestibular impairment. Study on illness behaviour 
may provide a better insight on this patients population. 
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Therefore the purpose of this study was 1) to describe the illness behaviour 
profile in patients with chronic vestibular symptoms 2) to investigate the effect of 
migraine on the illness behaviour profile and 3) to assess the relationship 
between illness behaviour, functional gait, postural control and subjective 
symptoms. It was hypothesised that patients particularly those with migraine 
may show different illness behaviour pattern from the age-matched control 
group.  
 
4.2 MATERIAL AND METHODS 
4.2.1 Subjects 
One hundred and ten participants were recruited into the study in which 77 were 
patients (Group P) and 33 age-matched healthy control participants (Group 
C).All participant were aged between 18 and 80 years old. Five patients 
declined to complete the set of given questionnaire after a written consent was 
obtained therefore the data from only 72 patients were taken into account in the 
analysis. Two participant groups were recruited: 
- Patients with  a diagnosed vestibular disorder or vestibular migraine (Group 
P)were recruited from outpatient clinics at the Department of Neuro-otology 
National Hospital for Neurology and Neurosurgery, Queen Square, London. All 
patients had completed routine audio-vestibular investigations performed by a 
senior audiologist prior to the recruitment. The routine audio-vestibular 
investigations include otoscopic examination, tympnanometry test, pure tone 
audiometry, bithermal caloric test (either videonystagmography (VNG) or 
Fitzgerald-Hallpike with optic fixation technique) and electronystagmography. 
Departmental norms were used for significant canal paresis and directional 
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preponderance. A significant canal paresis was either based on Fitzgerald-
Hallpike caloric testing as measured by the duration parameter using the 
Jongkee‘s formula of more than 8% in the absence of the optic fixation or ≥20% 
on VNG bithermal caloric. For directional preponderance, 12% for Fitzgerald-
Hallpike or 20% for VNG are the normal values. Diagnosis (or exclusion) of 
vestibular disorders or vestibular migraine was based upon review of the 
history, clinical assessment, caloric and ENG data by the attendant consultant 
neuro-otologist. Inclusion criteria were no other chronic medical/health problems 
(i.e. orthopaedic injury) which would impact on ability to perform balance and 
gait assessment and patient was able to walk independently. Patients with 
central vestibular disorder other than vestibular migraine, current participation in 
or previous completion of a vestibular rehabilitation programme and/or  anti 
migraine prophalaxis (i.e. in the case of vestibular migraine) were excluded.   
- Healthy adults (Group C) were recruited via circular email to students and 
member of staff at King's College London, London, UK. The inclusion criteria 
were no self-reported history of vestibular or neurological disease, dizziness, 
balance disorder, migraine or any acute orthopaedic injury which would impact 
on ability to perform balance and gait assessment. 
Local ethic committee approval was obtained. Demographic data and clinical 










Table 10  The demographic characteristics of participants upon recruitment.  
Variable Group C 
(n=33) 





Age, mean (range),y 43 (18-71) 47 (26-76) 45 (18-72) 
Gender 
Male, n (%) 






































Abbreviations: Group C= control group; Group P= patients with chronic 
dizziness; CP=canal paresis either based on Fitzgerald - Hallpike caloric testing 
as measured by the duration parameter using the Jongkees formula of more 
than 8% in the absence of optic fixation or ≥20 % asymmetry for video-
nystagmography; DP = directional preponderance either ≥ 12% based on 
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Fitzgerald - Hallpike caloric testing or ≥ 20 % asymmetry for video-
nystagmography; BPPV= Benign Paroxysmal Positional Vertigo;BVH = Bilateral 
vestibular hypofunction based on caloric and/or electronystagmography (ENG) 
findings; VN=vestibular neuritis 
 
4.2.2 Self-report assessments 
All participants completed a set of validated questionnaires relating to dizziness 
symptoms, impact of symptoms on ADL,  balance confidence on conducting 
ADL and impact on global  level of function and independence, anxiety and 
depression  experienced within the last month prior to the recruitment. Five 
questionnaires i.e. SVQ, ABC, HADS, VADL and VSS used in this study have 
previously beendescribed in Chapter 2 (section 2.2.2). Two additional 
questionnaires used for the current study are:  
a. The Dizziness Handicap Inventory (DHI) (Jacobson and Newman, 1990) is a 
25 item questionnaire designed to evaluate an individual‘s self-perception of 
disability associated with symptomsof dizziness. The scale consists of a 7-item 
physical subscale, a 9-item emotional subscale, and a 9-item functional 
subscale. Scores for each item range from 0 (no) to 4 (yes) with a total 
composite score ranged between 0 (no disability) to 100 (significant disability).A 
total score of 0–30 indicates mild, 31–60 moderate, and 61–100 severe 
dizziness handicap (Whitney et al., 2004b). The DHI demonstrated good test-
retest reliability and validity (Jacobson and Newman, 1990, Whitney et al., 
1999). 
b. Illness Behaviour Questionnaire (IBQ)(Pilowsky and Spence, 1994) is a 62-
items self-assessment instrument which assesses an individual's ideas, 
behavioural and attribution to the illness symptoms.  The IBQ use dichotomous 
 132 
 
scale (yes/no response) and the score responses across seven factors: General 
hypochondriasis (GH-anxious: health related concern), Disease conviction (DC: 
belief that 'a real disorder or disease is present), Psychological vs somatic 
focussing (P-S:tendency to attribute illness either psychological or physical 
causes), Denial (D: tendency to attribute life stress to physical problems), 
Affective inhibition (AI: Inability to express negatives personal feeling to others ), 
Affective disturbance (AD: anxiety, depression) and Irritability(I: anger). 
Examples of IBQ items are ' Are you afraid of illness?' (General 
hypochondriasis factor) and 'Do you think there is something seriously wrong 
with your body?' (Disease conviction factor). 
The IBQ is primarily used to provide an indication of normality (or abnormality) 
of an individual's behaviour towards his/her illness. These seven IBQ factors 
can be used to measure individual differences in illness behaviour with high 
score on all factors except Psychological vs Somatic perception suggesting an 
abnormal perception, evaluation or action in relation to a person' own health 
status, inhibition and irritability in relation to others (Pilowsky and Spence, 
1994). Two second-order factors i.e. Affective state (AS) and Disease 
Affirmation (DA) are derived from the IBQ. The score for AS is obtained by the 
sum of scores of general hypochondriasis, affective disturbance and irritability 
factor, i.e. AS = GH+AD+I. While DA is a composite measure comprising the 
Disease conviction plus Psychological vs somatic preoccupation (P/S) scored in 
favour of somatic concern, i.e. DA = DC +(5-P/S). The second-order factors of 
IBQ provide information about global aspects of illness behaviour. Healthy 
controls were instructed to complete IBQ Form B format, which does not 




4.2.3 Functional Gait Assessment (FGA) 
The FGA has been described previously in Chapter 2 (section 2.2.3.2). 
 
4.2.4 Computerized Dynamic Posturography (CDP):Sensory Organization 
Test 
The Sensory Organization Test (SOT) was performed according to a published 
protocol  (Equitest; Neurocom International, Oregon). Testing is performed 
under six different sensory conditions to assess the influence of visual, 
vestibular and somatosensory inputs on standing balance. In conditions 1 to 3 
subjects stand on a stationary support surface with eyes open, eyes closed, and 
with sway-referenced vision, respectively. In conditions 4 to 6 a similar 
procedure is followed except the support surface is also sway referenced. The 
program yields an average composite equilibrium score, ranging from 0 % (no 
balance) to 100% (maximum stability). Scores below 70% are considered 
abnormal (Neurocom, 1999). 
 
4.2.5 Data analysis 
IBM SPSS statistics 19 was used for statistical analysis. Data are presented as 
mean ± S.D. Between-groups differences were determined using the Mann- 
Whitney Test. Spearman‘s bivariate correlation was used to assess whether 
there was a relationship between illness behaviour and both objective and 
subjective standard clinical outcome measures. Multiple regression analysis 
was performed to assess whether migraine, age and symptom duration would 
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be significant predictors to the outcome measures. Age and symptoms duration 
were not significantly different between-groups.  Only significant findings are 
reported. Significant results for all tests were assumed if p<0.05. 
 
4.3 RESULTS 
4.3.1 Comparison of Illness Behaviour Questionnaire (IBQ) between 
patients and control groups 
 
Significant between-group differences were noted for affective state (AS) (z=-
4.35;p=0.00) and Disease Affirmation (DA) (z=-6.36;p=0.00) whereby scores 
were higher (i.e. worse) for Group P. A significant effect of migraine on both 
affective state (F(1,99)=17.1, p<0.05] and disease affirmation (F(1,99)=49.9, 
p<0.05] was identified with higher (i.e. worse) scores in those with migraine 
after controlling for age and symptom duration. Mean (SD)of the second order 
factors(i.e. AS and DA) in patients for with vestibular disorders with and without 




Figure 18 Mean (SD) of the Affective state and Disease affirmation (IBQ second order-
factors) between studied groups. 
Abbreviation: IBQ= Illness behaviour questionnaire. *p<0.05 indicates significant 
different between groups. 
 
 
Analysis on the IBQ domains showed a significant effect of group on General 
hypochondriasis [F(2,101)= 6.0, p<0.05], Disease conviction [F(2,101)= 34.9, 
p<0.05], Affective disturbance [F(2,101)= 14.5, p<0.05] and Irritability [F(2,101)= 
10,4, p<0.05]. Following post-hoc analysis, both disease conviction (DC) and 
affective disturbance (AD) scores significantly different between the groups 
wherein migraniuers scores significanlty higher (i.e. worse) compared to non-
migraineurs and healthy control groups [DC t(101)=4.9; p<0.05; AD 
t(101)=2.6,p<0.05]. Figure 19 shows mean (+SD) of the IBQ in patients with 







Figure 19 Mean (SD) of the IBQ subscales score between healthy control, patients with 
and without migraine. 










4.3.2 Association between IBQ Second-order factors and outcome 
measures in patients. 
 
Increased affective state or disease affirmation scores were significantly 
associated with greater anxiety (p<0.05), depression (p<0.05)autonomic anxiety 
(p>0.05), visual vertigo (p<0.05) and DHI subscale scores (p<0.05) as well as 
with decreased balance confidence (p<0.05) and each VDADL subscales 
(p<0.05) scores. Computerised dynamic posturography (CDP) was significantly 
associated with affective state (r=0.25;p=0.04) in which increased (i.e. worse) 
affective state was associated with increased (i.e. better) CDP performance. 
Correlation coefficient values were presented in table 11 and only data with 












Table 11 Correlation coefficient values of IBQ and self-reported outcome measures 
Abbreviations: SVQ=Situational Vertigo Questionnaire;HAD-A=Hospital Anxiety and Depression (Anxiety scale);HAD-
D=Hospital Anxiety and Depression (Depression scale); VSS-A=Vertigo Symptom Scale (autonomic and somatic anxiety 
symptoms);ABC=The Activities Specific Balance Confidence Scale; VADL-F= Vestibular Activities of Daily Living Scale 
(functional subscale); VADL-A= Vestibular Activities of Daily Living Scale (ambulation subscale); VADL-I= Vestibular Activities 
of Daily Living Scale (Instrument subscale); DHI-T= Dizziness Handicap Inventory (total score); DHI-P=Dizziness Handicap 
Inventory (Physical subscale); DHI-E= Dizziness Handicap Inventory (Emotional subscale); DHI-F=Dizziness Handicap 
Inventory (Functional subscale). Significant level p<0.05; n.s= not significant. 












































4.3.3 Self-reported outcome measures 
Significant differences were noted between-groups for all self-reported outcome 
measures i.e. SVQ, VSS, ABC, VADL, HAD and DHI scales. Group P scored 
significantly lower (i.e worse) on the ABC scale [z=-6.97; p<0.01] and showed a 
significantly higher (i.e worse) mean score for all other scales [VADL 
subscale,F:z=-6.50; p<0.01; A:z=-6.77;p<0.01; and I:z=-6.62; p<0.01; VSS-
V:z=-7.28;p<0.01 and VSS-A:z=-6.57;p<0.01; HAD-A:z=-5.69;p<0.01 and HAD-
D:z=-5.57;p<0.01; SVQ:z=-6.49;p<0.01; DHI-E:z=7.67;p<0.01; DHI-F:z=-
7.64;p<0.01 and DHI-P:z=-7.77;p<0.01] compared to Group C. Descriptive data 
and statistics are displayed in Table 12. 
Table 12  Mean (SD) score and range for self-reported outcome measures 






















1.22  (0.91) 
[0-3.56] 













































































































Abbreviations: Group P= all patients; Group C= control healthy; 
SVQ=Situational Vertigo Questionnaire;HAD-A=Hospital Anxiety and 
Depression (Anxiety scale);HAD-D=Hospital Anxiety and Depression 
(Depression scale); VSS-V=Vertigo Symptom Scale (common vestibular 
symptoms); VSS-A=Vertigo Symptom Scale (autonomic and somatic anxiety 
symptoms);ABC=The Activities Specific Balance Confidence Scale; VADL-F= 
Vestibular Activities of Daily Living Scale (functional subscale); VADL-A= 
Vestibular Activities of Daily Living Scale (ambulation subscale); VADL-I= 
Vestibular Activities of Daily Living Scale (Instrument subscale); DHI-T= 
Dizziness Handicap Inventory (total score); DHI-P=Dizziness Handicap 
Inventory (Physical subscale); DHI-E= Dizziness Handicap Inventory (Emotional 
subscale); DHI-F=Dizziness Handicap Inventory (Functional subscale).  
The asterisks (*) denotes a significant between-group differences,  p<0.05. 
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Multiple regression was conducted to predict the effect of migraine, the 
symptom duration and age of patient participants on each subjective outcome 
measures. The prediction model was statistically significant for ABC (R2=0.12, 
F(3,67)=91.7,p<0.05), Depression subscale of HAD (R2=0.10, F(3,67)=4.13, 
p<0.05), Emotional subscale of DHI (R2=0.12, F(3,67)=10.7,p<0.05) and VSS-A 
(R2=0.23, F(3,67)=1.03, p<0.05) and migraine was demonstrated to be a 
significant predictor to poor subjective outcome measures.   
 
4.3.4 Objective measures 
Both FGA and CDP composite scores were significantly lower (i.e. worse) in 
Group P compared to Group C [FGA:z=-5.50;p=0.00; CDP:z=-4.19;p=0.00]. 
Following the multiple regression analysis, age is the only significant predictor 
of FGA scores in patients [R2=0.15, adjusted R2=0.11, F(3,66)=3.95, 
p<0.05].Descriptive data and statistics are displayed in Table 13. 
 
 
Table 13 Mean (SD) of objective outcome measures 
 












Abbreviations:FGA= Functional Gait Assessment; CDP=Computerised Dynamic 
Posturography.The asterisks (*) denotes a significant between-group 
differences  (**p<0.01) 
 
4.4 DISCUSSION 
The aims of this study were to investigate illness behaviour patterns in patients 
with  vestibular disorder and/or vestibular migraine as compared to healthy 
controls, to look at the effect of migraine on outcome measures and to assess 
the association between illness behaviour, functional gait, postural control and 
subjective symptoms in patients. Overall, Affective state (AS) and Disease 
affirmation (DA) of IBQ second order factor scores differed significantly between 
groups with higher (i.e. worse) score  noted in patients with migraine. Patients 
with migraine also scored worse on Disease conviction and Affective 
disturbance of IBQ domain. These findings suggest that the IBQ can be used to 
differentiate illness behaviour patterns between patients with vestibular 
disorders (including migraine) and healthy controls. Increased Affective state or 
Disease affirmation scores were significantly associated with greater anxiety, 
depression, visual vertigo, and self-perception of disability as well as with 
reduced balance confidence and activity of daily living. The discussion is 
separated into (i) illness behaviour profile in patients with vestibular disorders 
and/or migraine, (ii) relationship between illness behaviour and standard clinical 





(i) Illness behaviour profile in patients with vestibular disorders with and 
without a migraine component  
Current findings revealed that IBQ profile was significantly different between 
person with a vestibular disorder and healthy individuals and also between 
person with and without migraine history. Scores on Disease Conviction, 
Affective disturbance domains as well as the second-order factors of IBQ (i.e. 
Affective state (AS) have been shown capable to differentiate between the 
experimental groups with higher (i.e. worse) scores in those with migraine. High 
scores on both second order factors suggest global aspects of abnormal illness 
behaviour (Pilowsky & Spence, 1994). 
The IBQ does not have a predefined threshold for each of its subscales that 
categorise a given score as abnormal. Some cut-off scores have been provided 
in the IBQ manual (Pilowsky and Spence, 1994) which were set from a 
particular setting (i.e. pain clinic and general practice). Apart from the cut-offs, 
the scale scores can be used in their raw forms and can be considered in 
relation to a normative population. Pilowsky and Spence (1994) suggested that 
the mean score of ≥ 3 on disease conviction can be used to identify abnormal 
illness behaviour in patients with a chronic low back pain. Similar finding was 
also noted in a stroke rehabilitation population with a subtle modification on the 
cut-off point for disease conviction (Clark and Smith, 1997). The authors 
suggested that mean score of ≥2 on disease conviction is able to differentiate 
between patients who developed abnormal illness behaviour and those who 
were not in stroke rehabilitation setting (Clark and Smith, 1997). Data from the 
current study showed patients with migraine has a mean score of >3 on the 
disease conviction dimension which suggests abnormal illness behaviour. 
 144 
 
However the interpretation of the current finding based on the suggested cut-off 
point should be conducted with caution due to different patients population. 
Pilowsky and Spence (1994) indicated that a high score on Affective 
disturbance domain suggests that a high level of anxiety and/or depression may 
be present. It was noted in the current study that patients with migraine scored 
higher on the Affective disturbance domain than those without migraine.  In 
addition, higher (i.e. worse) anxiety and depression mean scores were also 
noted in individuals with migraine. It is known that anxiety-related disorders or 
depression are strongly associated with vestibular disorders and vertigo 
(Godemann et al. 2005). There was evidence showing vestibular migraine, 
anxiety and depression are linked with somatoform vertigo and dizziness (SVD) 
and some patients with vestibular disorders were susceptible to develop SVD 
(Tscahn et al., 2011) or abnormal illness behaviour (Savastano et al., 1996).  A 
study on patients with Meniere's Disease (MD)  demonstrated that anxious or 
depressed MD patients had a tendency to interpret their illness in somatic term 
compared to those emotionally stable patients (without anxiety or depression) 
(Savastano et al., 1996). Although not all patients with a vestibular disorder or 
migraine develop a psychiatric disorder, it is  useful to screen those who are at 
risk of developing SVD. Therefore this suggests the potential use of  IBQ as a 
tool to identify patients with greater risk of developing somatoform or chronic 
subjective dizziness. However more study using the IBQ is needed to 
understand the association between psychological state, abnormal illness 
behaviour and chronic subjective dizziness.  
The current study also revealed that person with migraine scored higher on both 
second-order factors (Affective state and Disease affirmation) as compared to 
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non migrainuers and healthy groups. Affective state (AS) measures the global 
degree of depression, anxiety, irritability and phobic concern about one's 
healthy while disease affirmation evaluates the tendency to perceive the 
somatic symptoms of the disease, explaining them in term of physical illness. 
This is not unexpected as second-order factors are a combination of individual 
IBQ dimensions (Pilowsky and Spence, 1994). Previously, Disease affirmation 
and Affective state scores have been shown able to  predict abnormal illness 
behaviour in different patient populations including chronic pain (Pilowsky and 
Spence, 1994) and stroke (Clark and Smith, 1997). Pilowsky and Spence 
(1994) suggested that the mean score of ≥ 7 on Disease affirmation can be 
used to identify abnormal illness behaviour in patients with a chronic low back 
pain. More works need to be done using the IBQ to determine the levels of 
abnormal illness behaviour in the current study patient cohort.   
Overall, the IBQ profile from the current study revealed that person with a 
migraine show a significantly greater fear concern about their health status, 
disease conviction, dysphoria and irritability. More importantly a tendency for 
somatisation was noted in migraine. The IBQ  profile for migraine was 
comparable to those reported in person with chronic pain (Piloswky and 
Spence, 1994). Link between balance, migraine and anxiety disorders as well 
as pain has been discussed extensively (Balaban, 2011, Balaban et al., 2011). 
High levels of psychiatric disturbance and pain (in the case of vestibular 
migraine) are key features of vestibular disorders. Shared organizational and 
neurochemical features of the vestibular system and pain information explain 
some aspects of the co-morbid balance disorder and interactions between 
anxiety and migraine (Balaban et al. 2011). The role of psychological factors in 
the manifestation of chronic pain is well documented and 'Attention 
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management' (e.g. Cognitive-behavioural therapy) a treatment approach that 
helps in shifting patient's attention  from focussing on structural pathology as 
the cause of pain (somatic focus) to pyschosocial focus has been noted 
beneficial for a chronic pain treatment (Morley, 2011). Previous study 
highlighted on the neural pathways link between balance, anxiety, pain and 
migraine. Current study findings showed similarity in IBQ scores between 
migraine and chronic pain disorders. These findings suggest work on chronic 
pain management might be relevant to patients with vestibular disorder 
particularly with migraine component. 
There is a vast literature concerning abnormal illness behaviour or inappropriate 
responses to illness as measured by the IBQ, traditionally in patients with 
chronic pain (Pilowsky and Katsikitis, 1994, Waddell et al., 1989, Large and 
Mullins, 1981, Main and Spanswick, 1995, Margoles, 1990)  and psychiatric 
problem (Pilowsky, 1993b, Boyle and Le Déan, 2000, Guo et al., 2001, Duddu 
et al., 2006, Lykouras et al., 2006). However such studies often represent 
isolated application of the IBQ to a particular illness.The IBQ has been used 
successfully to understand illness behaviour patterns in patients with a 
Meniere‘s Disease (Savastano et al., 1996). Findings of the current study 
demonstrated that person with migraine has a tendency for somatisation and 
similar tendency was also reported previously in patients with MD (Savastano et 
al., 1996). High level of psychological disturbance (i.e. anxiety or depression) 
and pain  in addition to unpredictable, more severe and uncontrollable nature of 
attacks in both vestibular migraine and Meniere's disease could  possibly 
explain the abnormal illness behaviour observed. This suggests that the IBQ is 
suitable to be used in patients with vestibular disorders including migraine. 
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Illness behaviour plays an important role in the development of unexplained 
physical symptoms and is one of most frequent reasons for which people seek 
medical help  (Rief et al., 2001). Irrespective of the actual mechanism involved 
in the formation of the symptoms, assessing inappropriate illness behaviour 
may offer insight into the reasons why some individuals display symptoms or 
signs which are not consistent with medical diagnosis or less responsive to 
treatment. Further exploration of the IBQ in patients with vestibular disorder or 
migraineurs should also promote a clearer understanding of the nature of 
abnormal illness behaviour observed in this group of patients. 
 
 (ii) Relationship between illness behaviour and standard clinical outcome 
measures in patients 
Current findings show that both second-order factors i.e. affective state and 
disease affirmation correlated significantly with all self-reported outcome 
measures except VSS-V. This is suggesting increased autonomic/somatic 
anxiety, increased disability, reduced ability of ADL, poor balance confidence 
are associated with worse affective state and increased disease affirmation. 
Furthermore migraine has been shown as the highest predictor on both 
affective state and disease affirmation.   
The IBQ has been shown to be associated with psychological state i.e. anxiety 
or depression in various patient populations  (Fava et al., 1982, Rief et al., 
2005, Guo et al., 2001, Lykouras et al., 2006), physical quality of life (i.e. ALD & 
social activities) (Clark & Smith, 1997; 1998) and chronic pain (Pilowsky and 
Spence, 1994, Keefe et al., 1986). It is well documented that poor psychological 
state associated with abnormal illness behaviour (AIB) could exacerbate the 
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impact of illness behaviour (Fava et al., 1982, Hobbis et al., 2003,  Clark and 
Smith, 1997).  
No study to date have investigated the effect of abnormal IBQ and treatment 
outcome. A study in person with stroke reported that  AIB has been associated 
with reduced performance in activities of daily living (ADL)(Clark and Smith, 
1998) measured at the time of discharged  and at 12 months after rehabilitation. 
Reduced social activities level was also noted in patients with AIB in respect to 
the non-AIB (Clark and Smith, 1998). In addition, the authors also investigated 
the effect of depression and AIB in a long-term rehabilitation outcomes for 
stroke patients. The finding showed that ADL ability measured at 12 months 
following discharge from stroke rehabilitation was predominantly a function of 
AIB and depression was not. The authors concluded that AIB is a key 
determinant of long term functional disability while depression associated with 
poorer social functioning in patients with stroke (Clark and Smith, 1998). These 
studies support finding of the current study which showed significant association 
between increased IBQ second-order factor scores and reduced ADL ability in 
patients with vestibular disorders or migraine. However further research is 
needed to identify the relationship between IBQ and treatment outcomes. 
Affective state (AS) was positively correlated with computerised dynamic 
posturography (CDP) in which increased AS was associated with better CDP 
performance. The computerised dynamic posturography (CDP) is an objective 
assessment tools that allow quantification of postural sway during stance under 
dynamic conditions (changing surface and/or visual conditions). The Sensory 
Organisation Test (SOT), one of the specific CDP test, provides systematic 
evaluation of the main sensory systems involved in balance control. Several 
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studies have demonstrated the association between impaired (i.e. low) SOT 
equilibrium scores and fall risks  in patients with vestibular disorder (Whitney et 
al. 2006) and older adults (Girardi et al., 2001). However association between 
posturography and psychological state has not clearly explored. One study 
found no association between posturography and subjective outcome measures 
(questionnaire) relating to vertigo symptoms experienced during the previous 
month, visual vertigo, and emotional state in patients with peripheral vestibular 
disorders (Pavlou et. al., 2004). In our study, it was unclear as to why positive 
association between affective state and posturography has been shown here in 
patients with peripheral vestibular disorders and migraine. Further studies are 
needed to clarify what this means in term of objective balance tests, particularly 
in light of the concerns about the effectiveness of posturography in detecting 
abnormalities in the studied patients‘ population.  
 
iii) Clinical implications 
The study of illness behaviour has many applications in research, clinical care, 
public health, and social policy (Mechanic, 1986). At a clinical level, awareness 
on how people interpret illness, present symptoms, and respond to medical care 
can improve understanding thereby helping health professionals to provide 
more effective management. 
Illness behaviour places primary emphasis on illness responses at the level of 
the individual (Mechanic, 1986). It affects how person attends to somatic 
information, interprets and respond to symptoms, and finally seeks medical 
care. Although symptoms may objectively share quite similar characteristics, 
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there is substantial inter-individual variability in the manner in which people 
perceive, interpret, and therefore respond to symptoms (Sirri and Grandi, 2012).  
The role of psychological factors in the manifestation of illness behaviour is well 
noted. It is importance to highlight the existence of psychiatric co-morbidity in 
patients with a vestibular disorder including those with migraine component. It is 
known that vestibular rehabilitation is the mainstay of treatment for patients with 
vestibular disorders, in combination with anti-migraine prophylaxis for patients 
with vestibular migraine (Wrisley et al., 2002, Alghadir et al., 2013, Herdman et 
al., 2012). Although the majority of patients improve, some do not (Herdman et 
al., 2012). Further work needs to be done to investigate the relationship 
between illness behaviour and treatment outcome. Recent work has shown that 
cognitive-behavioural therapy (CBT) may be a beneficial adjunct to treatment in 
patients with a vestibular disorder although future work is needed (Schmid et 
al., 2011, Edelman et al., 2012). Greater reduction in anxiety, depression and 
self-reported handicap was reported among patients with dizziness following 8 
to12 weeks of both self-administered VR and CBT compared to those who only 
received in isolation (Holmberg et al., 2006). A more recent study showed that 
dizziness-related symptoms, disability and functional impairment  significantly 
improve following  shorter CBT intervention (3 sessions) (Edelman et al., 2012). 
It is important to acknowledge the effectiveness of CBT and physical therapy to 
reduce anxiety, depression and disability related to chronic dizziness. It is also 
important to highlight the link between abnormal illness behaviour and 
depression (Clark and Smith, 1997).The authors suggested that the most likely 
cause to the AIB emergence was factors intrinsic (i.e. depression)  to the 
patients, although factors such as medical condition and rehabilitation 
environment should not be neglected (Clark and Smith, 1997). Therefore this 
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gives credence to the possibility that treating psychological problem (i.e. 
depression) may hinder development of abnormal illness behaviour. However 
further works are needed to explore the impact of rehabilitation and medical 
management on illness behaviour as well as to investigate  the long-term 
outcomes in patients with vestibular disorder including vestibular migraine.  
Understanding how patients behave towards their illness may lead to a better 
treatment strategies for patients with a vestibular disorder in future. It is 
important to acknowledge combined treatment for holistic multidisciplinary. 
Early diagnosis and appropriate referral could result in effective and efficient 
management of illness behaviour in patients with a vestibular disorder including 
migraine. 
Preliminary findings of the current study have provided valuable information 
regarding the illness behaviour profile in patients with a vestibular disorder and 
vestibular migraine. Previous study highlighted the link between vestibular 
disorders and anxiety or depression (Godemann et al., 2005) as well the link 
between anxiety and depression with chronic somatoform vertigo and dizziness 
(SVD) (Tschan et al., 2011; Staab and Ruckenstien, 2003). However analysis 
on this aspect could not be done due to lack of data related to SVD in the 
current study. Therefore it is suggested to extend investigations to include other 
group of patients who experience chronic dizziness in the absence of an active 
physical neuro-otological deficit (i.e. psychogenic). Hopefully it will help to 







Findings indicate that patients with a vestibular disorder including migraine have 
an IBQ profile that differs from that in an age-matched healthy control group. 
Patients with a vestibular migraine show a significantly greater fear concern 
about their health status, disease conviction, dysphoria and irritability. 
Importantly a tendency for somatisation was noted in these patients which has 
implications for future management strategies. Future studies should investigate 
the relationship between specific vestibular diagnoses and illness behaviour, 
the effect of illness behaviour on treatment outcome and the role of CBT 




CHAPTER 5:  GENERAL DISCUSSION AND CONCLUSION 
 
The results of each experimental study were presented and discussed in the 
relevant chapters. This discussion chapter will provide a summary of all results 
and a general overview of the entire research.  
Thesis summary 
Balance control during bipedal gait is an interaction of many systems and 
subsystems within an individual and its surrounding environment. It is known 
that functional maintenance of balance requires integration of multiple sensory 
inputs from the visual, somatosensory and vestibular systems as well as 
appropriate muscle strength, movement strategies and cognitive function. 
Impaired performance in any of these functions may lead to postural instability 
and increase risk of falls (Harris et al., 2005, Herdman et al., 2000).  In addition, 
the ability to adapt gait according to environmental and task demands is crucial 
when navigating in challenging and unpredictable environments such as during 
community ambulation (Patla, 2001).  
Eight environmental dimensions have been identified as important factors for 
safe and independent mobility within the community (Patla and Shumway-Cook 
1999). The eight environmental dimensions include distance, speed, ambient 
conditions (e.g. light level, weather conditions), terrain characteristics, physical 
load, attentional demands, postural transition and traffic level.  It has been 
proposed that these dimensions are critical determinants of mobility disability 
because disability is inversely related to the ability to effectively manage the 
demands within each environmental dimension (Shumway-Cook et al., 2003). 
Most studies focusing on  postural control during ambulation have been 
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conducted either in a laboratory or clinical setting, which may not reflect the 
complex environmental and task demands encountered during community 
ambulation (Chastan et al., 2010, Bhatt and Pai, 2009, Iosa et al., 2012b).  
The ultimate goal of gait analysis is to identify the underlying causes of balance 
impairments. Instrumented three-dimensional (3D) gait analysis system 
provides quantitative measures and has been accepted as a ‗gold standard‘ 
assessment for gait in patient populations including stroke (Ferrarello et al., 
2013). Despite advantages offered by the standard instrumented 3D gait 
analysis system (e.g. camera-based system), the use of the system in a clinical 
setting is still restricted by the fact that the system is complex, time demanding, 
expensive and requires a high-level interpretive skills (Coutts, 1999). Thus, 
observational gait analysis (i.e. naked-eyes or video-taped) remains as a 
preferred gait assessment method in clinical settings (Ferrarello et al., 2013) 
despite  its high degree of subjectivity in the interpretation of gait impairment 
compared to instrumented gait analysis system (Ferrarello et al., 2013). 
Accelerometers are wearable motion sensors that have been shown to be 
reliable and  are cost-effective alternative for the measurement of gait 
(Mayagoitia et al., 2002, Kavanagh et al., 2006). They provide an objective 
measurement of postural control during gait and can quantify gait pattern in 
healthy individuals and individuals with balance or gait problems e.g. elderly, 
stroke, Parkinson disease, multiple sclerosis (Menz et al., 2003c, Menz et al., 
2003a, Huisinga et al., 2012, Latt et al., 2009, Iosa et al., 2012b). 
Accelerometer allows continuous data collection over an extended time and 
over long distances which are the main limitation in a standard instrumented 
gait analysis system. Furthermore accelerometers are relatively easy to 
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manage operating system, portable and lightweight thus allowing  gait data 
collection in the environment (i.e. indoor or outdoor setting) which is not feasible 
for camera-based system. Based on the literature, we know that people with a 
vestibular disorder or stroke experience difficulties ambulating in real 
environment (Iosa et al., 2012a, Donovan et al., 2008,Lord et al., 2006) and 
accelerometers  are available now to allow us to measure this.   
The first two studies (Chapter 2 and Chapter 3) of the current thesis explored 
the effectiveness of use of accelerometers in measuring upper body stability 
control when walking in real urban environment for healthy individuals and 
individuals with a vestibular disorder or stroke. The findings of the current study 
showed that accelerometers can be used to measure gait and balance 
impairment particularly in outdoor settings i.e. urban walking environment. The 
findings demonstrated that accelerometers were able to differentiate the 
postural strategies utilised by people with a vestibular disorder or stroke 
compared to healthy controls. More specifically, both patient groups employed 
compensatory mechanisms including reduced walking speed and reduced trunk 
accelerations in order to maintain postural stability during gait in urban 
environments. However, greater AP head accelerations were noted in patients 
with stroke, indicating that stroke patients have difficulties stabilizing their head 
in space during walk in urban environment. In addition, mobilising on uneven 
surfaces had greatest effect and induced head instability particularly in ML 
direction in patients with vestibular disorders and in the AP direction (the 
direction of progression) in patients with stroke. These results indicate that 
walking in an urban environment provides challenges to postural stability control 
in people with vestibular disorders or stroke. It has been reported that reduced 
gait speed is a compensatory strategy to reduce upper-body accelerations and 
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maintain balance in patients with sub-acute stroke (Iosa et al., 2012a; Iosa et 
al., 2012b) and in older adults (Menz. et al., 2003c). Impairment of 
neuromuscular and musculoskeletal systems following stroke however could 
further compromise postural control, particularly at the head level in the 
direction of progression wherein greater head acceleration may interfere with 
the maintenance of gaze stability during ambulation. 
In this thesis, significant correlation has been noted between accelerometry 
data and some standard clinical assessment tools i.e. Time up and go (TUG) 
and Functional gait assessment (FGA). Functional gait assessment or time up 
and go is a commonly used clinical tool for assessing functional mobility in 
patient populations including those with vestibular disorders (Wrisley et al., 
2004, Whitney et al., 2004a, Gil-Body et al., 2000) or stroke (Ng and Hui-Chan, 
2005). Both FGA and TUG are useful screening tools to identify potential 
balance problems and predict falls risk however they do not provide information 
regarding quality of performance such as ability to modify gait to task demands. 
Findings of the current studies suggested that data from accelerometry could be 
used to assess dynamic functional performance which may be helpful in 
understanding the underlying cause of balance and gait impairments that may 
limit functional independence in patients with a vestibular disorder or stroke. 
The final study (Chapter 4) of the thesis investigated the pattern of illness 
behaviour by using illness behaviour questionnaire (IBQ) in patients with 
vestibular impairment including vestibular migraine. Findings of this study 
showed that the IBQ can be used to differentiate illness behaviour patterns 
between patients with vestibular disorders including vestibular migraine and 
healthy controls. Patients with vestibular migraine show a significantly greater 
 157 
 
fear concern about their health status, disease conviction, dysphoria and 
irritability which suggested the global aspects of abnormal illness behaviour. In 
addition greater anxiety and depression level were also noted in people with 
migraine.   
The term abnormal illness behaviour (AIB) is used to describe individuals with 
maladapted response to an underlying organic pathology or diagnosis and 
when inappropriate treatment is sought (Mechanic, 1986). Although symptoms 
may share similar clinical characteristics, different forms of illness behaviour 
may be elicited suggesting substantial inter-individual variability in a way a 
person respond to their symptoms (Mechanic, 1986). Our study on illness 
behaviour provides a possible profile of AIB in people with vestibular disorders, 
particularly those with migraine components, namely high level anxiety and 
depression and showed a tendency for somatisation.  Early detection of 
possible somatisation in patients with migraine may lead to better intervention. 
Early intervention will allow abnormal illness beliefs and attitudes to be modified 
before it becomes resistant to change. 
It is known that illness behaviour questionnaire (IBQ) has been used to assess 
abnormal illness behaviour (AIB) in various patient populations but traditionally 
it was used more in patients with chronic pain or with a psychiatric condition 
(Prior and Bond, 2008). The IBQ has also been used successfully in patients 
with Meniere's Disease (Savastano et al., 1996) and the current study has given 
further support to the fact that IBQ is well-placed to be used in wider subgroups 
of patient with vestibular disorders. Having said that, the association between 
somatisation, psychological factors and illness behaviour in patients with 
vestibular disorder or vestibular migraine require further exploration. Further 
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exploration of the IBQ could promote a clearer understanding of the nature of 
AIB observed in this group of patients.  
Clinical implications and future directions 
The findings of Chapter 2 and 3 have highlighted the impact of vestibular 
disorders and chronic stroke on gait including changes in postural stability and 
spatio-temporal gait parameters. Most clinically available gait assessment tools 
and tests involve the measurement of spatial-temporal parameters such as gait 
speed, but do not provide information about the postural control strategies used 
during gait. Furthermore, the tests are commonly performed in a controlled 
environment and measure parameters only over a short walking distance, which 
may not reflect the actual conditions where balance control is challenged during 
community ambulation. Community ambulation usually requires patients to walk 
for a longer distance, around obstacles, over uneven ground and moving 
between indoor and outdoor settings (e.g. shopping mall, shops, local high 
street).  Results from the first two studies (Chapter 2 & 3) successfully 
demonstrated the ability of  accelerometers to determine actual performance in 
a real-environment. The acceleration patterns can be used to further explain the 
outcome meaning of standard clinical assessment. The standard clinical tests 
identify who will have greater problems with community ambulation while the 
accelerometers provide specific information related to balance control. 
Therefore using accelerometers as part of the clinical assessment may provide 
specific information which in turn may influence treatment strategies.  
There is evidence on the influence of gait analysis data on clinical decision-
making in the management of post-stroke patients (Ferrarin et al.m 2015). The 
use of gait analysis data has been proven to be associated with better clinical 
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recommendation with regards to chronic stroke care among clinicians (Ferrarin 
et al., 2015). This finding might support the potential use of accelerometry data 
which is more convenient to be used i.e. less complicated instruments 
compared to a standard non-wearable 3D gait analysis system, in clinical 
settings. 
The application of accelerometers in clinical practice may be useful for various 
patient groups in the different departments in hospital settings. For example, in 
the Neurology Department, where the functional ability of patients is affected by 
diseases e.g. stroke or in Falls Clinic setting where patients are screened for fall 
risk based on mobility assessment.  Although accelerometers have been shown 
to be a potentially useful tool to identify gait abnormality in patients with balance 
or vestibular disorders, a thorough evaluation and validation of its performance 
in different population and clinical settings is necessary. In addition, a reference 
data base of healthy individuals with varying subject characteristics (e.g. age) is 
required to ensure the correct interpretation of gait analysis and to enable 
identification of subtle changes in gait patterns.   
The use of illness behaviour questionnaire (IBQ) has been shown to provide 
valuable information on how patients react to their illness symptoms. The 
potential use of IBQ in assessing abnormal illness behaviour patterns in 
different subgroups of vestibular disorders has been noted previously and in the 
present thesis. The role of psychological factors in the manifestation of illness 
behaviour is well reported. It is important to highlight the existence of psychiatric 
comorbidity in patients with vestibular disorders including those with migraine. 
Identification of psychiatric disturbance or abnormal illness behaviour could also 
lead to referral to an appropriate professional to deal with the psychological 
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factors prior to the mainstay of intervention (i.e. vestibular rehabilitation or anti-
migraine prophylaxis ) for patients with vestibular impairment or vestibular 
migraine.    
Previous studies have demonstrated that abnormal illness behaviour is linked to 
increased utilisation of healthcare services such as  the overuse of medical 
services or seeking unnecessary treatment (Clark and Smith, 1998, Guo et al., 
2002). The presence of co morbid anxiety or depression has been shown to 
impede recovery in patients and has increased long-term functional disability in 
patients who received stroke rehabilitation (Guo et al., 2002). These studies 
(Clark and Smith, 1998, Guo et al., 2002) have highlighted the impact of AIB on 
patient's management outcomes, therefore it is important to consider 
assessment of AIB in patient populations who are at a higher risk for AIB.  
Although IBQ have been shown to be a potentially useful tool to identify 
abnormal illness behaviour patients with vestibular disorders including 
vestibular migraine, its application in the clinical setting requires further work. 
Thorough evaluation and validation of IBQ responses across and within 
subgroups of vestibular dysfunction is necessary. In addition, the lack of 
normative data will make interpretation of IBQ scale in identifying abnormal 
illness behaviour difficult. Furthermore, the use of IBQ in clinical settings and 
without comparative data from a control group, may result in a high degree of  
subjectivity in the interpretation of data. It is not clear from the literature how 
illness behaviour change overtime and what factors cause individuals to 
respond differently to similar stressor (e.g. disease/disorder). Future studies 
should investigate the relationship between specific vestibular diagnoses and 
 161 
 
illness behaviour, utilising knowledge of abnormal illness behaviour in treatment 
planning and to investigate  its effect on the treatment outcomes.  
Overall, the three studies in the current thesis present novel findings and open 
up to further exciting areas of research aiming at intervention options for 
patients with vestibular disorders, vestibular migraine or stroke. Findings from 
the two walking studies (Chapter 2 and Chapter 3) provide better understanding 
about the effect of community ambulation on gait and postural stability control in 
healthy individuals and in patients with  vestibular disorders or stroke. Findings 
from illness behaviour study highlighted on the possibility of abnormal illness 
behaviour prevalent in certain subgroup of vestibular disorders.  Investigation of 
patient's functional mobility in real environment and the examination of patient's 
illness behaviour associated with their vestibular impairment may provide a 
critical way to identify and  better understand factors that could hinder some 
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APPENDIX 1 Situational vertigo questionnaire (SVQ) 
 
Identification no. :_____________________ 
 
Today’s date :______________________(DD/MM/YEAR) 
Vertigo is the medical term used for symptoms which patients often describe as 
feelings of unusual disorientation, dizziness, giddiness, lightheadedness or 
unsteadiness.  Please ring a number to indicate the degree to which each of the 
situations listed below causes feelings of vertigo, or makes your vertigo worse.  
If you have never been in one of the situations then for that item ring ―N.T.‖ for 
―Not Tried‖. The categories are: 
 
0 1 2 3 4 N.T. 
 
Not at all Very 
slightly 




Riding as a passenger in a car on straight, flat roads                      
0      1      2      3      4    N.T. 
 
Riding as a passenger in a car on winding or bumpy roads               
0      1      2      3      4      N.T. 
 
Walking down a supermarket aisle                                                    
0       1      2      3      4      N.T. 
 
Standing in a lift while it stops                                                           
0       1      2      3      4      N.T. 
 
Standing in a lift while it moves at a steady speed                             




Riding in a car at a steady speed                                                        
0       1       2      3      4     N.T. 
 
Starting or stopping in a car                                                              
0       1       2      3      4     N.T. 
 
Standing in the middle of a wide open space (e.g. large field or square)                                 
 0       1       2      3      4     N.T. 
 
Sitting on a bus                                                                                  
0       1        2     3      4     N.T. 
 
Standing on a bus                                                                               
0      1      2      3      4       N.T. 
 
Heights                                                                                              
0      1      2      3      4       N.T. 
 
Watching moving scenes on the T.V. or at the cinema                     
0      1      2      3      4       N.T. 
 
Travelling on escalators       
0      1      2      3      4       N.T. 
 
 
Looking at striped or moving surfaces (e.g. curtains, Venetian blinds, flowing 
water)                             
0      1      2      3      4       N.T. 
 
Looking at a scrolling computer screen or microfiche                 




Going through a tunnel looking at the lights on the side               
0       1      2      3     4       N.T. 
 
Going through a tunnel looking at the light at the end                       
0       1      2      3      4      N.T 
 
Driving over the brow of a hill, around bends, or in wide open spaces    
0       1      2      3      4      N.T. 
 
Watching moving traffic or trains (e.g. trying to cross the street, or at the station)                 





APPENDIX 2 Hospital anxiety and depression scale 
Hospital Anxiety and Depression Scale (HADS) 
Identification no. : _____________ 
Today‘s Date : ___________________ (DD/MM/YEAR) 
Please pick the answer that most accurately describe your current feelings. 
 1 I feel tense or 'wound up':   
  Most of the time 3 
  A lot of the time 2 
  From time to time, 
occasionally 
1 
  Not at all 0 
  
2 I still enjoy the things I used 
to enjoy: 
  
  Definitely as much 0 
  Not quite so much 1 
  Only a little 2 
  Hardly at all 3 
 
3 I get a sort of frightened 
feeling as if something 
awful is about to happen: 
  
  Very definitely and quite 
badly 
3 
  Yes, but not too badly 2 
  A little, but it doesn't worry 
me 
1 




4 I can laugh and see the 
funny side of things: 
  
  As much as I always could 0 
  Not quite so much now 1 
  Definitely not so much now 2 
  Not at all 3 
  
5 Worrying thoughts go 
through my mind: 
  
  A great deal of the time 3 
  A lot of the time 2 
  From time to time, but not 
too often 
1 
  Only occasionally 0 
  
6 I feel cheerful:   
  Not at all 3 
  Not often 2 
  Sometimes 1 
  Most of the time 0 
 
7 I can sit at ease and feel 
relaxed: 
  
  Definitely 0 
  Usually 1 
  Not Often 2 





8 I feel as if I am slowed 
down: 
  
  Nearly all the time 3 
  Very often 2 
  Sometimes 1 
  Not at all 0 
  
9 I get a sort of frightened 
feeling like 'butterflies' in 
the stomach: 
  
  Not at all 0 
  Occasionally 1 
  Quite Often 2 
  Very Often 3 
  
10 I have lost interest in my 
appearance: 
  
  Definitely 3 
  I don't take as much care as I 
should 
2 
  I may not take quite as much 
care 
1 




 11 I feel restless as I have to 
be on the move: 
  
  Very much indeed 3 
  Quite a lot 2 
  Not very much 1 




12 I look forward with 
enjoyment to things: 
  
  As much as I ever did 0 
  Rather less than I used to 1 
  Definitely less than I used to 2 
  Hardly at all 3 
  
13 I get sudden feelings of 
panic: 
  
  Very often indeed 3 
  Quite often 2 
  Not very often 1 
  Not at all 0 
  
14 I can enjoy a good book or 
radio or TV program: 
  
  Often 0 
  Sometimes 1 
  Not often 2 
  Very seldom 3 
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APPENDIX 3 Vestibular disorders activities of daily living scale  
 
ID:____________ Rater: ____________ Date:__________(DD/MM/YEAR) 
 
   
Instructions 
This scale evaluates the effects of vertigo and balance disorders on independence in routine activities of daily living. Please 
rate your performance on each item. If your performance varies due to intermittent dizziness or balance problems please use 
the greatest level of disability. For each task indicate the level which most accurately describes how you perform the task. If 
you never do a particular task, please check the box in column NA. The rating scales are explained below. 
Explanation of Independence Rating Scale 
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This scale will help us to determine how inner ear problems affect your ability to perform each task. Please indicate your 
current performance on each task, as compared to your performance beforedeveloping an inner ear problem, by checking one 
of the columns in the center of the page. Pick the answer that most accurately describes how you perform the task. 
 
1 I am not disabled, perceive no change in performance from before developing an inner ear impairment. 
2 I am uncomfortable performing the activity but perceive no difference in the quality of my performance. 
3 I perceive a decrement in the quality of my performance, but have not changed the manner of my performance. 
4 I have changed the manner of my performance, eg, I do things more slowly or carefully than before, or I do 
things without bending. 
 
5 I prefer using an ordinary object in the environment for assistance (eg, stair railing) but I am not dependent on 
the object or device to do the activity. 
6 I must use an ordinary object in the environment for assistance, but I have not acquired a device specifically 
designed for the particular activity. 
 
7 I must use adaptive equipment designed for the particular activity (eg, grab bars, cane, reachers, bus with lift, 
wedge pillow). 
8 I require another person for physical assistance or, for an activity involving 2 people, I need unusual physical 
assistance. 
9 I am dependent on another person to perform the activity. 
 
10 I no longer perform the activity due to vertigo or a balance problem. 
 
NA  I do not usually perform this task or I prefer not to answer this question. 
 










Task  1 2 3 4 5 6 7 8 9 10 
F-1 Sitting up from lying down           
F-2 Standing up from sitting on the bed or chair 
          
F-3 Dressing the upper body (eg, shirt, brassiere, 
undershirt) 
          
F-4 Dressing the lower body (eg, pants, skirt, 
underpants) 
          
F-5 Putting on socks or stockings 
          
F-6 Putting on shoes 
          
F-7 Moving in or out of the bathtub or shower 











































































































































































































































Task  1 2 3 4 5 6 7 8 9 10 
F-8 Bathing yourself in the bathtub or shower           
F-9 Reaching overhead (eg, to a cupboard or shelf) 
          
F-10 Reaching down (eg, to the floor or a shelf) 
          
F-11 Meal preparation 
          
F-12 Intimate activity (eg, foreplay, sexual activity) 
          
A-13 Walking on level surfaces 
          
A-14 Walking on uneven surfaces 









































































































































































































































Task  1 2 3 4 5 6 7 8 9 10 
A-15 Going up steps           
A-16 Going down steps           
A-17 Walking in narrow spaces (eg, corridor, grocery 
store aisle) 
          
A-18 Walking in open spaces           
A-19 Walking in crowds           
A-20 Using an elevator           









































































































































































































































Task  1 2 3 4 5 6 7 8 9 10 
I-22 Driving a car           
I-23 Carrying things while walking (eg, package, 
garbage bag) 
          
I-24 Light household chores (eg, dusting, putting 
items away) 
          
I-25 Heavy household chores (eg, vacuuming, 
moving furniture) 
          
I-26 Active recreation (eg, sports, gardening)           
I-27 Occupational role (eg, job, child care, 
homemaking, student) 
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APPENDIX 4 Vertigo symptom scale (VSS) 
 
 
Identification no.:__________________Today‘s date: _______________ 
(DD/MM/YEAR)  
VERTIGO SYMPTOM SCALE  
The following questions ask about the type of symptoms you experience and how often 
they occur. Please circle the appropriate number to indicate about how many times you 
have experienced each of the symptoms listed below during the past month. 
 
 
0 1 2 3 4 
Never A few times 
( 1-3 times a 
month) 
Several times 




more than 4-7 




once a day) 
 
How often in the past month have you had the following symptoms: 
 
 
1. A feeling that either you, or things around you, are spinning or moving, lasting 
(PLEASE ANSWERS ALL THE CATEGORIES) 
 
a. Less than 2 minutes 0 1 2 3 4 
b. Up to 20 minutes 0 1 2 3 4 
c. 20 minutes to one hour 0 1 2 3 4 
d. Several hours 0 1 2 3 4 
e. More than 12 hours 0 1 2 3 4 
 
 
2. Pains in the heart or chest region 
 
0 1 2 3 4 
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0 1 2 3 4 
 
4. Unsteadiness so severe that you actually fall 
 
0 1 2 3 4 
 
5. Nausea (feeling sick), stomach churning 
 
0 1 2 3 4 
 
 
6. Tension/soreness in your muscles 
 
0 1 2 3 4 
     
 
 
7. A feeling of being light-headed, ’swimmy’ or giddy, lasting  
(PLEASE ANSWERS ALL THE CATEGORIES) 
 
a. Less than 2 minutes 0 1 2 3 4 
b. Up to 20 minutes 0 1 2 3 4 
c. 20 minutes to one hour 0 1 2 3 4 
d. Several hours 0 1 2 3 4 
e. More than 12 hours 0 1 2 3 4 
 
 
8. Trembling, shivering 
 
0 1 2 3 4 
 
9. Feeling of pressure in the ear(s) 
 
0 1 2 3 4 
 
10. Heart pounding or fluttering 
 




0 1 2 3 4 
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12. Heavy feeling in arms or legs 
 
0 1 2 3 4 
 
 
13. Visual disturbances (e.g. blurring, flickering, spots before the eyes) 
 
0 1 2 3 4 
 
14. Headache or feeling of pressure in the head 
 
0 1 2 3 4 
 
15. Unable to stand or walk properly without support 
 




16. Difficulty in breathing, short of breath 
 
0 1 2 3 4 
 
17. Loss of concentration or memory 
 
0 1 2 3 4 
 
 
18. Feeling unsteady, about to lose balance lasting: 
(PLEASE ANSWER ALL THE CATEGORIES) 
 
a. Less than 2 minutes 0 1 2 3 4 
b. Up to 20 minutes 0 1 2 3 4 
c. 20 minutes to one hour 0 1 2 3 4 
d. Several hours 0 1 2 3 4 
e. More than 12 hours 0 1 2 3 4 
 
 
19.  Tingling, prickling or numbness in parts of the body 
 
0 1 2 3 4 
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20. Pains in the lower part of your back 
 
0 1 2 3 4 
 
21. Excessive sweating 
 
0 1 2 3 4 
 
22. Feeling faint, about to black out 
 
0 1 2 3 4 
 
23. Feeling ‘spaced out’, out of touch with your body 
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APPENDIX 5 Activities-specific balance confidence (ABC) scale 
 
Identification no. :_________________ 
 
Today‘s date : _________________ (DD/MM/YEAR) 
 
The Activities-specific Balance Confidence (ABC) Scale 
 
Instructions to Participants: 
 
For each of the following, please indicate your level of confidence in doing the 
activity without losing your balance or becoming unsteady from choosing one of 
the percentage points on the scale form 0% to 100%. If you do not currently do 
the activity in question, try and imagine how confident you would be if you had 
to do the activity. If you normally use a walking aid to do the activity or hold onto 
someone, rate your confidence as it you were using these supports. If you have 
any questions about answering any of these items, please ask the 
administrator. 
 
For each of the following activities, please indicate your level of selfconfidence by 
choosing a corresponding number from the following rating scale: 
 
0% 10 20 40 50 60 70 80 90 100% 
No 
confidence 




“How confident are you that you will not lose your balance or become unsteady 
when you… 
 
1. …walk around the house? ____% 
 
2. …walk up or down stairs? ____% 
 
3. …bend over and pick up a slipper from the front of a closet floor ____% 
 
4. …reach for a small can off a shelf at eye level? ____% 
 
5. …stand on your tiptoes and reach for something above your head? ____% 
 
6. …stand on a chair and reach for something? ____% 
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7.…sweepthe floor? ____% 
 
8. …walk outside the house to a car parked in the driveway? ____% 
 
9. …get into or out of a car? ____% 
 
10. …walk across a parking lot to the mall? ____% 
 
11. …walk up or down a ramp? ____% 
 
12. …walk in a crowded mall where people rapidly walk past you? ____% 
 
13. …are bumped into by people as you walk through the mall? ____% 
 
14. … step onto or off an escalator while you are holding onto a railing? ____% 
 
15. … step onto or off an escalator while holding onto parcels such that you cannot hold 
onto the railing? ____% 
 
16. …walk outside on icy sidewalks? ____% 
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Please tick the best answer for each question regarding your dizziness and/or 
unsteadiness problems, specifically considering your condition during the last 
month. 
 








F3 Because of your problem, do you restrict your travel for 











F5 Because of your problem, do you have difficulty getting into or 





F6 Does your problem significantly restrict your participation in 
social activities, such as going out to dinner, going to the 






F7 Because of your problem, do you have difficulty reading? o Yes 





P8 Does performing more ambitious activities such as sports, 
dancing, household chores (sweeping or putting dishes away) 






E9 Because of your problem, are you afraid to leave your home 
























F14 Because of your problem, is it difficult for you to do strenuous 






E15 . Because of your problem, are you afraid people may think 
you are intoxicated? 
o Yes 



















F19 Because of your problem, is it difficult for you to walk around 
















E22 Has the problem placed stress on your relationships with 






E23  Because of your problem, are you depressed? o Yes 
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 o Sometimes 
o No 
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This questionnaire collects information about your illness and how it affects you. 
Please circle an appropriate answer for each question.  
ILLNESS BEHAVIOUR QUESTIONNAIRE (IBQ) 
No. Items Answer 
1 Do you worry a lot about your health? 
 
Yes No 




3 Does your illness interfere with your life a great deal? 
 
Yes No 
4 Are you easy to get on with when you are ill? 
 
Yes No 
5 Does your family have a history of illness? 
 
Yes No 




7 If the doctor told you that he could find nothing wrong with 
you would you believe him? 
 
Yes No 
8 Is it easy for you to forget about yourself and think about all 
sorts of other things? 
 
Yes No 
9 If you feel ill and someone tells you that you are looking 
better, do you become annoyed? 
Yes No 
  Page 200 
 
 
10 Do you find that you are often aware of various things 
happening in your body? 
 
Yes No 
11 Do you ever think of your illness as a punishment for 
something you have done wrong in the past? 
 
Yes No 
12 Do you have trouble with your nerves? 
 
Yes No 








15 Does it upset you to talk to the doctor about your illness? 
 
Yes No 
16 Are you bothered by many pains and aches? 
 
Yes No 
17 Does your illness affect the way you get on with your family 
or friends a great deal? 
 
Yes No 
18 Do you find that you get anxious easily? 
 
Yes No 
19 Do you know anybody who has had the same illness as you? 
 
Yes No 
20 Are you more sensitive to pain than other people? 
 
Yes No 
21 Are you afraid of illness? 
 
Yes No 
22 Can you express your personal feelings easily to other 
people? 
Yes No 
  Page 201 
 
 
23 Do people feel sorry for you when you are ill? 
 
Yes No 




25 Do you find that your illness affects your sexual relations? 
 
Yes No 
26 Do you experience a lot of pain with your illness? 
 
Yes No 




28 Do you care whether or not people realise you are sick? 
 
Yes No 




30 Do you ever have silly thoughts about your health which 
you can’t get out of your mind, no matter how hard you try? 
 
Yes No 
31 Do you have any financial problems? 
 
Yes No 
32 Are you upset by the way people take your illness? 
 
Yes No 
33 Is it hard for you to believe the doctor when he tells you 
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35 Are you sleeping well? 
 
Yes No 
36 When you are angry, do you tend to bottle up your feelings? 
 
Yes No 
37 Do you often think that you might suddenly fall ill? 
 
Yes No 
38 If a disease is brought to your attention (through the radio, 
television, newspapers or 
someone you know) do you worry about getting it yourself? 
 
Yes No 




40 Are you upset by the appearance of your face or body? 
 
Yes No 








43 Do you have any family problems? 
 
Yes No 
44 Do you think there is something the matter with your mind? 
 
Yes No 
45 Are you eating well? 
 
Yes No 
46 Is your bad health the biggest difficulty of your life? 
 
Yes No 
47 Do you find that you get sad easily? 
 
Yes No 
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48 Do you worry or fuss over small details that seem 
unimportant to others? 
 
Yes No 
49 Are you always a co-operative patient? 
 
Yes No 
50 Do you often have the symptoms of a very serious disease? 
 
Yes No 
51 Do you find that you get angry easily? 
 
Yes No 
52 Do you have any work problems? 
 
Yes No 
53 Do you prefer to keep your feelings to yourself? Yes No 
 
54 Do you often find that you get depressed? Yes No 
 




56 Are you more irritable towards other people? Yes No 
 
57 Do you think that your symptoms may be caused by worry? Yes No 
 




59 Is it hard for you to relax? Yes No 
 
60 Do you have personal worries which are not caused by 
physical illness? 
Yes No 
61 Do you often find that you lose patience with other people? Yes No 
 
62 Is it hard for you to show people your personal feelings? Yes No 
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This questionnaire collects information about your illness and how it affects you. 
Please circle an appropriate answer for each question.  
ILLNESS BEHAVIOUR QUESTIONNAIRE (IBQ) 
No. Items Answer 
1 Do you worry a lot about your health? 
 
Yes No 








4 Are you easy to get on with when you are ill? 
 
Yes No 
5 Does your family have a history of illness? 
 
Yes No 




7 If the doctor told you that he could find nothing wrong with 
you would you believe him? 
 
Yes No 
8 Is it easy for you to forget about yourself and think about all 
sorts of other things? 
 
Yes No 
9 If you feel ill and someone tells you that you are looking 
better, do you become annoyed? 
Yes No 
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10 Do you find that you are often aware of various things 
happening in your body? 
 
Yes No 
11 Do you ever think that you have an which is a punishment 
for   something you have done wrong in the past? 
 
Yes No 
12 Do you have trouble with your nerves? 
 
Yes No 








15 Does it upset you to talk to the doctor about illness? 
 
Yes No 
16 Are you bothered by many pains and aches? 
 
Yes No 
17 Do you have an illness which affects the way you get on 
with your family or friends a great deal? 
 
Yes No 
18 Do you find that you get anxious easily? 
 
Yes No 
19 Do you have an illness which is the same as anybody you 
know has had?  
 
Yes No 
20 Are you more sensitive to pain than other people? 
 
Yes No 
21 Are you afraid of illness? 
 
Yes No 
22 Can you express your personal feelings easily to other 
people? 
Yes No 
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23 Do people feel sorry for you when you are ill? 
 
Yes No 




25 Do you have an illness which affects your sexual relations? 
 
Yes No 
26 Do you have an illness with a lot of pain? 
 
Yes No 
27 Except for illness, do you have any problems in your life? 
 
Yes No 








30 Do you ever have silly thoughts about your health which 
you can’t get out of your mind, no matter how hard you try? 
 
Yes No 
31 Do you have any financial problems? 
 
Yes No 




33 Is it hard for you to believe the doctor when he tells you 
there is nothing for you to worryabout? 
 
Yes No 




35 Are you sleeping well? Yes No 
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36 When you are angry, do you tend to bottle up your feelings? 
 
Yes No 
37 Do you often think that you might suddenly fall ill? 
 
Yes No 
38 If a disease is brought to your attention (through the radio, 
television, newspapers orsomeone you know) do you worry 
about getting it yourself? 
 
Yes No 
39 Do you get the feeling that people are not taking your illness 
seriously enough when you are sick? 
 
Yes No 
40 Are you upset by the appearance of your face or body? 
 
Yes No 








43 Do you have any family problems? 
 
Yes No 
44 Do you think there is something the matter with your mind? 
 
Yes No 
45 Are you eating well? 
 
Yes No 
46 Is bad health the biggest difficulty of your life? 
 
Yes No 
47 Do you find that you get sad easily? 
 
Yes No 
48 Do you worry or fuss over small details that seem 
unimportant to others? 
Yes No 
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49 Are you always a cooperative patient? 
 
Yes No 
50 Do you often have the symptoms of a serious disease? 
 
Yes No 
51 Do you find that you get angry easily? 
 
Yes No 
52 Do you have any work problems? 
 
Yes No 
53 Do you prefer to keep your feelings to yourself? Yes No 
 
54 Do you often find that you get depressed? Yes No 
 




56 Are you more irritable towards other people? Yes No 
 
57 Do you have symptoms may be caused by worry? Yes No 
 




59 Is it hard for you to relax? Yes No 
 
60 Do you have personal worries which are not caused by 
physical illness? 
Yes No 
61 Do you often find that you lose patience with other people? Yes No 
 
62 Is it hard for you to show people your personal feelings? Yes No 
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APPENDIX 9 Functional Gait 
Assessment (FGA) 
 
Identification no. ______________ 
 
Date : ___________________ 
 
 
Requirements: A marked 6-m (20-ft) 
walkway that is marked with a 
30.48-cm (12-in) width. 
 
 
______1. GAIT LEVEL SURFACE 
Instructions: Walk at your normal 
speed from here to the next mark (6 
m [20 ft]). 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Walks 6 m (20 ft) in 
less than 5.5 seconds, no assistive 
devices, good speed, no evidence 
for imbalance, normal gait pattern, 
deviates no more than 15.24 cm (6 
in) outside of the 30.48-cm (12-in) 
walkway width. 
 
(2) Mild impairment—Walks 6 m (20 
ft) in less than 7 seconds but greater 
than 5.5 seconds, uses assistive 
device, slower speed, mild gait 
deviations, or deviates 15.24–25.4 
cm (6–10 in) outside of the 30.48-
cm (12-in) walkway width. 
 
(1) Moderate impairment—Walks 6 
m (20 ft), slow speed, abnormal gait 
pattern, evidence for imbalance, or 
deviates 25.4– 
38.1 cm (10–15 in) outside of the 
30.48-cm (12-in) walkway width. 
Requires more than 7 seconds to 
ambulate 6 m (20 ft). 
 
(0) Severe impairment—Cannot 
walk 6 m (20 ft) without assistance, 
severe gait deviations or imbalance, 
deviates greater than 38.1 cm (15 
in) outside of the 30.48-cm (12-in) 
walkway width or reaches and 
touches the wall. 
 
______2. CHANGE IN GAIT 
SPEED 
Instructions: Begin walking at your 
normal pace (for 1.5 m [5 ft]). When 
I tell you “go,” walk as fast as you 
can (for 1.5 m [5 ft]). When I tell you 
“slow,” walk as slowly as you can 
(for 1.5 m [5 ft]). 
 
Grading: Mark the highest category 
that applies. 
(3) Normal—Able to smoothly 
change walking speed without loss 
of balance or gait deviation. Shows 
a significant difference inwalking 
speeds between normal, fast, and 
slow speeds.Deviates no more than 
15.24 cm (6 in) outside of the 30.48-
cm (12-in) walkway width. 
 
(2) Mild impairment—Is able to 
change speed but demonstrates 
mild gait deviations, deviates 15.24–
25.4 cm (6–10 in) outsideof the 
30.48-cm (12-in) walkway width, or 
no gait deviations but unable to 
achieve a significant change in 
velocity, or uses an 
assistive device. 
 
(1) Moderate impairment—Makes 
only minor adjustments to walking 
speed, or accomplishes a change in 
speed with significantgait deviations, 
deviates 25.4–38.1 cm (10–15 in) 
outside the 30.48-cm (12-in) 
walkway width, or changes speed 
but loses balance but is able to 
recover and continue walking. 
 
(0) Severe impairment—Cannot 
change speeds, deviates greater 
than 38.1 cm (15 in) outside 30.48-
cm (12-in) walkway width,or loses 
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balance and has to reach for wall or 
be caught. 
 
_______3. GAIT WITH 
HORIZONTAL HEAD TURNS 
Instructions: Walk from here to the 
next mark 6 m (20 ft) away. Begin 
walking at your normal pace. Keep 
walking straight; after 3 steps, turn 
your head to the right and keep 
walking straight while looking to the 
right. After 3 more steps, turn your 
head to the left and keep walking 
straight while looking left. Continue 
alternating looking right and left 
every 3 steps until you have 
completed 2 repetitions in each 
direction. 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Performs head turns 
smoothly with no change in gait. 
Deviates no more than 15.24 cm (6 
in) outside 30.48-cm (12-in) 
walkway width. 
 
(2) Mild impairment—Performs head 
turns smoothly with slight change in 
gait velocity (eg, minor disruption to 
smooth gaitpath), deviates 15.24–
25.4 cm (6–10 in) outside 30.48-cm 
(12-in) walkway width, or uses an 
assistive device.  
 
(1) Moderate impairment—Performs 
head turns with moderate change in 
gait velocity, slows down, deviates 
25.4–38.1 cm(10–15 in) outside 
30.48-cm (12-in) walkway width but 
recovers, can continue to walk. 
 
(0) Severe impairment—Performs 
task with severe disruption of gait 
(eg, staggers 38.1 cm [15 in] outside 
30.48-cm (12-in) walkway width, 




_______4. GAIT WITH VERTICAL 
HEAD TURNS 
Instructions: Walk from here to the 
next mark (6 m [20 ft]). Begin 
walking at your normal pace. Keep 
walking straight; after 3 steps, tip 
your head up and keep walking 
straight while looking up. After 3 
more steps, tip your head down, 
keep walking straight while looking 
down. Continue alternating looking 
up and down every 3 steps until you 
have completed 2 repetitions in 
each direction. 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Performs head turns 
with no change in gait. Deviates no 
more than 15.24 cm (6 in) outside 
30.48-cm (12-in) walkway width. 
 
(2) Mild impairment—Performs task 
with slight change in gait velocity 
(eg, minor disruption to smooth gait 
path), deviates15.24–25.4 cm (6–10 
in) outside 30.48-cm (12-in) 
walkway width or uses assistive 
device. 
 
(1) Moderate impairment—Performs 
task with moderate change in gait 
velocity, slows down, deviates 25.4–
38.1 cm (10–15 in)outside 30.48-cm 
(12-in) walkway width but recovers, 
can continue to walk. 
 
(0) Severe impairment—Performs 
task with severe disruption of gait 
(eg, staggers 38.1 cm [15 in] outside 
30.48-cm (12-in) walkway width, 
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_______5. GAIT AND PIVOT TURN 
Instructions: Begin with walking at 
your normal pace. When I tell 
you,“turn and stop,” turn as quickly 
as you can to face the opposite 
direction and stop. 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Pivot turns safely within 
3 seconds and stops quickly with no 
loss of balance. 
 
(2) Mild impairment—Pivot turns 
safely in _3 seconds and stops with 
no loss of balance, or pivot turns 
safely within 3 secondsand stops 
with mild imbalance, requires small 
steps to catch balance. 
 
(1) Moderate impairment—Turns 
slowly, requires verbal cueing, or 
requires several small steps to catch 
balance following turn and stop. 
 
(0) Severe impairment—Cannot turn 
safely, requires assistance to turn 
and stop. 
 
_______6. STEP OVER 
OBSTACLE 
Instructions: Begin walking at your 
normal speed. When you come to 
the shoe box, step over it, not 
around it, and keep walking. 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Is able to step over 2 
stacked shoe boxes taped together 
(22.86 cm [9 in] total height) without 
changing gaitspeed; no evidence of 
imbalance. 
 
(2) Mild impairment—Is able to step 
over one shoe box (11.43 cm [4.5 in] 
total height) without changing gait 
speed; no evidence of imbalance. 
 
(1) Moderate impairment—Is able to 
step over one shoe box (11.43 cm 
[4.5 in] total height) but must slow 
down and adjust steps to clear box 
safely. May require verbal cueing. 
 
(0) Severe impairment—Cannot 
perform without assistance. 
 
 
_______7. GAIT WITH NARROW 
BASE OF SUPPORT 
Instructions: Walk on the floor with 
arms folded across the chest, feet 
aligned heel to toe in tandem for a 
distance of 3.6 m [12 ft]. The 
number of steps taken in a straight 
line are counted for a maximum of 
10 steps. 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Is able to ambulate for 
10 steps heel to toe with no 
staggering. 
 




Ambulates 4–7 steps. 
 
(0) Severe impairment—Ambulates 
less than 4 steps heel to toe or 
cannot perform without assistance. 
 
_______8. GAIT WITH EYES 
CLOSED 
Instructions: Walk at your normal 
speed from here to the next mark (6 
m [20 ft]) with your eyes closed. 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Walks 6 m (20 ft), no 
assistive devices, good speed, no 
evidence of imbalance, normal gait 
pattern, deviates no more than 
15.24 cm (6 in) outside 30.48-cm 
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(12-in) walkway width. Ambulates 6 
m (20 ft) in less than 7 seconds. 
 
(2) Mild impairment—Walks 6 m (20 
ft), uses assistive device, slower 
speed, mild gait deviations, deviates 
15.24–25.4 cm(6–10 in) outside 
30.48-cm (12-in) walkway width. 
Ambulates 6 m (20 ft) in less than 9 
seconds but greater than 7 seconds. 
 
(1) Moderate impairment—Walks 6 
m (20 ft), slow speed, abnormal gait 
pattern, evidence for imbalance, 
deviates 25.4–38.1cm (10–15 in) 
outside 30.48-cm (12-in) walkway 
width. Requires more than 9 
seconds to ambulate 6 m (20 ft). 
 
(0) Severe impairment—Cannot 
walk 6 m (20 ft) without assistance, 
severe gait deviations or imbalance, 
deviates greater than 38.1cm (15 in) 
outside 30.48-cm (12-in) walkway 




Instructions: Walk backwards until I 
tell you to stop. 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Walks 6 m (20 ft), no 
assistive devices, good speed, no 
evidence for imbalance, normal gait 
pattern, deviates nomore than 15.24 
cm (6 in) outside 30.48-cm (12-in) 
walkway width. 
 
(2) Mild impairment—Walks 6 m (20 
ft), uses assistive device, slower 
speed, mild gait deviations, deviates 
15.24–25.4 cm(6–10 in) outside 
30.48-cm (12-in) walkway width. 
 
(1) Moderate impairment—Walks 6 
m (20 ft), slow speed, abnormal gait 
pattern, evidence for imbalance, 
deviates 25.4–38.1cm (10–15 in) 
outside 30.48-cm (12-in) walkway 
width. 
 
(0) Severe impairment—Cannot 
walk 6 m (20 ft) without assistance, 
severe gait deviations or imbalance, 
deviates greater than 38.1 cm (15 
in) outside 30.48-cm (12-in) 




Instructions: Walk up these stairs as 
you would at home (ie, using the rail 
if necessary). At the top turn around 
and walk down. 
 
Grading: Mark the highest category 
that applies. 
 
(3) Normal—Alternating feet, no rail. 
 
(2) Mild impairment—Alternating 
feet, must use rail. 
 
(1) Moderate impairment—Two feet 
to a stair; must use rail. 
 

















  Page 213 
  
APPENDIX 10 Time Up and Go Test (TUG) 
Example of TUG protocol and instruction 
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Computerised dynamic posturography: Sensory organisation test (SOT) 
Testing is performed under six different sensory conditions: 
1. Subjects stand on a stationary support surface with eyes open, fixed visual 
surround 
2. Subjects stand on a stationary support surface with eyes closed 
3. Subject stand on a stationary support surface with sway-referenced vision 
4. Subject stand on a sway reference support surface with eyes open, fixed 
visual surround 
5. Subject stand on a sway reference support surface with eyes closed 
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APPENDIX 12 Information sheet (Study 1-Healthy participant) 
 
INFORMATION SHEET FOR PARTICIPANTS 
 
REC ReferenceNumber: BDM/09/10-56 
 
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
 
Study of free walking of healthy individuals using data from triaxial accelerometer 
sensors. 
We would like to invite you to participate in thispostgraduate research project.  You 
should only participate if you want to; choosing not to take part will not disadvantage 
you in any way. Before you decide whether you want to take part, it is important for you 
to understand why the research is being done and what your participation will involve.  
Please take time to read the following information carefully and discuss it with others if 
you wish.  Ask us if there is anything that is not clear or if you would like more 
information. 
We are studying the way people walk in everyday environments, such as climbing 
stairs, walking in quiet and busy environments, and crossing the road. To do this we 
would like to ask volunteers who are willing to go for a kilometre (km)-long walk in the 
London Bridge area following a set route. We would like to gather by using sensor 
boxes (match size box) placed on a small of the back, neck and on the head. This type 
of sensor has already been used for assessing standing, walking and stair climbing 
with older persons in a laboratory environment but we would like now to test it in free 
walking. We would also like to do some basic tests about your general level of function. 
We need volunteers between the ages of 18 and 65 years who can perform all 
activities of daily living (e.g. walk outdoors, go up and down stairs, cross the road etc.) 
independently  
You will be asked to do the following: 
Sign the consent form and complete a screening questionnaire.  
Get up from a chair, walk ahead three meters and return to the chair in order to assess 
how long these daily tasks take you to complete. 
Complete a 10-item test which assesses walking ability during different tasks such as 
walking at different speeds, over an obstacle, or with simultaneous head movements.  
Walk following a set route in the London Bridge area, in the middle of morning or 
afternoon. For this you will be asked to wear a small sensor box stuck to the skin at the 
small of your back, at the neck level and on your head hidden in a hat. You will also be 
asked to carry a data logger and light weight notebook in a backpack. You will be 
followed by at least one researcher to help you in case you need assistance. You can 
wear your usual clothing and shoes but please avoid high heels and also please DO 
NOT drink alcohol for 24 hours before the test.  
The test can be arranged for a day and session that is convenient for you. You will 
have to come to Guy‘s Campus of King‘s College London, in London Bridge, London 
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SE1 1UL. Your travel costs will be reimbursed. The entire tests will take approximately 
one and half hours.  
 
During the test there are risks of falling and dealing with traffic but they should not be 
greater than the risks you face during your daily activities. We will use a hypoallergenic 
adhesive tape to fix the sensor on the skin at the small of your back and neck. We will 
use a spray under the adhesive that will help it to come off easily when the test is 
finished. There might be some discomfort (similar to taking off sticking plaster) when 
the sensor comes off but there should be no lasting damage or irritation to the skin. 
There is also a risk of having an allergic reaction to the adhesive tape. If you have an 
allergy to adhesives, please inform the staff before the test. 
All data will be treated in confidence, no names will be mentioned in any of the reports 
of the study and care will be taken so that individuals cannot be identified from details 
in reports and publications of the study. It is up to you to decide whether to take part or 
not.  If you decide to take part you are still free to withdraw at any time and without 
giving a reason. 
If this study has harmed you in any way you can contact King's College London using 
the details below for further advice and information:  
 
1.MsMarniza Omar (PhD student) 
Division of Applied  Biomedical Research, 
Room 3.11 Shepherd‘s House,  
Guy‘s Campus, King‘s College London,  




2. Dr MarousaPavlou PhD BA MCSP (Supervisor) 
King‘s College London 
School of Biomedical and Health Sciences 
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APPENDIX 13 Consent form (Study 1) 
CONSENT FORM FOR PARTICIPANTS IN RESEARCH STUDIES 
 
Please complete this form after you have read the 
Information Sheet and/or listened to an explanation 
about the research. 
Title of Study: Study of free walking of healthy individuals using data from triaxial 
accelerometer sensors 
King‘s College Research Ethics Committee Ref: BDM/09/10-56 
Thank you for considering taking part in this research. The person organising the 
research must explain the project to you before you agree to take part. 
If you have any questions arising from the Information Sheet or explanation already 
given to you, please ask the researcher before you decide whether to join in. You will 
be given a copy of this Consent Form to keep and refer to at any time. 
I understand that if I decide at any time during the research that I no longer wish to 
participate in this project, I can notify the researchers involved and withdraw from it 
immediately without giving any reason. Furthermore, I understand that I will be able to 
withdraw my data up to ( the point of publication or up until the point stated on the 
Information Sheet). 
 
I consent to the processing of my personal information for the purposes explained to 
me.  I understand that such information will be handled in accordance with the terms of 





agree that the research project named above has been explained to me to my 
satisfaction and I agree to take part in the study. I have read both the notes written 
above and the Information Sheet about the project, and understand what the research 
study involves. 
 
Signed      Date 
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APPENDIX 14 Information sheet for patient (Study 1 ) 
 
 
The National Hospital for Neurology and Neurosurgery 
Department of Neuro-otology 
 Box 127 
 Queen Square, London 
WC1N 3BG 
INFORMATION SHEET FOR PARTICIPANTS 
Study of free walking in patients with a peripheral vestibular disorder 
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
You are being invited to take part in a research project. Here is some information to 
help you decide whether or not to take part. Before you decide whether you want to 
take part, it is important for you to understand why the research is being done and what 
your participation will involve.  Please take time to read the following information 
carefully and discuss it with friends, relatives and your GP if you wish. Please do not 
hesitate to ask us if there is anything you do not understand or if you would like more 
information. Please do take time to decide whether you wish to take part. You should 




It has been shown that individuals with balance disorders arising from the inner ear 
may feel more unsteady when walking, particularly in busy environments (i.e. crowds) 
or on uneven surfaces. Patients may also have difficulty maintaining their balance 
when moving their head while walking and may also experience unpleasant feelings of 
motion or blurred vision when walking or turning their head. It has also been shown that 
patients show changes in walking style compared to healthy adults without a balance 
disorder. 
 
However these studies have been conducted in a closed laboratory setting, which is 
very different to walking during daily activities in a real outdoor environment. Therefore 
these studies may not provide a true indication of the walking of patients with balance 
problems in everyday life.  
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What is the purpose of this study? 
Until recently it was not possible to assess walking in real environments because 
measuring instruments had not been developed. Now howevertheuse of matchbox-size 
sensor-boxes placed at the small of the back and on back of the head are able to 
record walking in a wide variety of real environments in healthy adults. Therefore the 
aim of this study is to use this technique to assess balance strategies used by patients 
with inner ear balance disorders when walking in five common urban environments 
including an area with a checkerboard floor pattern, a darker area, a busy section, a 
quiet section, and on an uneven surface (cobbled pathway). This information will be 
used to develop advances in rehabilitation for patients with inner ear balance disorders. 
 
Why have I been chosen? 
You have been asked to participate in this study because you are between 18-65 years 
of age and have been diagnosed with a peripheral inner ear balance disorder. You 
have been referred by your consultant physician. 
 
Do I have to take part? 
It is up to you to decide whether to take part. We will describe the study to you and 
then go through this information sheet. If you agree to participate we will ask you to 
give your verbal consent and sign a consent form to show that you have agreed to take 
part. You are free to withdraw at any time without giving a reason. This will not affect 
the standard of care you receive. 
 
What will happen to me if I take part? 
If you decide to participate, you will be asked to attend the Academic Department of 
Physiotherapy, King‘s College London based at London Bridge, London SE1 1UL for a 
single visit to complete a brief set of questionnaires, two short walking tests in the 
laboratory, and the outdoor walking test. The brief set of questionnaires will ask about 
particular symptoms and their severity (for example, feelings of unsteadiness), the 
situations that may produce these symptoms (for example, crowds), emotional state, 
the ability to perform various daily activities, and confidence in your ability to maintain 
balance in everyday activities.  
 
The indoor balance tests will look at your normal walking speed and your ability to 
maintain your balance in standing or while walking during different conditions, such as 
when the surface is unsteady or when you move your head at the same time.  
 
The outdoor walking test will involve following a set route in the London Bridge area, in 
the middle of the morning or the afternoon. We would like to gather data by using 
sensor boxes placed at the small of your back, at the neck level and on the head 
(hidden in a hat) which are about the size of match box. You will also carry a wireless 
data logger in a pouch or pocket. You will be followed by two researchers to help you in 
case you need assistance. You can wear your usual clothing and shoes but please 
avoid high heels and also please DO NOT drink alcohol for 24 hours before the test.  
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The test can be arranged for a day and session that is convenient for you. Your travel 
costs will be reimbursed. The total test will take approximately two hours and 30 
minutes.  
 
Are there any risks to me from taking part? 
You may, on occasions feel unsteady while performing some of the more challenging 
walking tasks and when undertaking the balance tests. There are risks of falling and 
risks handling traffic but they should not be greater than the risks you face during your 
daily activities. You will be closely supervised throughout when performing all tests. If 
you feel particularly unsteady at any point you can stop the test.  
 
Hypoallergenic adhesive tape will be used to fix the sensor on the skin at the small of 
your back and on the base of your neck. We will use a spray under the adhesive that 
will help it to come off easily when the test is finished. There might be some discomfort 
(similar to taking off sticking plaster) when the sensor comes off but there should be no 
lasting damage or irritation to the skin. There is also a risk of having an allergic reaction 
to the adhesive tape. If you have an allergy to adhesives, please inform the staff before 
the test. 
 
What are the benefits of taking part? 
We cannot promise we will be able to help you, but, the extended assessment may 
help provide further information about the specific balance strategies patients use when 
walking in challenging outdoor environments. The information from this study will be 
used to develop an advanced vestibular rehabilitation programme. 
 
Will my taking part be kept confidential? 
All information that is collected about you during the course of this research will be kept 
strictly confidential. All information for this project will be stored on password-protected 
computers used only by research staff. Any documents leaving the hospital or testing 
site will have all personal identifiable information removed. 
 
Will my GP or Medical team know about my participation and results of this 
investigation? 
With your permission we would like to share this information with your referring medical 
team. Your GP will not be informed of your participation in this study. 
 
Will this affect my current treatment? 
Participating in this study will not affect your current treatment. 
What happens if there is a problem? 
This study has been reviewed and accepted by the National Hospital for Neurology and 
Neurosurgery and Institute of Neurology Joint Ethics Committee. The consultant in charge 
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of this investigation is Dr Doris Eva Bamiou (Consultant in Audiological Medicine, NHNN). 
Other investigators conducting this study are Professor Linda Luxon, Professor in 
Audiovestibular Medicine and Consultant Neuro-otological Physician at NHNN, 
Dr.MarousaPavlou (Lecturer in Physiotherapy, King‘s College London), Dr Ruth 
Mayagoitia-Hill (Lecturer in assistive technology, King‘s College London) and Mrs. Marniza 
Omar (Audiologist, PhD student at King‘s College London). 
If you have any concerns regarding the study please contact Dr MarousaPavlou, the 
physiotherapist who will be leading the testing and who will try to answer your 
questions (contact details below). If you are unhappy and wish to complain formally, 
you can do this through the NHS complaints procedure. Details can be obtained from 
the hospital. 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone‘s negligence, then you may have grounds for legal action 
for compensation against University College London Hospitals NHS Trust, but you may 
have to pay for legal costs. The normal NHS complaints procedure will still be available 
to you.  
It is up to you to decide whether to take part or not.  If you decide to take part you are 
still free to withdraw at any time and without giving a reason. A decision to withdraw at 
any time, or a decision not to take part, will not affect the treatment you receive from 
your medical or therapy team in any way. You may withdraw your data from the project 
at any time up until it is transcribed for use in the final report in December 2010. 
If you do decide to take part you will be given this information sheet to keep and be 
asked to sign a consent form. Your data will be kept anonymously and will not be 
passed on outside of your medical care team. 
 
Who can I contact for further information? 
If you have any queries please contact Dr MarousaPavlou, the Physiotherapist leading 
the testing for this study.  
Dr MarousaPavlou PhD BA MCSP 
King‘s College London 
School of Biomedical and Health Sciences 
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APPENDIX 15 Consent form (Study 1) 
CONSENT FORM 
 
Centre Number:       UCLH Project ID 
number: 
Patient Identification Number for this study:    Form version:  
Title of project: Study of free walking in patients with a peripheral vestibular disorder. 
Name of Chief Investigator:Dr. Doris-Eva Bamiou, 
Consultant in Audiological Medicine, National Hospital for Neurology and Neurosurgery 
(University College London NHS trust) and Senior Lecturer, Ear Institute (University 
College London) 
         Please initial box 
 
1. I confirm that I have read and understood the information sheet dated …….. 




2.  I confirm that I have had sufficient time to consider whether or not I want to 




3. I understand that my participation in this study is voluntary and that I am free 
to withdraw at any time, without giving any reason, and without my medical 
care or legal rights being affected. 
 
4. I understand that sections of my medical notes may be looked at by 
responsible individuals from King‘s College London, The National Hospital 
for Neurology and Neurosurgery or from regulatory authorities where it is 
relevant to my taking part in research.  I give permission for these 
individuals to have access to my records. 
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Centre Number:       UCLH Project ID 
number: 




Title of project: Study of free walking in patients with a peripheral vestibular disorder. 
Name of Principal investigator:Dr. Doris-Eva Bamiou, 
Consultant in Audiological Medicine, National 
Hospital for Neurology     and Neurosurgery 
(University College London NHS trust) and Senior 
Lecturer, Ear Institute (University College London). 
 
__________________________ _________________         __________________ 
Name of patient    Date   Signature 
 
________________                        _______________          ____________________ 
Name of Person taking consent  Date               Signature 
(if different from researcher) 
 
_______________                       ______________ ______________________ 
Researcher (to be contacted   Date     Signature 
if there are any problems)  
         
Comments or concerns during the study  
If you have any comments or concerns you may discuss these with 
the investigator.   If you wish to go further and complain about any 
aspect of the way you have been approached or treated during the 
course of the study, you should write or get in touch with the 
Complaints Manager, UCL hospitals.  Please quote the UCLH project 
number at the top this consent form. 
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APPENDIX 16 Information sheet for people with stroke (Study 2) 
 
The National Hospital for Neurology and Neurosurgery 
Department of Neuro-otology 
 Box 127 
 Queen Square, London 
WC1N 3BG 
INFORMATION SHEET FOR PARTICIPANTS 
Study of free walking in patients with stroke 
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET 
You are being invited to take part in a research project. Here is some information to 
help you decide whether or not to take part. Before you decide whether you want to 
take part, it is important for you to understand why the research is being done and what 
your participation will involve.  Please take time to read the following information 
carefully and discuss it with friends, relatives and your GP if you wish. Please do not 
hesitate to ask us if there is anything you do not understand or if you would like more 
information. Please do take time to decide whether you wish to take part. You should 




Walking ability is significantly limited in many people with stroke, with some 
experiencing falls while moving from one place to another. Several stroke patients have 
also reported that they feel more unsteady when walking, particularly in busy 
environments (i.e. crowds) or on uneven surfaces. Decreased speed and walking 
capacity in addition to balance deficits have been shown to largely contribute to the 
increased falls rate and decreased ability to walk in the community after stroke. 
Patients may also have difficulty maintaining their balance when moving their head 
while crossing the road for example, and may also experience unpleasant feelings of 
motion or blurred vision when walking or turning their head.  
 
The different tests used to examine community walking abilities in people with stroke 
are often performed in laboratory based or hospital environments, which are very 
different to walking in a real outdoor environment. Therefore these tests may not 
provide a true indication of the walking abilities or the strategies used by stroke patients 
with balance problems in everyday life. It is important to identify how different 
environments affect the ability people with stroke to manage their balance when 
walking.  
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What is the purpose of this study? 
Until recently it was not possible to assess walking in real environments because 
measuring instruments had not been developed. Now howeverthe use of matchbox-
size sensor-boxes placed on back of the head and the small of the back are able to 
record how the body moves when walking in a wide variety of real environments. 
Therefore the aim of this study is to use this technique to assess balance strategies 
used by patients with walking deficits after stroke, when walking in five common urban 
environments; an area with a checkerboard floor pattern, a darker area, a busy section, 
a quiet section, and on an uneven surface (cobbled pathway).  
This information will be used to develop advances in rehabilitation for stroke patients 
with problems when walking in the community. 
 
Why have I been chosen? 
You have been asked to participate in this study because you have been diagnosed 
with a stroke at least 6 months ago. 
 
Do I have to take part? 
It is up to you to decide whether to take part. We will describe the study to you and 
then go through this information sheet. If you agree to participate we will ask you to 
give your verbal consent and sign a consent form to show that you have agreed to take 
part. You are free to withdraw at any time without giving a reason. This will not affect 
the standard of care you receive. 
 
What will happen to me if I take part? 
If you decide to participate, you will be asked to attend the Academic Department of 
Physiotherapy, King‘s College London based at London Bridge, London SE1 1UL for a 
single visit to complete a brief set of questionnaires, two short walking tests in the 
laboratory, and the outdoor walking test. The brief set of questionnaires will ask about 
particular symptoms and their severity (for example, feelings of unsteadinessand ability 
to move), the situations that may produce these symptoms (for example, crowds), 
emotional state, the ability to perform various daily activities, and confidence in your 
ability to maintain balance in everyday activities.  
 
The indoor balance tests will look at your normal walking speed and your ability to 
maintain your balance in standing or while walking during different conditions, such as 
when the surface is unsteady or when you move your head at the same time.  
 
The outdoor walking test will involve following a set route in the London Bridge area, in 
the middle of the morning or the afternoon. We would like to gather data by using 
sensor boxes placed at the small of your back, at the neck level and on the head 
(hidden in a hat) which are about the size of match box. You will also carry a wireless 
data logger in a pouch or pocket. You will be followed by two researchers to help you in 
case you need assistance. You can wear your usual clothing and shoes but please 
avoid high heels and also please DO NOT drink alcohol for 24 hours before the test.  
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The test can be arranged for a day and session that is convenient for you. Your travel 
costs will be reimbursed. The total test will take approximately two hours and 30 
minutes.  
 
Are there any risks to me from taking part? 
You may, on occasions feel unsteady while performing some of the more challenging 
walking tasks and when undertaking the balance tests. There are risks of falling and 
risks handling traffic but they should not be greater than the risks you face during your 
daily activities. You will be closely supervised throughout when performing all tests. If 
you feel particularly unsteady at any point you can stop the test.  
 
Hypoallergenic adhesive tape will be used to fix the sensor on the skin at the small of 
your back and on the base of your neck. We will use a spray under the adhesive that 
will help it to come off easily when the test is finished. There might be some discomfort 
(similar to taking off sticking plaster) when the sensor comes off but there should be no 
lasting damage or irritation to the skin. There is also a risk of having an allergic reaction 
to the adhesive tape. If you have an allergy to adhesives, please inform the staff before 
the test. 
 
What are the benefits of taking part? 
We cannot promise we will be able to help you, but, the extended assessment may 
help provide further information about the specific balance strategies patients use when 
walking in challenging outdoor environments. The information from this study will be 
used to develop an advanced balance and walking rehabilitation programme for people 
with stroke. 
 
Will my taking part be kept confidential? 
All information that is collected about you during the course of this research will be kept 
strictly confidential. All information for this project will be stored on password-protected 
computers used only by research staff. Any documents leaving the hospital or testing 
site will have all personal identifiable information removed. 
 
Will my GP or Medical team know about my participation and results of this 
investigation? 
With your permission we would like to share this information with your referring medical 
team. Your GP will be informed of your participation in this study. 
 
Will this affect my current treatment? 
Participating in this study will not affect your current treatment. 
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What happens if there is a problem? 
This study has been reviewed and accepted by the National Hospital for Neurology and 
Neurosurgery and Institute of Neurology Joint Ethics Committee. The consultant in charge 
of this investigation is Dr Doris Eva Bamiou (Consultant in Audiological Medicine, NHNN). 
Other investigators conducting this study are Dr.MarousaPavlouand Dr Isaac Sorinola 
(Lecturers in Physiotherapy, King‘s College London), Dr Ruth Mayagoitia-Hill (Lecturer in 
Assistive Technology, King‘s College London) Mrs. Marniza Omar (Audiologist, PhD 
student at King‘s College London). 
 
If you have any concerns regarding the study please contact Dr MarousaPavlou, the 
physiotherapist who will be leading the testing and who will try to answer your 
questions (contact details below). If you are unhappy and wish to complain formally, 
you can do this through the NHS complaints procedure. Details can be obtained from 
the hospital. 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone‘s negligence, then you may have grounds for legal action 
for compensation against University College London Hospitals NHS Trust, but you may 
have to pay for legal costs. The normal NHS complaints procedure will still be available 
to you.  
 
It is up to you to decide whether to take part or not.  If you decide to take part you are 
still free to withdraw at any time and without giving a reason. A decision to withdraw at 
any time, or a decision not to take part, will not affect the treatment you receive from 
your medical or therapy team in any way. You may withdraw your data from the project 
at any time up until it is transcribed for use in the final report in December 2012. 
 
If you do decide to take part you will be given this information sheet to keep and be 
asked to sign a consent form. Your data will be kept anonymously and will not be 
passed on outside of your medical care team. 
 
Who can I contact for further information? 
If you have any queries please contact either Marniza Omar (Audiologist, PhD student 
at King‘s College London) or Dr MarousaPavlou, the Physiotherapist leading the testing 
for this study.  
 
1.Ms. Marniza Omar 
Centre of Human & Aerospace Physiological Sciences, 
Shepherd‘s House 
Guy‘s Campus, London 
SE1 1UL 
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Phone: Office: 02078486679; mobile: 07970981127 
Email: marniza.omar@kcl.ac.uk 
 
2.DrMarousaPavlou PhD BA MCSP 
King‘s College London 
School of Biomedical and Health Sciences 
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APPENDIX 17 Consent form (Study 2) 
 
Centre Number:       UCLH Project ID 
number: 
Patient Identification Number for this study:    Form version:  
CONSENT FORM 
 
Title of project: Study of free walking in patients with stroke 
Name of Chief Investigator:Dr. Doris-Eva Bamiou, 
Consultant in Audiological Medicine, National Hospital for Neurology and Neurosurgery 
(University College London NHS trust) and Senior Lecturer, Ear Institute (University 
College London) 
          Please initial 
box 
 
1. I confirm that I have read and understood the information sheet dated …….. 




2.  I confirm that I have had sufficient time to consider whether or not I want to 




3. I understand that my participation in this study is voluntary and that I am free 
to withdraw at any time, without giving any reason, and without my medical 
care or legal rights being affected. 
 
4. I understand that sections of my medical notes may be looked at by 
responsible individuals from King‘s College London, The National Hospital 
for Neurology and Neurosurgery or from regulatory authorities where it is 
relevant to my taking part in research.  I give permission for these 
individuals to have access to my records. 
 










Centre Number:       UCLH Project ID 
number: 
Patient Identification Number for this study:    Form version:  
CONSENT FORM 
 
Title of project: Study of free walking in patients with stroke 
 
Name of Principal investigator:Dr. Doris-Eva Bamiou, 
Consultant in Audiological Medicine, National Hospital for Neurology     and 
Neurosurgery (University College London NHS trust) and Senior Lecturer, Ear Institute 
(University College London). 
 
________________  _________________  _____________________ 
Name of patient  Date     Signature 
 
 
______________         _____________________  ______________________ 
Name of Person taking consent Date     Signature 
(if different from researcher) 
 
_______________   ____________________  ______________________ 
Researcher (to be contacted   Date     Signature 
if there are any problems)  
    
Comments or concerns during the study  
If you have any comments or concerns you may discuss these with the investigator.   If 
you wish to go further and complain about any aspect of the way you have been 
approached or treated during the course of the study, you should write or get in touch 
with the Complaints Manager, UCL hospitals.  Please quote the UCLH project number 
at the top this consent form.  
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Study Title:Prevalence of illness behaviour in patients with vestibular migraine and 
vestibular neuritis. 
 
We would like to invite you to take part in a research study in the department of Neuro-otology 
at the National Hospital for Neurology and Neurosurgery.  Please take time to read the 
following information carefully and discuss it with others (friends, relative and your GP)  if you 
wish.  Ask us if there is anything that is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part.  
What is the purpose of the study 
 
The purpose of this research project is to find out relevant information about patients’ 
experience and attitudes in relation to their symptoms of migraine associated dizziness 
and inner ear upsets.  Previous studies have shown that these factors may influence the way 
patients react to their balance disorder.  Very little is known about how the 
patients’understanding of their diagnosis affectstheir balance confidence, mobility and daily 
activities. It is hoped that the outcomes of this study may provide us with useful information to 
develop better treatments for patients with migraine associated dizziness and inner ear upsets.  
Why have I been chosen? 
You have been asked to participate in this study because you are between 18-80 years of age 
and have been diagnosed with either migraine associated dizziness or an inner ear upset. You 
have been referred by your consultant physician. 
Do I have to take part? 
It is up to you to decide whether to take part. We will describe the study to you and then go 
through this information sheet. If you agree to participate we will ask you to give your verbal 
consent and sign a consent form to show that you have agreed to take part. You are free to 
withdraw at any time without giving a reason. This will not affect the standard of care you 
receive. 
What will happen to me if I take part? 
If you decide to take part you will be given a questionnaire (Illness Behaviour 
Questionnaire)during your visit to the Neuro-otology department, NHNN. The completion of 
the questionnaire will not take more than 15 minutes. The questionnaire collects information 
about your experience and attitudes in relation to your symptoms of migraine associated 
dizziness and inner ear upsets. We also will ask you to complete Functional Gait Assessment. 
This test assesses walking ability during different task such as walking over an obstacle or 
walking with head movements in pitch or yaw. The walking test will take approximately 10 
minutes to complete. The whole study will take approximately 30 minutes in addition to your 
visit time at the neuro-otology department. 
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What are the possible disadvantages and risks of taking part. 
You may, on occasions feel unsteady while performing some of the more challenging walking 
tasks. However this should not be greater than the risks you face during your daily activities. 
You will be closely supervised throughout when performing all tests. The procedures 
themselves do not involve pain or discomfort and there are no risks directly associated with the 
study. You will be offered breaks between individual testing sessions.  
What are the possible benefits of taking part? 
 
There will be no direct benefit for you taking part in this study.  However we hope that by 
conducting this study we will learn more about how patients’ with migraine associated dizziness 
and inner ear balance upsetsview their diagnosis and how this affects their confidence and 
mobility. This information may help us to improve our treatment strategies in the future.  
 
What will happen to the results of the research study? 
 
The results are likely to be published in a scientific journal but you will not be identifiable in 
any way. When this study is completed we would like to continue to store your results and to 
hold the data on our computer.  This is because it may be useful to look at the data again in the 
light of discoveries that may be made in the future.  Your medical records will be protected in 
accordance with the European Data Protection legislationbut you may ask for your personal 
information to be removed from the database at any time in accordance with the Data Protection 
Act 1998. Hard copies will be shredded after the storage time is completed. 
Can I withdraw from the study? 
Your participation in this study is entirely voluntary and you may withdraw at any time without 
providing an explanation.  Your decision will not affect any aspect of your healthcare.  
 
What if there is a problem? 
 
This study has been reviewed and accepted by the(the information will be filled once it 
confirm)Committee. The consultant in charge of this investigation is Dr Rosalyn Davies 
(Consultant Audio-Vestibular Physician, NHNN). Other investigators conducting this study are 
Dr.MarousaPavlou (Lecturer in Physiotherapy, King’s College London), Dr. Doris-Eva Bamiou 
(Consultant in Audiovestibular Medicine, NHNN), Mrs. Marniza Omar (Audiologist, PhD student 
at King’s College London) and Mr. Andrew Walker (MSc Student at King’s College London). 
If you have any concerns regarding the study please contact Dr MarousaPavlou, the 
physiotherapist who will be leading the testing and who will try to answer your questions 
(contact details below). If you are unhappy and wish to complain formally, you can do this 
through the NHS complaints procedure. Details as below: 
PALS 
Department of Neuro-otology 
Box 127 
National Hospital for Neurology & Neurosurgery 
Queen Square 
London WC1N 3BG 
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In the event that something does go wrong and you are harmed during the research and this is 
due to someone’s negligence, then you may have grounds for legal action for compensation 
against University College London Hospitals NHS Trust, but you may have to pay for legal 
costs. The normal NHS complaints procedure will still be available to you.  
 
It is up to you to decide whether to take part or not.  If you decide to take part you are still free 
to withdraw at any time and without giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect the treatment you receive from your medical or therapy 
team in any way.  
 
If you do decide to take part you will be given this information sheet to keep and be asked to 
sign a consent form. Your data will be kept anonymously and will not be passed on outside of 
your medical care team. 
 
Who can I contact for further information? 
If you have any queries please contact Dr MarousaPavlou, the Physiotherapist leading the 
testing for this study.  
Dr MarousaPavlou PhD BA MCSP 
King’s College London 
Centre of Human & Aerospace Physiological Sciences, 




Phone: office: 02078486328; mobile: 07834406530 
Email: marousa.pavlou@kcl.ac.uk 
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Title of project: Prevalence of illness behaviour in patients with vestibular 
migraine and vestibular neuritis   
 
Name of Chief Investigator :MarousaPavlou, Lecturer in Physiotherapy. 
 
Name of person completing the form : 
 
Please tick and initial the box: 
           
1. I confirm that I have read and understood the information sheet for the 
above study and have had the opportunity to ask questions. 
  
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care 
or legal rights being affected. 
 
 
3. I understand that sections of any of my medical notes may be looked at 
by responsible individuals from the Neuro-otology Department or from 
regulatory authorities where it is relevant to my taking part in research.  I 
give permission for these individuals to have access to my records, 
which will be kept confidential. 
 
 
Department of Neuro-otology  
 Box 127 
National Hospital for Neurology & 
Neurosurgery 
Queen Square 
London WC1N 3BG     
 
Telephone: 0845 155 5000 Ext 723385 
Direct Line: 020 7692 2375 
Fax:  020 7829 8775 
Web-site: www.uclh.org 
 


















Patient Identification Number: 
UCLH Project ID Number 
 
 
4. I understand that my personal details and information about me that is 
gathered for this research study will be held on a secure, confidential 
computerised database that is only accessible to the Department of 
Neuro-otology. This is in accordance with the Data Protection Act 1998. 
 
 




6. I agree to take part in the study  
 
 
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CONSENT FORM (CONFIDENTIAL) 
 
Title of project:Prevalence of illness behaviour in patients with vestibular 
migraine and vestibular neuritis   
 
Name of Chief Investigator:MarousaPavlou, Lecturer in Physiotherapy. 
 
 
_____________________________  ________ _____________________ 
Name of subject    Date    Signature 
 
 
_____________________________   ________ _____________________ 
Name of Person taking consent  Date    Signature 
(if different from researcher) 
 
 
___________________________  _________ _____________________ 
Researcher (to be contacted                        Date                               Signature 
if there are any problems) 
 
 
Comments or concerns during the study 
 
If you have any comments or concerns you may discuss these with the investigator.  If 
you wish to go further and complain about any aspect of the way you have been 
approached or treated during the course of the study, you should write or get in touch 
with the Complaints Manager, UCL hospitals.  Please quote the UCLH project number 




1 form for Patient 
1 to be kept as part of the study documentation, 
1 to be kept with the hospital notes    
 
 
